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Abstract	  
Chlamydia	   trachomatis	   is	   an	   obligate	   intracellular	   bacterium,	   which	   is	   the	   leading	  
cause	   of	   acquired	   blindness	   and	   the	   most	   prevalent	   bacterial	   sexually	   transmitted	  
infection	  worldwide.	  Chlamydiae	  exist	   in	  two	  distinct	  forms.	  The	   infectious	  spore-­‐like	  
elementary	   bodies	   (EBs)	   that	   invade	   host	   cells	   differentiate	   into	   non-­‐infectious	  
reticulate	   bodies	   (RBs)	   that	   replicate	   intracellularly	   within	   a	   modified	   membrane-­‐
bound	   vacuole	   called	   the	   inclusion.	  Under	   stress,	  Chlamydiae	   can	   enter	   a	   persistent	  
state,	   in	   which	   aberrant	   bodies	   (ABs)	   with	   reduced	   metabolic	   activity	   are	   formed.	  
Surprisingly	   little	   is	   known	   about	   the	   mechanisms	   employed	   by	   the	   bacteria	   to	  
maintain	  and	  manipulate	  their	  environment	  within	  host	  cells.	  This	   thesis	   investigates	  
the	   role	   of	   inorganic	   ions	   in	   sustaining	   the	   inclusion	   throughout	   the	   Chlamydia	  
infection	  cycle.	  
Potassium	  starvation	  of	   intracellular	  RBs	  either	  after	  specific	   ionophore	  treatment	  or	  
inhibition	   of	   inward	   rectifying	   cellular	   potassium	   channels	   induced	   the	   formation	   of	  
ABs,	   which	   no	   longer	   differentiated	   into	   infectious	   EBs.	   These	   data	   demonstrate	   an	  
essential	  role	  for	  potassium	  during	  C.trachomatis	  replication.	  Analysis	  of	  live	  RBs,	  using	  
a	   potassium	   sensitive	   fluorescent	   probe,	   illustrated	   that	   potassium	   is	   actively	  
scavenged	   from	   the	   host	   cell.	   Furthermore,	   when	   bacteria	   undergo	   RB-­‐EB	  
differentiation	   accumulated	   potassium	   is	   released	   prior	   to	   inclusion	   lysis.	  
Experimentally	   reducing	   potassium	   ion	   concentration	   at	   this	   stage	   caused	   cells	   to	  
expel	   bacteria	   in	   bursts.	   This	   event	   is	   distinct	   from	   previously	   described	   extrusion	  
mechanisms,	  where	  either	  the	  inclusion	  is	  released	  intact	  or	  the	  host	  cell	  is	  lysed.	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These	   data	   show	   that	   RBs	   actively	   accumulate	   potassium	   during	   replication,	   with	  
starvation	  leading	  to	  persistence.	  Loss	  of	  potassium	  ions	  during	  re-­‐differentiation	  into	  
EBs	  suggests	  that	  potassium	  efflux	  has	  a	  role	  in	  triggering	  inclusion	  lysis	  or	  bacteria	  exit	  
from	  the	  host	  cell.	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   1,5-­‐bis{[2-­‐(di-­‐methylamino)ethyl]amino}-­‐4,8-­‐dihydroxyanthracene-­‐9,	  
10-­‐dione	  
DTT	   dithiothreitol	  
EB	   elementary	  body	  
EDTA	   ethylenediaminetetraacetic	  acid	  	  
EMS	   ethyl	  methanesulphonate	  
ER	   endoplasmic	  reticulum	  
FBS	   decomplemented	  fetal	  bovine	  serum	  
FITC	   fluorescein	  isothiocyanate	  
FOV	   field	  of	  view	  
FRAP	   fluorescence	  recovery	  after	  photobleaching	  
GCIP	   grap2	  cyclin	  D-­‐interacting	  protein	  
GFP	   green	  fluorescent	  protein	  
GTPases	   guanosine	  5’-­‐triphosphotases	  
H+	   hydrogen	  ions	  
HBSS	   Hank's	  balanced	  salt	  solution	  
HF-­‐12	   Ham	  F-­‐12	  nutrient	  mix	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Hoechst	   bisbenzimide	  H	  33342	  trihydrochloride	  
hpi	   hours	  post	  infection	  
IFN-­‐	  γ	   interferon-­‐γ	  
IFs	   intermediate	  filaments	  
IFU	   inclusion	  forming	  unit	  
IgG	   Immunoglobulin	  G	  
K+	   potassium	  ions	  
Kir	   inwardly	  rectifying	  K+	  channels	  	  
LAMP	   lysosome-­‐associated	  membrane	  protein	  	  
LGV	   lymphogranuloma	  venereum	  
LPS	   lipopolysaccharide	  
MOI	   multiplicity	  of	  infection	  (per	  cell)	  
MOMP	   major	  outer	  membrane	  protein	  
MTOC	   microtubule	  organising	  centre	  
MVB	   multivesicular	  bodies	  
MYPT1	   myosin	  phosphatase	  target	  subunit	  1	  	  
N-­‐WASP	   neuronal	  Wiskott-­‐Aldrich	  syndrome	  protein	  	  
Na+	   sodium	  ions	  
NAATs	   nucleic	  acid	  amplification	  tests	  
NF-­‐κB	   nuclear	  factor-­‐κB	  
NO2-­‐	   nitrite	  ions	  
Omp	   outer	  membrane	  protein	  
ORF	   open	  reading	  frame	  
PBFI	   potassium	  binding	  benzofuran	  isophthalate	  	  
PBS	   phosphate	  buffered	  saline	  
PCR	   polymerase	  chain	  reaction	  
PFA	   paraformaldehyde	  
PID	   pelvic	  inflammatory	  disease	  
PLT	   psittacosis-­‐lymphogranuloma	  venereum-­‐trachoma	  
Pmps	   polymorphic	  membrane	  proteins	  
PRRs	   pathogen	  recognition	  receptors	  
RB	   reticulate	  body	  
RNA	   ribonucleic	  acid	  
ROI	   region	  of	  interest	  
RT	   room	  temperature	  
SBFI	   sodium	  binding	  benzofuran	  isophthalate	  	  
SNARE	   soluble	  NSF	  attachment	  protein	  receptor	  
SPG	   sucrose-­‐phosphate-­‐glutamic	  acid	  buffer	  
STI	   sexually	  transmitted	  infection	  
SUR	   sulphonylurea	  receptor	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T2SS	   type	  II	  secretion	  system	  
T3SS	   type	  III	  secretion	  system	  
TARP	   translocated	  actin	  recruitment	  protein	  
TRIC	   trachoma	  and	  inclusion	  conjunctivitis	  
Tris	   tris(hydroxymethyl)aminomethane	  	  
U	   units	  
WGA	   wheat	  germ	  agglutinin	  AlexaFluor®	  594	  conjugate	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1.1 Taxonomy	  
The	   Chlamydiaceae	   are	   a	   family	   of	   obligate	   intracellular	   bacterial	   pathogens.	   The	  
Chlamydiaceae	   share	   a	   biphasic	   developmental	   cycle	   that	   occurs	   within	   a	   unique	  
membrane	  bound	  compartment,	  termed	  an	  inclusion,	  within	  host	  cells.	  First	  described	  
in	  1907	  by	  Halberstaedter	  and	  von	  Prowazek	  the	  Chlamydiaceae	  historically	  comprised	  
a	   single	   genus,	   divided	   into	   two	   species.	   Bacteria	   that	   produced	   uniformly	   round	  
inclusions	   that	   contained	   electron	   dense	   glycogen,	   which	   were	   known	   as	   trachoma	  
and	  inclusion	  conjunctivitis	  (TRIC),	  were	  termed	  Chlamydia	  trachomatis.	  Bacteria	  from	  
the	   species	   known	  as	  psittacosis-­‐lymphogranuloma	  venereum-­‐trachoma	   (PLT),	  which	  
inhabit	   irregular	   inclusions	   that	   do	   not	   contain	   glycogen,	   were	   termed	   Chlamydia	  
psittaci	   (Gordon	   and	   Quan,	   1965).	   Initially	   the	   Chlamydiaceae	   were	   classified	   as	  
viruses,	  however	  as	  understanding	  of	  the	  developmental	  cycle	  progressed,	   it	  became	  
apparent	   that	   these	   organisms	   appeared	   more	   like	   bacteria.	   For	   example,	   cell	  
envelopes	  were	  comparable	   in	   structure	   to	  Gram-­‐negative	  bacteria	   (Moulder,	  1966),	  
and	   they	   reproduce	   by	   binary	   fission,	   unlike	   viruses	   (Higashi,	   1965;	  Moulder,	   1966).	  
The	  Chlamydiaceae	  were	  then	  reclassified	  to	  the	  kingdom	  bacteria.	  	  
Phylogenetic	   comparison	   of	   16S	   rRNA	   divided	   the	   family	   Chlamydiaceae	   into	   two	  
genera	   (Figure	  1.1).	  The	  Chlamydia	  genus	  contains	  all	   species	  previously	  classified	  as	  
C.trachomatis,	  and	  the	  Chlamydophila	  genus	  contains	  all	  C.psittaci	  species	  (Everett	  et	  
al.,	   1999;	   Bush	   and	   Everett,	   2001).	   However	   this	   new	   classification	   remains	  
controversial.	   Stephens	  et	  al.	   (2009)	   suggest	   that	   the	  genus	  demarcation	   is	   arbitrary	  
due	   to	   the	   fact	   that	   the	   16S	   rRNA	   homology	   between	   the	   proposed	  Chlamydia	  and	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Figure	   1.1.	   Bush	   and	   Everett	   taxonomic	   structure	   of	   the	   order	   Chlamydiales.	  
Adapted	   from	   Bush	   and	   Everett,	   1999.	   (A)	   Historical	   taxonomy	   including	   TRIC	  
(C.trachomatis)	   and	   PLT	   (C.psittaci)	   pathogens.	   (B)	   Typical	   hosts	   for	  Chlamydiaceae	  
species.	  (C)	  Everett	  et	  al.	  Chlamydiales	  taxonomy.	  
	  
	  
	  	   22	  
Chlamydophila	  genera	  is	  96%,	  which	  is	  the	  same	  as	  homology	  between	  both	  C.felis	  and	  
C.pecorum,	   and	   C.pecorum	   and	   C.pneumoniae,	   which	   are	   not	   allocated	   to	   separate	  
genera.	  This	  viewpoint	  led	  them	  to	  propose	  a	  simplified	  single	  genus,	  multiple	  species	  
phylogenetic	   structure	   (Figure	   1.2).	   Like	   the	   Everett	   et	   al.	   (1999)	   classification,	   this	  
single	  genus	  phylogeny	  has	  yet	  to	  be	  universally	  accepted,	  and	  the	  current	   literature	  
remains	   divided.	   For	   the	   purpose	   of	   this	   introduction	   the	   Everett	   et	   al.	   (1999)	  
classification	   system,	   as	   depicted	   in	   Figure	   1.1,	   will	   be	   used,	   as	   it	   is	   the	   current	  
taxonomic	   structure	  of	   the	  Chlamydiales	  published	   in	   the	   second	  edition	  of	  Bergey’s	  
Manual	  of	  Systematic	  Bacteriology	  (Corsaro	  et	  al.,	  2003).	  
	  
1.2 Genomics	  
The	   Chlamydiaceae	   present	   a	   considerable	   challenge	   to	   researchers	   due	   to	   several	  
technical	   limitations.	   Firstly,	   owing	   to	   the	   obligate	   intracellular	   nature	   of	   the	  
Chlamydiaceae,	   the	   bacteria	  must	   be	   propagated	   using	   suitable	   cultured	   eukaryotic	  
cells.	  	  HeLa	  and	  McCoy	  cell	  lines	  are	  traditionally	  used,	  however	  these	  do	  not	  perfectly	  
represent	   the	   polarised	   epithelia	   the	   bacteria	   would	   encounter	   under	   physiological	  
conditions	   (Dautry-­‐Varsat	   et	   al.,	   2005),	   which	   must	   be	   taken	   into	   account	   when	  
interpreting	  experimental	   results.	   Secondly,	  Chlamydiae	  are	   intractable	   to	   traditional	  
methods	  of	  genetic	  manipulation,	  such	  as	  deletion	  or	  inactivation	  of	  genes,	  therefore	  
mutated	   strains	   are	   difficult	   to	   obtain.	   Clinical	   strains	   containing	   natural	   mutations	  
have	  been	  successfully	   isolated,	  and	  subsequent	  characterisation	  has	  provided	  useful	  
insight	   into	   the	   chlamydial	   lifecycle.	   For	   example,	   non-­‐fusogenic	   C.trachomatis	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Figure	   1.2.	   Chlamydia	   species	   tree	   showing	   percentage	   homology	   between	   16S	  
rRNA	  genes.	  Adapted	  from	  Bush	  et	  al.,	  2009.	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variants,	  i.e.	  bacteria	  that	  remained	  in	  multiple	  individual	  inclusions	  within	  a	  host	  cell,	  
had	  a	  variety	  of	  mutations	  within	  the	   IncA	  gene	  (Suchland	  et	  al.,	  2000;	  Geisler	  et	  al.,	  
2001),	   demonstrating	   a	   role	   for	   the	   IncA	   inclusion	   protein	   in	   vesicle	   fusion.	  
Transformation	  of	  C.trachomatis	  has	  been	  demonstrated	  using	  shuttle	  vectors,	  based	  
on	   the	   C.trachomatis	   LGV2	   plasmid	   and	   Escherichia	   coli	   plasmid	   pBR325.	   This	   was	  
verified	   by	   the	   production	   of	   bacteria	   expressing	   green	   fluorescent	   protein	   (GFP)	  
(Wang	   et	   al.,	   2011;	   Ding	   et	   al.,	   2013;	   Bauler	   and	   Hackstadt,	   2014).	   Chemical	  
mutagenesis,	   using	   mutagens	   such	   as	   ethyl	   methanesulphonate,	   has	   been	   used	   to	  
create	   strains	  with	  between	  3	   and	  30	  mutations	  per	   chlamydial	   genome	   (Kari	  et	  al.,	  
2011;	   Nguyen	   and	   Valdivia,	   2012;	   2013).	   Targeted	   null	  mutants	   can	   be	   obtained	   by	  
screening	  EMS	  mutagenised	  strains	  using	  CEL	  1	  digestion	  to	  identify	  single	  nucleotide	  
polymorphisms	   in	   the	   target	   gene	   (Kari	   et	   al.,	   2011).	  Whole	   genome	   sequencing	   of	  
these	   strains	   has	   enabled	   phenotype-­‐genotype	   comparisons	   and	   could	   eventually	  
provide	  insight	  into	  chlamydial	  gene	  functions.	  	  
The	   Chlamydia	   trachomatis	   genome	   consists	   of	   a	   1,042,519	   base	   pair	   (bp)	  
chromosome	  and	  a	  7493bp	  plasmid	  which	  encodes	  894	  potential	  open	  reading	  frames	  
(ORFs)	  (Stephens	  et	  al.,	  1998;	  Kalman	  et	  al.,	  1999).	  This	   is	  significantly	  different	  from	  
the	  1,230,230bp	  Chlamydophila	  pneumoniae	  genome	  with	  1,073	   likely	  ORFs	   (Kalman	  
et	  al.,	  1999).	  Analysis	  of	  both	  genomes	  revealed	  a	  number	  of	  conserved	  areas,	  such	  as	  
three	  distinct	  chromosomal	  locations	  encoding	  a	  type	  III	  secretion	  system	  (T3SS)	  (Hsia	  
et	   al.,	  1997;	   Kalman	   et	   al.,	   1999).	   In	   fact,	  C.trachomatis	   serovar	   D	  dedicates	   almost	  
10%	   of	   the	   894	   ORFs	   to	   encode	   the	   components	   of	   the	   T3SS	   (Betts-­‐Hampkian	   and	  
Fields,	   2010).	   T3SS	   is	   a	   complex	   protein	   transport	   system	   common	   to	   a	   number	   of	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pathogenic	   Gram-­‐negative	   bacteria	   including	   Salmonella	   enterica,	   Pseudomonas	  
aeruginosa,	   and	   Yersinia	   spp.	   (Hueck,	   1998;	   Kubori	   et	   al.,	   1998;	   Galán	   and	   Collmer,	  
1999).	  Although	  core	  components	  of	  the	  T3SS	  appear	  to	  be	  conserved	  among	  Gram-­‐
negative	   bacteria,	   the	   chlamydial	   T3SS	   contain	   distinct	   features	   due	   to	   the	   unique	  
chlamydial	  development	  cycle	  (Galán	  and	  Collmer,	  1999;	  Büttner,	  2012;	  Mueller	  et	  al.,	  
2014).	  	  
T3SS	   systems	   have	   evolved	   to	   facilitate	   the	   translocation	   of	   virulence	   factors	   and	  
effector	  proteins	  across	  the	  inner	  membrane,	  periplasmic	  space,	  and	  outer	  membrane	  
of	  the	  bacterial	  cell	  envelope	  into	  either	  host	  cells	  or	  extracellular	  space	  independently	  
of	  sec	  mediated	  secretion	  systems	  (i.e.	  type	  II	  secretion	  system	  [T2SS])	  (Hueck,	  1998;	  
Tseng	   et	   al.,	   2009).	   The	   basic	   components	   of	   T3SS	   apparatus	   have	   been	   well	  
characterised.	   The	   apparatus	   comprises	   of	   a	  membrane-­‐spanning	   assembly	   of	  more	  
than	   20	   proteins	   including	   two	   upper	   rings,	   which	   interact	   with	   the	   bacterial	   outer	  
membrane,	  and	  two	  inner	  rings,	  which	  integrate	  into	  the	  cytoplasmic	  membrane.	  This	  
is	  often	  referred	  to	  as	  the	  injectisome,	  and	  resembles	  a	  flagellar	  basal	  body	  (Galán	  and	  
Collmer,	   1999;	   Büttner,	   2012;	   Mueller	   et	   al.,	   2014).	   Proteins	   are	   transported	   via	   a	  
needle-­‐like	   complex,	  which	   is	   80nm	   long	  and	  13nm	  wide	   in	  Salmonella	   typhimurium	  
(Kubori	   et	   al.,	   1998).	   Rosqvist	   et	   al.	   (1995)	   showed	   that,	   although	   there	   are	   no	  
common	   peptide	   sequences,	   proteins	   transported	   by	   T3SS	   can	   be	   exported	   by	  
pathogens	  that	  employ	  a	  heterologous	  T3SS.	  For	  example,	  Shigella	  flexneri	  IpaB	  will	  be	  
translocated	  by	  Yersinia	  pseudotuberculosis.	  Protein	  secretion	  is	  mediated	  by	  a	  diverse	  
range	  of	  specific	  chaperones,	  which	  maintain	  partially	  unfolded	  substrates	  and	  target	  
them	   for	   secretion	   (Mueller	   et.al.,	   2014).	   Effector	   protein	   secretion	   is	   regulated	   by	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ATPases	   (Buttner,	   2012).	   In	   C.pneumoniae,	   CdsN	   has	   been	   identified	   as	   the	   T3SS	  
ATPase	  based	  on	  sequence	  similarity	  to	  T3SS	  ATPases	  and	   interaction	  with	  structural	  
components	   of	   the	   T3SS	   basal	   body	   and	   T3SS	   chaperones	   (Stone	   et	   al.,	   2008).	   The	  
conservation	   of	   T3SS	   apparatus	   across	   the	   Chlamydiaceae	   genus	   reinforces	   the	  
fundamental	  importance	  of	  protein	  secretion	  to	  the	  intracellular	  survival	  of	  bacteria.	  	  
In	   most	   Gram-­‐negative	   bacteria	   T3SS	   encoding	   genes	   are	   often	   located	   within	  
pathogenicity	  islands,	  a	  set	  of	  virulence	  genes	  that	  are	  unique	  to	  pathogenic	  bacteria	  
(Groisman	   and	   Ochman	   et	   al.,	   1996).	   In	   chlamydial	   systems	   however,	   T3SS	   effector	  
genes	   appear	   dispersed,	   and	   structural	   components	   occur	   in	   three	   distinct	  
chromosomal	   loci	   (Kalman	   et	   al.,	   1999;	   Harris	   et	   al.,	   2012;	   Mueller,	   2014).	   The	  
incorporation	  of	  virulence	  genes	  into	  bacterial	  pathogens	  by	  horizontal	  gene	  transfer	  is	  
thought	  to	  be	  an	  important	  step	  in	  the	  coevolution	  of	  bacteria	  and	  their	  specific	  hosts	  
(Groisman	  and	  Ochman	  et	  al.,	  1996;	  Harris	  et	  al.,	  2012).	  
	  
1.3 Pathogenesis	  
The	  Chlamydiaceae	  family	  contains	  pathogens	  specifically	  adapted	  to	  a	  wide	  range	  of	  
hosts.	   This	   thesis	   is	   primarily	   concerned	   with	   species	   that	   cause	   human	   infection	  
therefore	   the	   following	   section	   will	   introduce	   the	   most	   common	   human	   pathogens	  
Chlamydia	  trachomatis	  and	  Chlamydophila	  pneumoniae,	  as	  well	  as	  animal	  pathogens	  
which	  have	  been	  used	  as	  model	  infections.	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1.3.1	  Chlamydia	  trachomatis	  
Chlamydia	   trachomatis	   serovars	   comprise	   two	   disease	   biovars:	   trachoma,	   which	  
contains	   both	   ocular	   and	   urogenital	   serovars,	   and	   lymphogranuloma	   venereum	  
(LGV)(Table	  1.1).	  	  
biovar	   serovars	   target	  cells	   sequelae	  
trachoma	  
(ocular)	   A,	  B,	  Ba,	  C	   conjunctival	  epithelia	  
conjunctivitis,	  conjunctival	  
scarring	  and	  fibrosis,	  
trichiasis,	  and	  corneal	  opacity	  
trachoma	  
(urogenital)	  
D,	  E,	  F,	  G,	  
H,	  I,	  Ia,	  K	   genital	  epithelia	  
♂: urethritis, prostatitis, 
epididymitis, infertility?  




LGV	   L1,	  L2,	  L2a,	  L3	   genital	  epithelia	  
genital	  lesions,	  
lymphadenopathy,	  proctatitis	  
Table	  1.1.	  Chlamydia	  trachomatis	  biovars.	  C.trachomatis	  serotypes	  and	  consequences	  of	  infection	  for	  
men	  (♂)	  and	  women	  (♀).	  
	  
Trachoma	   is	   the	   leading	   cause	   of	   preventable	   blindness	   in	   developing	   countries.	  
Repeated	  inflammation	  of	  the	  conjunctiva	  coupled	  with	  trichiasis,	  the	  inversion	  of	  the	  
eyelashes,	   leads	  to	  corneal	  scarring	  and	  eventual	  blindness	   (Hu	  et	  al.,	  2010).	   In	  2011	  
an	  estimated	  1.2	  million	  individuals	  were	  suffering	  from	  total	  blindness	  and	  a	  further	  1	  
million	   with	   partial	   blindness	   as	   a	   result	   of	   chronic	   C.trachomatis	   infection	   (WHO,	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2012).	  Trachoma	  is	  spread	  by	  contact	  and	  is	  endemic	  in	  countries	  with	  limited	  access	  
to	  clean	  water	  and	  antibiotics.	  	  
C.trachomatis	  trachoma	  biovar	  is	  also	  the	  most	  common	  bacterial	  sexually	  transmitted	  
infection	   (STI)	   globally.	   Treatment	   of	   urogenital	   Chlamydia	   infections,	   and	   all	  
associated	  conditions,	  costs	  as	  much	  as	  $4	  billion	  annually	  in	  the	  USA	  (Stamm,	  1999).	  
In	   2005	   the	   World	   Health	   Organisation	   (WHO)	   reported	   101	   million	   new	   cases	   of	  
C.trachomatis	  infection	  worldwide	  (WHO,	  2011),	  the	  majority	  of	  which	  were	  reported	  
in	   the	   Indian	   subcontinent	   and	   south	   east	   Asia.	   C.trachomatis	   infections	   are	   an	  
increasing	  global	  problem.	  Between	  1996	  and	  2001	  cases	  of	  genital	  Chlamydia	  more	  
than	   doubled	   and	   in	   August	   2002	   Chlamydia	   diagnoses	   outnumbered	   infections	  
associated	   with	   any	   other	   pathogen	   (Eley,	   2003).	   It	   is	   estimated	   that	   urogenital	  
trachoma	  infections	  in	  Europe	  affect	  1-­‐3%	  of	  the	  population	  aged	  between	  18	  and	  44	  
(Howie	   et	   al.,	   2011)	   however,	   the	   majority	   of	   genital	   C.trachomatis	   infections	   are	  
asymptomatic	  which	  makes	  an	  exact	  figure	  impossible	  to	  estimate.	  The	  asymptomatic	  
nature	  of	  the	  genital	  tract	   infections	  increases	  the	  risk	  of	  complications	  as	  a	  result	  of	  
chronic	   infection.	   In	  women	  C.trachomatis	  causes	   salpingitis	  and	  cervicitis	  which	  can	  
lead	   to	   tubal	   scarring	   and	   pelvic	   inflammatory	   disease	   (PID)	   resulting	   in	   ectopic	  
pregnancies	  and	  in	  some	  cases	  infertility	  (Gottlieb	  et	  al.,	  2010;	  Stamm,	  1999).	  Between	  
18	  and	  50%	  of	   infants	  born	   to	  mothers	   infected	  with	  genital	  Chlamydia	  will	   develop	  
chlamydial	   conjunctivitis	   within	   6	   months	   of	   birth,	   and	   between	   3	   and	   20%	   will	  
develop	  pneumonia	  (Numazaki	  et	  al.,	  1989).	  C.trachomatis	  infections	  have	  been	  linked	  
to	  increased	  risk	  of	  squamous-­‐cell	  carcinoma	  of	  the	  cervix	  and	  have	  been	  implicated	  in	  
facilitated	   transmission	   of	   human	   immunodeficiency	   virus	   1	   and	   human	   papilloma	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virus	   (Malhotra	  et	  al.,	  2013).	   In	  men	  up	  to	  50%	  of	   reported	  cases	  of	  non-­‐gonococcal	  
urethritis	   can	   be	   attributed	   to	   C.trachomatis	   (Oriel,	   1992)	   however	   a	   link	   between	  
C.trachomatis	   infection	   and	   male	   infertility	   remains	   controversial.	   Incubation	   of	  
human	   sperm	   with	   chlamydial	   lipopolysaccharide	   (LPS),	   an	   endotoxin	   found	   in	   the	  
bacterial	   envelope,	   was	   shown	   to	   cause	   apoptosis	   (Eley	   et	   al.,	   2005),	   however	   the	  
physiological	  relevance	  of	  this	  remains	  disputed.	  	  
LGV	  serovar	  STIs	  cause	  chronic	  infection	  of	  the	  lymphatic	  system,	  characterised	  by	  the	  
swelling	  of	  lymph	  nodes.	  LGV	  often	  presents	  as	  severe	  proctitis	  (White,	  2009).	  LGV	  was	  
considered	  rare	  prior	  to	  an	  outbreak	  in	  the	  Netherlands	  in	  2004.	  It	  is	  now	  prevalent	  in	  
industrialised	  countries	  amongst	  homosexual	  men	  (White,	  2009).	  	  
Prior	   to	   the	   introduction	   of	   nucleic	   acid	   amplification	   tests	   (NAATs)	   chlamydial	  
infections	  were	  difficult	  to	  diagnose.	  Clinical	  diagnosis	  relied	  on	  cell	  culture	  methods,	  
which	   required	   viable	   bacteria,	   and	   various	   immunofluorescence	   techniques,	   which	  
were	   insensitive	   to	   low	   titres	   of	   infection.	   There	   are	   a	   number	   of	   different	   NAATs	  
available,	  with	  the	  most	  common	  being	  polymerase	  chain	  reaction	  (PCR)	  amplification	  
of	  chlamydial	  ompA.	  This	  has	  also	  been	  used	  to	  serotype	  infections	  (Jalal	  et	  al.,	  2007),	  
however	  recent	  comparison	  of	  whole	  genomes	  from	  clinical	  isolates	  suggest	  that	  there	  
is	   significant	   intra-­‐serovar	   recombination	   and	   exchange	   of	   ompA,	   which	   renders	  
current	  serotyping	  misleading	  (Harris	  et	  al.,	  2012).	  	  
Chronic	   and	   repeat	   ocular	   and	   genital	   Chlamydia	   infections	   have	   severe	   long-­‐term	  
effects	  as	  a	  result	  of	  inflammation	  and	  immune	  system	  activation	  (Stephens,	  2003).	  As	  
much	   as	   50%	   of	   reactive	   arthritis	   cases	   can	   be	   attributed	   to	   chronic	   C.trachomatis	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genital	   infection	  (Carter	  et	  al.,	  2012).	  Literature	  often	  cites	  that	  PID,	  and	  consequent	  
female	   infertility,	   is	   caused	   by	   scarring	   as	   a	   result	   of	   tissue	   damage	   following	   an	  
inflammatory	   response	   to	   chlamydial	   infection.	   However,	   approximately	   80%	   of	  
women	  diagnosed	  with	  a	  chlamydial	  infection	  will	  not	  develop	  PID,	  and	  many	  will	  clear	  
an	  infection	  without	  sustaining	  tissue	  damage	  (Taylor	  et	  al.,	  2011).	  The	  mechanisms	  of	  
tissue	   damage	   and	   the	   immunopathology	   of	   chlamydial	   infections	   are	   not	   fully	  
understood.	   Histopathological	   analyses	   of	   both	   natural	   and	   experimental	   chlamydial	  
infections	   showed	   cellular	   infiltration	   of	   polymorphonuclear	   neutrophils	   and	  
lymphocytes	   at	   the	   site	   of	   infection	   (Stephens,	   2003).	   This	   chronic	   inflammatory	  
response	   causes	   damage	   to	   the	   epithelium	   leading	   to	   the	   formation	   of	   scars.	  
Chlamydial	  protease-­‐like	  activity	   factor	   (CPAF),	   chlamydial	  protein	  CT795,	  and	  60kDa	  
chlamydial	  heat	  shock	  protein	  (cHsp60)	  can	  all	  induce	  a	  humoral	  immune	  response	  in	  
samples	   from	  patients	  with	   inflammatory	   trachoma	   (Skwor	  et	  al.,	  2010)	  and	  purified	  
cHsp60	  can	  activate	  nuclear	  factor-­‐κB	  (NF-­‐κB),	  and	  therefore	  induce	  the	  production	  of	  
pro-­‐inflammatory	   cytokines,	   in	   non-­‐immune	   cells	   (Stephens,	   2003).	   The	   range	   of	  
sequelae	   observed	   between	   individuals	   suggests	   differences	   in	   susceptibility	   to	  
scarring	  and	  fibrosis	  (Stephens,	  2003).	  	  
1.3.2	  Chlamydophila	  pneumoniae	  
Chlamydophila	  pneumoniae	  is	  the	  causative	  agent	  of	  atypical	  pneumonia,	  and	  is	  linked	  
to	  asthma,	  bronchitis,	  and	  obstructive	  pulmonary	  disease	  (Honarmand,	  2013;	  Roulis	  et	  
al.,	  2013).	  As	  observed	  in	  C.trachomatis	  infection,	  chronic	  C.pneumoniae	  infection	  has	  
been	   implicated	   in	  reactive	  arthritis	   (Carter	  et	  al.,	  2012;	  Roulis	  et	  al.,	  2013).	  Another	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controversial	   sequela	  of	  C.pneumoniae	   infection	   is	  atherosclerosis,	  and	  consequently	  
coronary	   heart	   disease	   (Honarmand,	   2013;	   Roulis	   et	   al.,	   2013).	   C.pneumoniae	   has	  
recently	   been	   identified	   as	   a	   zoonotic	   pathogen	   infecting	   amphibians,	   reptiles,	   and	  
mammals	  such	  as	  koalas	  and	  horses	  (Roulis	  et	  al.,	  2013).	  	  
1.3.3	  Animal	  pathogens	  
Chlamydia	   muridarum,	   the	   causative	   agent	   of	   mouse	   pneumonitis,	   which	   naturally	  
infects	  rodents	  (Figure	  1.1).	  C.muridarum	  infection	  of	  mice	  is	  a	  useful	  animal	  model	  for	  
exploring	   C.trachomatis	   pathogenesis	   (Barron	   et	   al.,	   1981).	   Similarly,	   Chlamydophila	  
caveae	   infection	   of	   guinea	   pigs	   has	   been	   used	   as	   a	   model	   for	   human	   genital	  
C.trachomatis	  infections.	  
Chlamydophila	   psittaci	   is	   predominantly	   an	   avian	   pathogen,	   however	   it	   can	   be	  
transmitted	  to	  humans	  by	  exposure	  to	  aerosolised	  bird	  excreta	  (Escalante-­‐Ochoa	  et	  al.,	  
1998;	  Moroney	  et	  al.,	  1998).	  The	  incidence	  of	  psittacosis	   in	  humans	  is	  relatively	  rare.	  
Outbreaks	   can	   usually	   be	   traced	   back	   to	   infected	   domestic	   birds	   or	   occupational	  
exposure,	   to	   ducks	   and	   turkeys	   in	   particular	   (Moroney	   et	   al.,	   1998).	   In	   humans	  
C.psittaci	   infections	   present	   as	   atypical	   pneumonias	   and	   fevers	   but	   vary	   greatly	   in	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1.4	   Prevention	  and	  control	  
Advances	   in	  speed	  and	  sensitivity	  of	  diagnostic	  techniques	  following	  the	   introduction	  
of	  NAATs	  led	  to	  the	  initiation	  screening	  programmes	  to	  limit	  the	  spread	  of	  Chlamydia	  
infections.	   However,	   the	   efficacy	   of	   screening	   as	   a	   tool	   to	   restrict	   the	   spread	   of	  
chlamydial	  infections	  is	  disputed	  (Jamil	  et	  al.,	  2013).	  Strategies	  such	  as	  SAFE	  (Surgery,	  
Antibiotics,	   Facial	   cleanliness,	   Environmental	   improvement)	   in	   trachoma	   endemic	  
countries	   have	   been	   introduced	   by	   WHO	   to	   treat	   infected	   individuals,	   reduce	   the	  
reservoir	   of	   infection,	   and	   prevent	   the	   spread	   of	   infections.	   These	   measures	   are	  
contributing	  to	  achieving	  the	  objective	  of	  the	  global	  WHO	  alliance	  for	  the	  elimination	  
of	  blinding	  trachoma	  by	  2020	  (WHO,	  2012).	  	  
Clinical	  C.trachomatis	  STIs	  are	  treated	  using	  tetracycline	  antibiotics,	  which	  bind	  to	  16S	  
rRNA,	   preventing	   bacterial	   protein	   synthesis	   (Brodersen	   et	   al.,	   2000).	   Tetracycline	  
resistance	  has	  been	  observed	   in	  a	  number	  of	  bacterial	  species	   including	  Helicobacter	  
pylori	   (Gerrits	  et	   al.,	   2002),	  which	  had	   a	  mutation	   in	   the	  16S	   rRNA	  gene.	  Reports	   of	  
tetracycline	  resistant	  strains	  of	  C.trachomatis	  from	  the	  USA	  and	  France	  have	  yet	  to	  be	  
confirmed	   in	  vitro	  (O’Neill	  et	  al.,	  2013),	  however	  mutations	  in	  the	  tetC	  gene	  of	  C.suis	  
has	  been	  shown	  to	  confer	  tetracycline	  resistance	  (Dugan	  et	  al.,	  2004).	  Recent	  whole-­‐
genome	   analysis	   of	   a	   large	   number	   of	   clinical	   C.trachomatis	   isolates	   has	   shown	   a	  
surprising	   degree	   of	   horizontal	   gene	   transfer	   among	   bacteria	   (Harris	   et	   al.,	   2012)	  
which,	   given	   the	   worldwide	   prevalence	   of	   chlamydial	   infections,	   could	   indicate	   a	  
potential	  challenge	  in	  the	  control	  and	  treatment	  of	  chlamydial	  infections.	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The	  ideal	  method	  for	  controlling	  Chlamydia	  transmission	  would	  be	  the	  development	  of	  
a	  vaccine.	  Early	   studies	  using	   inoculation	  with	   inactivated	  bacteria	  had	  some	  success	  
controlling	   animal	   infection.	   However,	   only	   short-­‐term	   protection	   against	   ocular	  
infection	  was	  observed	   in	  humans,	  and	  re-­‐infection	  produced	  exacerbated	  disease	   in	  
some	   individuals	   (Longbottom,	   2003).	   Chlamydial	   major	   outer	   membrane	   protein	  
(MOMP),	  a	  major	  component	  of	  the	  bacterial	  membrane,	  was	  shown	  to	  illicit	  a	  strong	  
humoral	   immune	   response,	   and	   has	   been	   the	   focus	   of	   a	   number	   of	   vaccine	  
development	   programmes,	   along	   with	   polymorphic	   membrane	   proteins	   (Pmps)	   and	  
cHsp60	   (reviewed	   by	   Longbottom,	   2003).	   A	   greater	   understanding	   of	   the	   complex	  
chlamydial	  lifecycle	  would	  increase	  the	  likelihood	  of	  effective	  vaccine	  development.	  
	  
1.5	   Lifecycle	  
The	  Chlamydiaceae	  share	  a	  unique	  infection	  cycle,	  comprising	  of	  two	  functionally	  and	  
morphologically	  distinct	  developmental	   forms	   (Moulder,	  1991).	   It	   is	   thought	   that	   the	  
two	  different	  forms	  are	  the	  result	  of	  the	  differing	  pressures	  exerted	  on	  the	  bacteria	  in	  
the	  extracellular	  and	  intracellular	  environments	  encountered	  during	  the	  infection	  cycle	  
(Liu	  et	  al.,	  2010).	  
1.5.1.	   Elementary	  body	  (EB)	  
Extracellular	  Chlamydiaceae	  exist	   as	   elementary	   bodies	   (EBs).	   EBs	   are	   the	   infectious	  
form	  of	  the	  bacteria,	  which	  are	  metabolically	  inert	  but	  capable	  of	  surviving	  outside	  the	  
host	  cell.	  Bacteria	  exist	  as	  EBs	  both	  at	  the	  beginning	  of	  the	  infection	  cycle,	  prior	  to	  host	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cell	   invasion,	  and	  at	  the	  end	  before	  bacteria	  are	  released	  to	  propagate	  infection.	  EBs	  
are	  approximately	  0.3µm	  in	  diameter	  and	  bound	  by	  a	  double	  membrane	  (Friis,	  1972).	  
Bacterial	   rigidity	   is	   maintained	   by	   an	   N-­‐lauroyl	   sarcosine	   insoluble	   ‘P-­‐layer’,	   rich	   in	  
cysteine	   cross-­‐linked	   proteins,	   known	   as	   the	   chlamydial	   outer	   membrane	   complex	  
(COMC).	  More	   than	   60%	  of	   the	   COMC	   is	   comprised	   of	  MOMP	  monomers	   that	   form	  
extensive	   disulphide	   bonds	   (Caldwell	   et	   al.,	   1981;	   Hatch,	   1996;	   Liu	   et	   al.,	   2010).	  
Chlamydial	   PmpD	   has	   also	   been	   identified	   within	   the	   COMC,	   along	   with	   other	  
hypothetical	   C.trachomatis	   (CT)	   proteins	   predicted	   to	   localise	   to	   the	   EB	   surface,	  
including	   CTL0493	   and	   CTL0645	   from	   the	   outer	   membrane	   protein	   (Omp)	   85	  
superfamily	  (Liu	  et	  al.,	  2010).	  This	  rigid	  structure	  appears	  to	  protect	  the	  bacteria	  from	  
osmotic	   lysis	   during	   transmission	   (Kaul	   et	   al.,	  1997;	   Liu	   et	   al.,	  2010).	   Ultrastructural	  
observation	  of	  EBs	  revealed	  spiky	  projections	  from	  the	  outer	  membrane	  (Fields	  et	  al.,	  
2003),	   which	   are	   predicted	   to	   be	   preformed	   T3SS	   needles	   necessary	   for	   inducing	  
bacterial	   internalisation	  by	  host	  cells.	  (Figure	  1.3A/B).	  EBs	  contain	  an	  electron	  dense,	  
condensed	  nucleoid	  containing	  chlamydial	  histone	  H1-­‐like	  proteins	  Hc1	  and	  Hc2,	  which	  
have	  been	  shown	  to	  cause	  DNA	  condensation	  in	  Escherichia	  coli	  (Kaul	  et	  al.,	  1997).	  
1.5.2	   Reticulate	  body	  (RB)	  
Intracellular	  bacteria	  exist	  as	  reticulate	  bodies	  (RBs),	  which	  are	  approximately	  1µm	  in	  
diameter	  (Friis,	  1972).	  RBs	  are	  also	  bound	  by	  a	  double	  membrane,	  however,	  unlike	  the	  
EB	   envelope,	   RB	   envelopes	   are	   sensitive	   to	   osmotic	   pressure.	   RBs	   contain	   a	   relaxed	  
chromosome	  without	  either	  of	  the	  identified	  chlamydial	  histone-­‐like	  proteins	  present	  
(Kaul	   et	   al.,	   1997).	   RBs	   remain	   in	   contact	   with	   the	   inclusion	   membrane	   during	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replication,	   presumably	   to	   enable	   the	   translocation	   of	   effector	   proteins	   from	   the	  
bacteria	  through	  the	  inclusion	  membrane	  into	  host	  cells	  (Matsumoto,	  1981;	  Peterson	  
and	  de	  la	  Maza,	  1988;	  Wilson	  et	  al.,	  2009).	  Although	  RBs	  are	  metabolically	  active	  they	  
are	   unable	   to	   invade	   host	   cells	   and	   are	   therefore	   entirely	   non-­‐infectious.	   Bacteria	  
remain	   in	   the	   RB	   form	   for	   the	   duration	   of	   the	   intracellular	   replication	   phase	   of	   the	  
infection	  cycle	  (Figure	  1.3C/D).	  
1.5.3 Infection	  cycle	  
The	  majority	  of	  the	  Chlamydiaceae	  development	  cycle	  occurs	  inside	  a	  host	  cell,	  within	  
the	   bacteria-­‐controlled	   inclusion	   (Figure	   1.4).	   Host	   cell	   invasion	   and	   inclusion	  
biogenesis	  mechanisms	  are	  of	  fundamental	  importance	  to	  the	  bacteria,	  however	  these	  
processes	  are	  not	  fully	  understood.	  
EB	   attachment	  was	   observed	   to	   occur	   in	   cholesterol	   rich	  microdomains	   of	   host	   cell	  
membranes	  (Jutras	  et	  al.,	  2003).	  Bacterial	  adhesion	  has	  been	  suggested	  to	  occur	  in	  two	  
stages:	   a	   reversible	   electrostatic	   interaction	   between	   bacterial	   adhesins,	   including	  
MOMP	   (Su	   et	   al.,	   1990;	   1996),	   and	   host	   heparan	   sulphate-­‐like	   glycosaminoglycans	  
(Zhang	  and	  Stephens,	  1992;	  Su	  et	  al.,	  1996;	  Carabeo	  and	  Hackstadt,	  2001),	  followed	  by	  
a	   temperature-­‐dependent	   irreversible	   attachment	   event	   (Carabeo	   and	   Hackstadt,	  
2001).	  	  
Once	  bacteria	  have	  adhered	  to	  the	  host	  cell	  they	  actively	  promote	  internalisation	  in	  a	  
process	  that	  is	  dependent	  upon	  host	  cell	  actin	  remodelling	  (Carabeo	  et	  al.,	  2002).	  Host	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Figure	   1.3.	   Two	   distinct	   morphological	   forms	   of	   the	   chlamydial	   life	   cycle.	   (A)	  
Confocal	   xy-­‐section	   of	   a	  HeLa	   cell	   infected	  with	  C.trachomatis	   LGV2	  when	  bacteria	  
are	  present	  as	  elementary	  bodies	   (EBs)	  at	  36hpi.	  Plasma	  membranes	  were	   labelled	  
using	  AlexaFluor®594	  conjugated	  WGA	  (red)	  prior	  to	  permeabilisation.	  Bacteria	  were	  
labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	   specific	   primary	   antibody	   followed	   by	  
AlexaFluor®488	  conjugated	  secondary	  antibody	  (green).	  Arrow	  indicates	  a	  single	  EB	  
within	  the	   inclusion.	  Scale	  bar,	  10µm.	  (B)	  A	   transmission	  electron	  micrograph	  of	  an	  
EB.	   Scale	   bar,	   0.5µm.	   (C)	   Confocal	   xy-­‐section	   of	   a	   HeLa	   cell	   infected	   with	  
C.trachomatis	   LGV2	   when	   bacteria	   are	   present	   as	   reticulate	   bodies	   (RBs	   at	   24hpi.	  
Plasma	  membranes	  were	  labelled	  using	  AlexaFluor®594	  conjugated	  WGA	  (red)	  prior	  
to	  permeabilisation.	  Bacteria	  were	  labelled	  with	  Chlamydia	  spp.	  MOMP/LPS	  specific	  
primary	   antibody	   followed	   by	   AlexaFluor®488	   conjugated	   secondary	   antibody	  
(green).	   Arrow	   indicates	   a	   single	   RB.	   Scale	   bar,	   10µM.	   (D)	   A	   transmission	   electron	  
micrograph	  of	  an	  RB.	  Scale	  bar,	  1µm.	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actin	   recruitment	   is	   initiated	   by	   translocated	   actin	   recruitment	   protein	   (TARP),	  
translocated	  by	  T3SS	  into	  the	  host	  during	  EB	  entry.	  TARP	  nucleates	  actin	  filaments	  and	  
promotes	  polymerisation	  (Carabeo	  et	  al.,	  2002;	  Jewett	  et	  al.,	  2006;	  2010).	  Rho	  family	  
small	   guanosine	   5’-­‐triphosphotases	   (GTPases)	   are	   recruited	   to	   the	   site	   of	   bacterial	  
entry,	  to	  interact	  with	  host	  activators	  of	  the	  actin-­‐related	  protein	  (Arp)	  2/3	  complex	  to	  
initiate	  actin	  branching	  at	  the	  site	  of	  bacterial	  attachment	  (Carabeo	  et	  al.,	  2004;	  2007).	  
The	   GTPases	   utilised	   by	   the	   bacteria	   seem	   to	   be	   species	   specific,	   for	   example	  
C.trachomatis	   requires	   Rac	   GTPases	   (Carabeo	   et	   al.,	   2004)	   whereas	   C.caviae	  
internalisation	   is	   inhibited	   in	  HeLa	  cells	  expressing	  cdc42	  dominant	  negative	  mutants	  
(Subtil	  et	  al.,	  2004).	  C.trachomatis	  protein	  CT166,	  which	  is	  conserved	  in	  all	  urogenital	  
serovars,	   acts	   as	   a	   glucosyltransferase.	   CT166	   is	   present	   in	   EBs,	   and	   in	   infected	   cell	  
lysate	  for	  the	  first	  hour	  after	   infection	  (Thalmann	  et	  al.,	  2010).	  Thalman	  et	  al.	  (2010)	  
showed	   that	   CT166	   glucosylates	   Rac1,	   thereby	   inducing	   actin	   reorganisation	   and	  
mediating	   EB	   uptake	   by	   host	   cells.	   Electron	   microscopic	   analysis	   of	   EB	   attachment	  
points	  at	  the	  host	  cell	  plasma	  membrane	  revealed	  pedestal-­‐like	  structures	  reminiscent	  
of	   the	   pedestals	   observed	   during	   enteropathogenic	   E.coli	   adhesion	   to	   host	   cells	  
(Carabeo	  et	  al.,	  2002)	  (Figure	  1.4A).	  	  
Once	   internalised,	   bacteria	   modify	   entry	   vesicles	   by	   inserting	   a	   number	   of	   serovar	  
specific	   effector	   proteins	   into	   the	  membrane.	   (Grieshaber	  et	   al.,	   2003;	   Lutter	  et	   al.,	  
2012;	  Mital	   et	   al.,	   2013).	   Inc	   proteins	   are	   a	   diverse	   family	   of	   effector	   proteins	   that	  
contain	   a	   characteristic	   bi-­‐lobed	   hydrophobic	   domain	   (Li	   et	   al.,	   2008;	   Lutter	   et	   al.,	  
2012;	   Mital	   et	   al.,	   2013).	   Inc	   proteins	   are	   predicted	   to	   localise	   to	   the	   inclusion	  
membrane	  (Bannantine	  et	  al.,	  2000),	  which	  has	  been	  experimentally	  demonstrated	  to	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be	  the	  case	  for	  a	  number	  of	   Incs	   (reviewed	  by	  Valdivia,	  2008	  and	  Betts	  et	  al.,	  2009).	  
IncB	   and	   C.trachomatis	   proteins	   CT101,	   CT222,	   and	   CT850,	   spontaneously	   induce	  
round	  vesicular	  structures	  when	  expressed	  in	  HeLa	  cells,	  indicating	  a	  role	  for	  these	  Incs	  
in	   inclusion	   membrane	   morphology	   (Mital	   et	   al.,	   2013).	   Chlamydiaceae	   encode	  
between	   39	   and	   59	   Inc	   proteins	   and,	   although	   there	   is	   very	   little	   primary	   sequence	  
similarity	  between	  the	   Incs	   (Lutter	  et	  al.,	  2012;	  Mital	  et	  al.,	  2013),	  all	  Chlamydiaceae	  
encode	  homologues	  of	  23	  core	  Incs	  (Lutter	  et	  al.,	  2012).	  	  
Within	   2h	   of	   internalisation,	   EB	   containing	   entry	   vesicles	   are	   trafficked	   to	   the	  
microtubule	   organising	   centre	   (MTOC)	   along	   microtubules	   in	   a	   dynein-­‐dependent	  
manner	  (Clausen	  et	  al.,	  1997;	  Grieshaber	  et	  al.,	  2003).	  In	  cases	  where	  multiple	  bacteria	  
invade	  a	  single	  host	  cell,	  entry	  vesicles	  will	  fuse	  to	  form	  a	  single	  inclusion	  (Matsumoto	  
et	   al.,	   1991;	   Van	   Ooij	   et	   al.,	   1998;	   Hackstadt	   et	   al.,	   1999),	   with	   the	   exception	   of	  
C.caviae	  strain	  GPIC	  (Van	  Ooij	  et	  al.,	  1998).	  Vesicle	  fusion	  requires	  IncA	  (Hackstadt	  et	  
al.,	  1999;	   Suchland	   et	   al.,	  2000),	   an	   Inc	   protein	   that	   is	   highly	   conserved	   among	   the	  
Chlamydiaceae	   that	   localises	   to	   the	   cytoplasmic	   face	   of	   the	   inclusion	   membrane	  
(Hackstadt	   et	   al.,	   1999;	   Scidmore-­‐Carlson	   et	   al.,	   1999).	   IncA,	   along	   with	   other	  
hypothetical	  C.trachomatis	  proteins	  including	  CT223	  and	  CT813,	  contains	  a	  soluble	  NSF	  
attachment	  protein	  receptor	  (SNARE)-­‐like	  motif.	  (Delevoye	  et	  al.,	  2008).	  These	  motifs	  
interact	  with	  host	  SNAREs,	  but	  full-­‐length	  IncA	  was	  demonstrated	  to	  specifically	  recruit	  
SNAREs	  involved	  in	  endosomal	  trafficking	  (Delevoye	  et	  al.,	  2008)	  (Figure	  1.4B).	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Once	  a	  nascent	  inclusion	  has	  been	  established,	  bacteria	  undergo	  EB-­‐RB	  differentiation	  
(Moulder,	   1991)	   (Figure	   1.4C),	   however	   the	   signals	   and	  mechanisms	   involved	   in	   this	  
transition	  are	  unknown.	  	  
A	   recent	   study	   has	   demonstrated	   the	   presence	   of	   peptidoglycan	   in	   bacteria	   during	  
reorganisation	   from	  EBs	  to	  RBs	   (Liechti	  et	  al.,	  2013).	  Peptidoglycan	   is	   involved	   in	  cell	  
division	  in	  most	  Gram-­‐negative	  bacteria	  (Egan	  and	  Vollmer,	  2013),	  but	  was	  previously	  
thought	  to	  be	  absent	   from	  Chlamydiaceae.	  The	   lack	  of	  detectable	  peptidoglycan	  was	  
considered	   to	   be	   the	   ‘chlamydial	   anomaly’	   (Liechti	   et	   al.,	   2013),	   as	   Chlamydiaceae	  
encode	   the	  majority	  of	  peptidoglycan	  biosynthesis	  machinery	  and	  are	  sensitive	   to	  β-­‐
lactam	  antibiotics	  that	  inhibit	  peptidoglycan	  synthesis,	  such	  as	  penicillin	  (Ghuysen	  and	  
Goffin,	   1999;	   Patin	   et	   al.,	   2012).	   The	   detection	   of	   peptidoglycan	   during	   EB-­‐RB	  
differentiation	  could	  be	  a	  significant	  step	  in	  understanding	  the	  mechanism	  of	  bacterial	  
reorganisation	  and	  consequent	  replication.	  
RBs	  multiply	   by	   binary	   fission	   (Higashi,	   1965;	  Moulder,	   1966)	   and	   remain	   in	   contact	  
with	   the	   inclusion	   membrane	   (Matsumoto,	   1981;	   Peterson	   and	   de	   la	   Maza,	   1988;	  
Wilson	  et	  al.,	  2009)	  (Figure	  1.4D).	  RB-­‐inclusion	  membrane	  contact	  sites	  are	  rich	  in	  IncF,	  
however	   it	   is	   not	   yet	   clear	   which	  membranes	   the	   protein	   interacts	   with	   (Scidmore-­‐
Carlson	  et	  al.,	  1999).	  Inclusions	  co-­‐opt	  host	  RhoA	  GTPases	  to	  form	  a	  scaffold	  of	  F-­‐actin	  
and	  intermediate	  filaments	  (IFs)	  to	  support	  the	  inclusion	  (Kumar	  and	  Valdivia,	  2008a;	  
2008b).	   Disruption	   of	   actin	   structures	   induces	   IL-­‐8	   chemokine	   expression,	   and	  
consequently,	   activation	  of	   an	   innate	   immune	   response.	   This	  would	   suggest	   that,	   as	  
well	  as	  providing	  stability	  to	  the	  inclusion,	  the	  assembled	  actin	  filament	  cage	  reduces	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the	   likelihood	   of	   pathogen	   recognition	   receptors	   (PRRs)	   stimulating	   chemokine	   and	  
cytokine	   signalling	   cascades	   (Kumar	   and	   Valdivia,	   2008a;	   2008b).	   As	   the	   inclusion	  
expands	  to	  accommodate	  replicating	  bacteria,	   IFs	  are	  processed	  by	  CPAF	  (Kumar	  and	  
Valdivia,	   2008a;	   2008b),	  which	   is	   translocated	   by	   the	   bacteria	   via	   T2SS	   (Chen	  et	   al.,	  
2010).	  
At	  the	  end	  of	  the	  infection	  cycle,	  RBs	  redifferentiate	  into	  EBs	  following	  Hc1	  expression,	  
which	   causes	   the	   formation	   of	   the	   condensed	   nucleoid	   of	   EBs	   (Kaul	   et	   al.,	   1997)	  
(Figure	   1.4E).	   EBs	   are	   then	   released	   from	   host	   cells	   to	   propagate	   infection.	   This	   is	  
achieved	  by	  at	  least	  two	  distinct	  mechanisms,	  cell	  lysis	  (Perfettini	  et	  al.,	  2003;	  Hybiske	  
and	   Stephens,	   2007)	   (Figure	   1.4F)	   and	   extrusion	   (Todd	   and	   Caldwell,	   1985;	   Hybiske	  
and	   Stephens,	   2007)	   (Figure	   1.4G).	   Bacterial	   exit	   by	   host	   cell	   lysis	   appears	   to	   be	  
independent	  of	  apoptotic	  mechanisms	  (Hybiske	  and	  Stephens,	  2007),	  but	  is	  reliant	  on	  
proteases,	  with	  cysteine	  protease	  inhibitor	  E64	  having	  a	  dramatic	  inhibitory	  effect	  on	  
lysis	   mechanisms.	   Extracellular	   calcium	   influx	   was	   also	   demonstrated	   to	   be	   an	  
important	   factor	   in	   the	   lysis	  of	  host	   cells	   (Hybiske	  and	  Stephens,	  2007).	   Extrusion	  of	  
intact	   inclusions	   requires	   actin	   polymerisation,	   neuronal	   Wiskott-­‐Aldrich	   syndrome	  
protein	  (N-­‐WASP),	  Rho	  GTPase,	  and	  Myosin	  II	  phosphorylation	  (Hybiske	  and	  Stephens,	  
2007,	   Lutter	   et	   al.,	   2013).	   Recent	   work	   has	   implicated	   interactions	   between	  
C.trachomatis	  protein	  CT228	  and	  myosin	  phosphatase	  target	  subunit	  1	  (MYPT1),	  along	  
with	  other	  subunits	  of	  the	  myosin	  phosphatase	  pathway,	  as	  regulators	  of	  the	  extrusion	  
pathway	  of	  host	  cell	  egress	  (Lutter	  et	  al.,	  2013).	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Figure	  1.4.	  Schematic	  representation	  of	  the	  chlamydial	  infection	  cycle.	  (A)	  Infectious	  
but	   metabolically	   inert	   elementary	   bodies	   (EBs;	   red)	   invade	   host	   cells.	   (B)	   Entry	  
vesicles	  are	  then	  trafficked	  to	  the	  microtubule	  organisation	  centre	  (MTOC)	  where	  the	  
inclusion	  is	  established.	  (C)	  EBs	  differentiate	  into	  reticulate	  bodies	  (RBs;	  green)	  which	  
are	  non-­‐infectious	  but	  metabolically	  active.	  (D)	  RBs	  replicate	  by	  binary	  fission	  within	  
the	   bacteria-­‐controlled	   inclusion.	   (E)	   RBs	   re-­‐differentiate	   into	   EBs,	   prior	   to	   release	  
from	   host	   cells	   either	   by	   lysis	   (F)	   or	   extrusion	   (G).	   (H)	   Stressors	   such	   as	   nutrient	  
deficiency	  or	   cytokine	  exposure	  can	   induce	  persistence	   identified	  by	  non-­‐infectious	  
but	  viable	  aberrant	  bodies	  (ABs;	  blue).	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1.5.4	   Intracellular	  nutrient	  acquisition	  
Bacteria	   interact	   extensively	   with	   the	   host	   cells	   during	   replication	   to	  maintain	   their	  
intracellular	  niche	  and	  obtain	  nutrients.	  The	  inclusion	  membrane,	  characterised	  by	  Inc	  
proteins	  secreted	  by	  the	  bacteria	  during	  inclusion	  biogenesis,	  is	  an	  important	  mediator	  
of	  these	  interactions	  (Scidmore	  et	  al.,	  2003).	  	  
Chlamydial	   inclusions	   remain	   distinct	   from	   endosome-­‐lysosome	   trafficking,	   unlike	  
many	   intracellular	  pathogens.	   For	  example,	  Salmonella-­‐containing	  vesicles	  will	   arrest	  
endosome	  maturation,	   transiently	   retaining	   early	   endosome	  markers	   such	   as	   Rab5,	  
and	   will	   selectively	   acquire	   later	   maturation	   markers	   such	   as	   lysosome-­‐associated	  
membrane	   protein	   (LAMP)-­‐1	   (reviewed	   by	   Bakowski	   et	   al.,	   2008).	   The	   chlamydial	  
inclusion	  does	  not	  acidify	  (Grieshaber	  et	  al.,	  2003),	  and	  does	  not	  acquire	  any	  lysosomal	  
markers	  (Scidmore	  et	  al.,	  2003).	  However,	  inclusions	  will	  selectively	  acquire	  elements	  
from	   exocytic	   pathways	   that	   are	   essential	   to	   development.	   For	   example,	   inclusions	  
intercept	  vesicles	  containing	  sphingolipids	  (Hackstadt	  et	  al.,	  1996;	  Heinzen	  et	  al.,	  1996)	  
and	   cholesterol	   (Carabeo	   et	   al.,	   2003)	   en	   route	   from	   the	   Golgi	   to	   the	   plasma	  
membrane.	   Sphingomyelin,	   synthesised	   using	   fluorescent	   C6-­‐NBD-­‐ceramide,	   was	  
incorporated	   into	   bacterial	   envelopes	   (Hackstadt	   et	   al.,	   1996;	   Heinzen	   et	   al.,	   1996).	  
Sphingolipid	  delivery	  to	  the	  inclusion,	  and	  consequently	  chlamydial	  development,	  was	  
disrupted	  by	  chemical	  inhibition	  of	  multivesicular	  bodies	  (MVBs)	  (Beatty,	  2006;	  2008),	  
organelles	   involved	   in	   sorting	   proteins	   and	   lipids	   for	   recycling	   in	   the	   Golgi.	   This	  
suggests	   a	   direct	   association	   between	  MVBs	   and	   the	   chlamydial	   inclusion,	   which	   is	  
reinforced	  by	  the	  observation	  that	  an	  MVB	  resident	  protein,	  CD63,	  is	  delivered	  to	  the	  
	  	   46	  
inclusion	   (Beatty,	   2006).	   However,	   CD63	   itself	   is	   not	   required	   for	   inclusion-­‐MVB	  
interactions	  (Beatty,	  2008).	  These	  interactions	  are	  mediated	  by	  the	  recruitment	  of	  Rab	  
GTPases	   involved	  in	  receptor	  recycling	  (Rab4	  and	  Rab11),	  and	  endoplasmic	  reticulum	  
(ER)	  –	  Golgi	  trafficking	  (Rab1)	  (Rzomp	  et	  al.,	  2003).	  Rab	  recruitment	  is	  achieved	  using	  
chlamydial	  Inc	  proteins,	  for	  example	  Rab4	  interacts	  with	  C.trachomatis	  protein	  CT229	  
(Rzomp	  et	  al.,	  2006).	  	  
Close	  association	  between	  truncated	  Golgi	  mini	   stacks	  and	   the	   inclusion	   is	  necessary	  
for	  chlamydial	  acquisition	  of	   lipids,	  as	   inhibiting	  cleavage	  of	  golgin-­‐84,	  a	  Golgi	  matrix	  
protein,	  disrupts	  delivery	  of	  lipids	  to	  the	  inclusion	  (Heuer	  et	  al.	  2009).	  Cocchiaro	  et	  al.	  
(2008)	   observed	   intact	   lipid	   droplets	   inside	   the	   inclusion	   lumen,	   indicating	   that	  
inclusions	  are	  capable	  of	  engulfing	  whole	  organelles,	  demonstrating	  another	  method	  
of	  nutrient	  acquisition	  by	  Chlamydiaceae.	  
Recent	  work	  in	  our	  lab	  has	  demonstrated	  that	  ER	  is	  recruited	  to	  the	  cytoplasmic	  face	  
of	  the	  inclusion	  in	  a	  biphasic	  manner.	  ER	  was	  recruited	  during	  bacterial	  entry	  and	  then	  
shed	   as	   inclusions	   developed.	   ER	   was	   once	   again	   recruited	   to	   mature	   inclusions.	  
Disruption	  of	  ER	  recruitment	  during	  mid-­‐cycle	  development	  resulted	  in	  bursting	  of	  the	  
inclusion	  (Dumoux	  et	  al.	  2012).	  The	  ER-­‐golgi	  lipid	  transfer	  protein	  CERT	  is	  recruited	  to	  
the	  chlamydial	   inclusion	  membrane	  via	   interaction	  with	   IncD	  at	   inclusion	  membrane-­‐
ER	   contact	   sites	   (Derré	  et	  al.,	  2011).	   Tomography	  of	   ER-­‐inclusion	  membrane	   contact	  
sites	  show	  that	  where	  an	  RB-­‐ER	  synapse	  occurs,	  an	  array	  of	  T3SS	  injectisomes	  can	  be	  
seen	   in	   contact	   with	   the	   inner	   and	   outer	   bacterial	   membranes,	   the	   inclusion	  
membrane	  and	  the	  rough	  ER	  (Dumoux	  et	  al.,	  2012).	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1.5.5	   Bacterial	  intervention	  in	  host	  cell	  processes	  
Chlamydiaceae	  have	  developed	  a	  number	  of	  strategies	  to	  modulate	  various	  aspects	  of	  
the	   cell	   cycle	   and	   protect	   their	   intracellular	   niche.	   As	   chlamydial	   entry	   vesicles	   are	  
trafficked	  to	  the	  MTOC,	  a	  close	  association	  is	  formed	  between	  the	  inclusion	  and	  host	  
centrosomes	   (Grieshaber	   et	   al.,	   2006).	   This	   association	   causes	   centrosome	  
amplification	   and	   prevents	   accurate	   chromosome	   division	   (Grieshaber	   et.al.,	   2006).	  
Furthermore,	   chlamydial	   infection	   causes	   defects	   during	   mitotic	   spindle	   formation	  
(Knowlton	  et	  al.,	  2011).	  	  
One	  of	  the	  better-­‐studied	  aspects	  of	  chlamydial	  infection	  is	  the	  ability	  of	  the	  bacteria	  
to	  inhibit	  host	  cell	  apoptosis,	  and	  therefore	  maintain	  intracellular	  survival.	  Apoptosis	  is	  
often	  triggered	   in	  response	  to	  damage-­‐related	  molecular	  pattern	  molecules	   (DAMPs)	  
in	  response	  to	  pathogen	  invasion.	  Chlamydiaceae	  prevent	  apoptotic	  response	  to	  host	  
cell	  invasion	  by	  recruiting	  signalling	  molecules	  and	  their	  pro-­‐apoptotic	  binding	  partners	  
to	   the	   inclusion.	   For	   example,	   IncG	   sequesters	   the	   14-­‐3-­‐3β	   signalling	   protein,	   and	  
consequently	   the	   pro-­‐apoptotic	   BH3-­‐only	   protein	   BAD.	   This	   prevents	   the	   signalling	  
cascade	   reaching	   the	  mitochondria,	   thus	  protecting	   the	  host	   cell	   from	  mitochondrial	  
apoptosis	   induction	   (Verbeke	   et	   al.,	   2006).	   Tse	   et	   al.	   (2005)	   showed	   that,	   during	  
intracellular	  replication,	  diacylglycerol	  is	  accumulated	  around	  the	  inclusion.	  The	  novel	  
protein	  kinase	  PKCδ,	  which	  has	  a	  diacylglycerol	  binding	  site,	   is	  therefore	  sequestered	  
away	  from	  the	  mitochondria,	  preventing	  cytochrome	  c	  release	  and	  downstream	  pro-­‐
apoptotic	   activity	   (Tse	   et	   al.,	   2005).	   The	   chlamydial	   protease	   CPAF	   also	   plays	   an	  
important	  role	  in	  modulating	  the	  host	  response	  to	  pathogen	  invasion,	  degrading	  BH3-­‐
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only	  and	  Bcl-­‐2	  pro-­‐apoptotic	  proteins	  (Pirbhai	  et	  al.,	  2006),	  and	  other	  factors	  involved	  
in	   adaptive	   immune	   response	   including	   RFX-­‐5	   and	   USF-­‐1,	   which	   correlates	   to	   the	  
suppression	  of	  class	  I	  and	  II	  MHC	  antigen	  expression.	  However,	  a	  recent	  study	  by	  Chen	  
et	   al.	   (2012)	   demonstrated	   that	   CPAF	   can	   survive	   cell	   lysis	   protocols,	   including	  
exposure	  to	  8M	  urea,	  and	  previously	  published	  substrates	  such	  as	  golgin-­‐84	  failed	  to	  
undergo	   proteolysis	   when	   CPAF	   was	   inhibited	   during	   cell	   processing.	   This	   suggests	  
that,	   although	   CPAF	   might	   have	   a	   variety	   of	   functions,	   the	   likelihood	   is	   that	  
Chlamydiaceae	   have	   a	   number	   of	   functional	   proteases.	   For	   example,	   CT441,	   a	   tail	  
specific	  protease	  that	  cleaves	  the	  p65/RelA	  subunit	  of	  NF-­‐κB,	  therefore	  inhibiting	  NF-­‐
κB	  activation	  (Lad	  et	  al.,	  2007). 
In	   addition	   to	   modulating	   host	   apoptosis,	   the	   Chlamydiaceae	   also	   disrupt	   various	  
housekeeping	   activities.	   For	   example,	   chlamydial	   proteins	   CT868	   (ChlaDub	   1)	   and	  
CT867	  (ChlaDub	  2),	  conserved	  across	  all	  Chlamydia	  species	  except	  C.pneumoniae,	  have	  
de-­‐ubiquitinating	   and	   de-­‐neddylating	   properties	   (Misaghi	   et	   al.,	   2006).	   Although	  
cellular	  substrates	  have	  yet	  to	  be	  determined	  for	  these	  de-­‐ubiquitinases	  their	  presence	  
could	   indicate	   chlamydial	   interference	   in	   ubiquitin-­‐dependent	   mechanisms	   such	   as	  
protein	   degradation	   and	   signalling	   pathways.	   Chlamydial	   CT847,	   a	   T3SS	   secreted	  
effector	   protein,	   interacts	   with	   Grap2	   cyclin	   D-­‐interacting	   protein	   (GCIP)	   which	   is	  
ubiquitously	  expressed	  throughout	  the	  cell	  cycle.	  GCIP	  is	  involved	  in	  the	  modulation	  of	  
eukaryotic	  cell	  proliferation,	  suggesting	  that	  Chlamydiaceae	  may	  also	  intervene	  in	  the	  
host	  cell	  cycle	  (Chellas-­‐Géry	  et	  al.,	  2007).	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1.5.6	  Persistence	  
The	   Chlamydiaceae	   enter	   a	   ‘persistent’	   state	   in	   response	   to	   a	   number	   of	  
environmental	   stressors	   (Figure	   1.4H).	   Persistence	   in	  Chlamydiaceae	  has	   a	   different	  
meaning	   to	   the	   term	   used	   most	   frequently	   when	   describing	   pathogens.	   Generally	  
persistence	   is	   used	   to	   describe	   chronic	   active	   infections.	   In	  Chlamydiaceae	   the	   term	  
persistence	   is	   used	   to	   describe	   an	   aberrant	   phase	   in	   the	   infection	   cycle	   where	  
metabolism	   slows	   and	   RBs	   fail	   to	   either	   replicate	   or	   differentiate	   into	   EBs.	   This	   is	  
usually	   characterised	   by	   the	   formation	   of	   large	   abnormal	   bodies,	   termed	   aberrant	  
bodies	   (ABs),	   which	   can	   revert	   back	   to	   RBs	   to	   complete	   a	   normal	   infection	   cycle	  
(Hogan	  et	  al.,	  2004).	  Persistence	  has	  been	  demonstrated	  in	  vitro,	  however	  controversy	  
still	   remains	   as	   to	   whether	   this	   state	   occurs	   in	   vivo.	   Persistence	   can	   be	   induced	   by	  
stressors	   such	  as	   interferon-­‐γ	   (IFN-­‐	  γ)	   (Pantoja	  et	  al.,	  2001),	  heat	   shock	   (Kahane	  and	  
Friedman,	  1992),	  and	  nutrient	  deficiencies	  such	  as	  iron	  depletion	  (Roulston,	  1997)	  and	  
amino	   acid	   starvation	   (Coles	   et	   al.,	   1993).	   Each	   of	   these	   conditions	   gives	   rise	   to	  
different	   gene	   expression	   profiles	   and	   AB	   morphologies,	   however	   all	   are	   termed	  
persistence	  (Hogan	  et	  al.,	  2004;	  Shoborg,	  2011).	  	  
	  
1.6 Potassium	  regulation	  in	  bacteria	  
Inorganic	   ions,	   such	   as	   potassium	   (K+),	   are	   vital	   for	  maintaining	   osmotic	   pressure	   in	  
cells,	  as	  well	  as	  regulating	  pH	  and	  performing	  a	  variety	  of	  signalling	  functions	  such	  as	  
activation	   of	   cytoplasmic	   enzymes.	   Intracellular	   bacteria	   such	   as	   C.trachomatis	   will	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encounter	  different	  ionic	  environments	  throughout	  their	  infection	  cycle,	  for	  example,	  
the	  concentration	  of	   intracellular	  K+	   is	  higher	   than	   the	  extracellular	  milieu,	  where	  as	  
intracellular	  sodium	  (Na+)	  concentrations	  will	  be	  lower.	  In	  order	  to	  be	  able	  to	  adapt	  to	  
their	  changing	  environments	  and	  maintain	  homeostasis,	  Gram-­‐negative	  bacteria	  have	  
developed	  three	  major	  ion	  transport	  systems	  (Epstein,	  2003;	  Su	  et	  al.,	  2009).	  The	  Trk	  
low	  affinity	  K+	  transport	  system	  is	  found	  in	  the	  largest	  number	  of	  bacterial	  species	  (Liu	  
et	  al.,	  2013).	  Trk	  rapidly	  transports	  K+	  under	  alkaline	  or	  neutral	  conditions	   (Liu	  et	  al.,	  
2013).	  Trk	  K+	  transport	  regulates	  secretion	  of	  S.typhimurium	  T3SS	  effector	  proteins	  and	  
therefore	   plays	   and	   important	   role	   in	   pathogenesis	   (Su	   et	   al.,	   2009).	   Kdp	   is	   a	   high	  
affinity	   K+	   uptake	   system	   that	   is	   induced	  by	   low	  K+	   environments	  or	   high	  osmolarity	  
(Frymier	  et	  al.,	  1997;	   Epstein,	   2003;	  Xue	  et	  al.,	  2011).	   Kdp	  activity	  has	   an	   important	  
regulatory	  effect	  on	  virulence	  gene	  transcription	  in	  Staphylococcus	  aureus	  (Xue	  et	  al.,	  
2011).	   Kup	   is	   induced	   under	   acidic	   conditions	   (Trchounian	   and	   Kobayashi,	   1999;	  
Epstein	  2003)	  and	  is	  the	  major	  K+	  uptake	  system	  utilised	  by	  E.coli	  under	  hyper-­‐osmotic	  
stress	  (Trchounian	  and	  Kobayashi,	  1999).	  
Although	   K+	   transport	   systems	   have	   yet	   to	   be	   identified	   in	   the	   Chlamydiaceae,	   the	  
C.trachomatis	  protein	  CT440	  has	  been	  shown	  to	  localise	  to	  the	  inclusion	  membrane	  (Li	  
et	  al.,	  2008;	  2011)	  and	  the	  predicted	  structure	  shows	  homology	  to	  a	  neurotransmitter-­‐
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1.7	   Aims	  
Due	  to	  the	  complexities	  of	  studying	  the	  Chlamydiaceae,	  very	  little	  is	  known	  about	  the	  
environment	  within	  the	  inclusion.	  Unlike	  the	  vacuoles	  inhabited	  by	  other	  intracellular	  
bacteria,	  such	  as	  Coxiella	  burnetii	  (Heinzen	  et	  al.,	  1996),	  the	  chlamydial	  inclusion	  is	  not	  
acidified	  and	  appears	   to	  maintain	  a	   similar	  pH	   to	   the	  host	  cytosol	   (Grieshaber	  et	  al.,	  
2002).	   In	   the	   same	   study,	   Grieshaber	   et	   al.	   (2002)	   demonstrated	   that	   the	   ionic	  
composition;	  i.e.	  the	  concentration	  of	  calcium	  (Ca2+),	  sodium	  (Na+),	  and	  potassium	  (K+),	  
within	  inclusion	  lumen	  was	  similar	  to	  that	  of	  the	  host	  cytosol.	  	  The	  aim	  of	  this	  project	  is	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2.1	  Cell	  culture	  
Unless	   otherwise	   stated	   all	   cell	   culture	   materials	   were	   purchased	   from	   Gibco	  
(Invitrogen,	   Carlsband,	   CA,	   USA).	   All	   sterile	   plasticware	   was	   purchased	   from	   VWR	  
International	  (West	  Chester,	  PA,	  USA).	  
2.1.1	  Cell	  lines	  and	  culture	  conditions	  
2.1.1.a	  HeLa	  cervical	  epithelial	  cells	  
Stocks	   of	   HeLa	   cells	   were	   previously	   prepared	   in	   the	   laboratory	   and	   stored	   in	  
liquid	   nitrogen.	   Cells	   were	   grown	   in	   high	   glucose	   Dulbecco’s	   modified	   eagle	  
medium	   (DMEM)	   +	   GlutaMAX	   supplemented	   with	   10%	   decomplemented	   fetal	  
bovine	   serum	   (FBS)	   and	   penicillin	   (100	   units	   [U]/ml)	   /streptomycin	   (100µg/ml)	  
antibiotic	   mixture,	   as	   recommended	   by	   the	   American	   Type	   Culture	   Collection	  
(ATCC).	  2x106	   cells	  were	  grown	   to	  70-­‐90%	  confluence	   in	  T75	  vented	   flasks	   in	  a	  
humidified	  incubator	  at	  37°C	  with	  5%	  CO2	  before	  passage	  every	  2-­‐3	  days.	  
2.1.1.b	  RL95-­‐2	  uterine	  endometrial	  cells	  
Stocks	  of	  RL95-­‐2	  cells	  were	  previously	  prepared	   in	  the	   laboratory	  and	  stored	   in	  
liquid	  nitrogen.	  Cells	  were	  grown	  in	  a	  1:1	  mixture	  of	  Ham	  F-­‐12	  nutrient	  mix	  (HF-­‐
12)	   +	   GlutaMAX	   and	   DMEM	   supplemented	   with	   10%	   FBS	   and	   penicillin	   (100	  
U/ml)	   /streptomycin	   (100µg/ml)	   antibiotic	   mixture,	   as	   recommended	   by	   the	  
ATCC.	   5x106	   cells	   were	   grown	   to	   70-­‐90%	   confluence	   in	   T75	   vented	   flasks	   in	   a	  
humidified	  incubator	  at	  37°C	  with	  5%	  CO2	  before	  passage	  every	  3-­‐4	  days.	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2.1.2	  Passage	  
Solutions:	  
• trypsin	  –	  0.05%	  trypsin,	  200µg/ml	  ethylenediaminetetraacetic	  acid	  (EDTA)	  
• HBSS/FBS	  –	  Hank’s	  balanced	  salt	  solution	  (HBSS),	  10%	  FBS	  
When	   cells	   reached	   a	   confluence	   of	   70-­‐90%	   in	   culture	   flasks	   growth	   medium	   was	  
removed	  and	  cells	  were	  washed	  in	  HBSS	  at	  37°C	  to	  remove	  excess	  FBS.	  Cells	  were	  then	  
dissociated	  from	  flask	  using	  trypsin	  at	  37°C	  for	  5min	  before	  collection	  in	  HSSS/FBS.	  Cell	  
suspension	  was	  then	  centrifuged	  at	  1200rpm	  using	  a	  Rotina	  420R	  centrifuge	  (Hettich	  
Lab,	   Technology,	   Tuttlingen,	  Germany)	   at	   4°C	   for	   10min.	   Supernatant	  was	   discarded	  
and	  pellet	  resuspended	  in	  HBSS/FBS	  for	  counting	  and	  seeding.	  
2.1.3	  Coverslip	  preparation	  
12mm	  glass	  coverslips	  (VWR,	  West	  Chester,	  PA,	  USA)	  were	  washed	  in	  70%	  ethanol	  for	  
10min	   then	   washed	   twice	   in	   excess	   HBSS	   prior	   to	   transfer	   into	   24-­‐well	   cell	   culture	  
plates.	  
2.1.4	  Counting	  and	  seeding	  
Following	   passage,	   5µl	   cells	   suspended	   in	   HBSS/FBS	   were	   added	   to	   5µl	   0.4%	   (w/v)	  
trypan	   blue	   solution	   and	   added	   to	   a	   KOVA	   Glasstic	   counting	   chamber	   (Hycor,	  
Indianapolis,	   IN,	  USA)	   and	   viewed	  under	   a	   light	  microscope.	   Viable	   cells,	   those	   non-­‐
permeable	   to	   trypan	   blue,	   were	   counted	   and	   added	   in	   appropriate	   volumes	   (see	  
Equation	  1)	  to	  sterile	  cell	  culture	  plates	  (Table	  2.1)	  and	  then	  left	  to	  adhere	  for	  18-­‐24h.	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   HeLa	   RL95-­‐2	  
35mm	  glass	  bottomed	  
petri	  dish	   7x10
5	  (30%)	   	  
90mm	  petri	  dish	   7x106	  (70%)	   	  
4	  chamber	  glass	  
bottomed	  labtek	   3.5x10
5	  (30%)	   	  
24	  well	  plate	   7x10
5	  (70%)	  	  	  	  1x104	  
(100%)	  
1x105	  (70%)	  1.5x105	  
(100%)	  
12	  well	  plate	   1x10
5	  (70%)	  1.5x105	  
(100%)	  
2x105	  (70%)	  3x105	  
(100%)	  
6	  well	  plate	   4x10
5	  (70%)	  	  	  	  7x105	  
(100%)	   	  
Table	   2.1.	   Cell	   Plating.	   Number	  of	   cells	   added	   to	  medium	   to	  achieve	   correct	   confluence	   (shown	   in	  










Equation	  1.	  Number	  of	  cells	  per	  ml.	  Where	  Ccount	  is	  the	  number	  of	  cells	  counted	  in	  9	  grid	  squares	  of	  




	  	   56	  
2.2	  Bacteria	  	  
2.2.1	  Chlamydia	  infection	  protocol	  
Solutions:	  
• HeLa	  cell	  infection	  medium	  –	  DMEM,	  10%	  FBS,	  25µg/ml	  gentamicin	  	  
• RL95-­‐2	   cell	   infection	   medium	   –	   45%	   DMEM,	   45%	   HF-­‐12,	   10%	   FBS,	   25µg/ml	  
gentamicin	  
Adherent	  cells	  were	  infected	  with	  between	  0.9-­‐1	  inclusion-­‐forming	  units	  (IFU)	  of	  stock	  
bacteria	   per	   cell,	   i.e.	   a	   multiplicity	   of	   infection	   (MOI)	   of	   1,	   diluted	   in	   appropriate	  
infection	   medium.	   Cells	   were	   then	   centrifuged	   at	   900rpm	   using	   a	   Rotina	   420R	  
centrifuge	   (Hettich	   Lab,	   Technology,	   Tuttlingen,	   Germany)	   for	   10min	   to	   ensure	  
synchronised	   infections.	  Cells	  were	   then	   incubated	   in	  a	  humidified	   incubator	  at	  37°C	  
with	  5%	  CO2	  for	  90min	  before	  medium	  was	   replaced	  with	   fresh	   infection	  medium	  to	  
remove	  any	  cell	  debris	  and	  dead	  bacteria.	  This	  second	  medium	  change	  was	  considered	  
to	  be	  the	  starting	  point	  of	  the	  infection	  (t=0	  hours	  post	  infection	  [hpi]).	  
2.2.2	  Quantification	  of	  infectivity	  
Due	  to	  the	  obligate	  intracellular	  nature	  of	  Chlamydiae,	  quantification	  of	  viable	  bacteria	  
presents	   a	   challenge.	   In	   order	   to	   estimate	   the	   quantity	   of	   infection	   forming	   units	  
(IFUs),	   a	   serial	   dilution	   of	   each	   bacteria	   stock	   was	   added	   to	   HeLa	   cell	   monolayers.	  
Infected	  cells	  were	  fixed	  at	  appropriate	  times	  post	  infection	  dependent	  on	  serovar	  (see	  
below	  in	  Section	  2.2.3).	  By	  assuming	  that	  each	  resultant	  inclusion	  was	  the	  product	  of	  a	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single	  viable	  bacterium	  (Azenabor	  et	  al.,	  2007),	  the	  concentration	  of	  the	  stock	  solution	  
(IFU/ml)	  can	  be	  quantified	  (See	  Equation	  2).	  An	  IFU	  0.9-­‐1	  will	  result	  in	  infection	  of	  90-­‐







Equation	   2.	   IFU	   quantification.	   The	   average	   number	   of	   inclusions	   and	   cells	   from	  10	   fields	   of	   view	  
(FOVs)	  can	  be	  used	  to	  calculate	  the	  quantity	  of	  infection	  forming	  units	  (IFU)	  in	  a	  sample.	  
	  
2.2.3	  Chlamydiae	  stocks	  
Solutions:	  
• sucrose-­‐phosphate-­‐glutamic	   acid	   buffer	   (SPG)	   –	   220mM	   sucrose,	   17.4mM	  
Na2HPO4,	  2.6mM	  NaH2PO4,	  20mM	  L-­‐glutamic	  acid	  
HeLa	   cell	  monolayers	  were	   infected	  with	  Chlamydiae	  stocks	   (Multiplicity	  of	   infection	  
(MOI)=1,	  i.e.	  1	  bacterium	  per	  cell).	  The	  duration	  of	  initial	  infection	  differed	  depending	  
on	  serovar.	  Inclusion	  development	  was	  monitored	  by	  light	  microscopy	  at	  late	  stages	  of	  
the	  infection	  and	  considered	  ready	  for	  collection	  once	  inclusions	  were	  full	  of	  EBs	  but	  
before	   the	   bacteria	   were	   released	   into	   the	   supernatant.	   Bacteria	   were	   collected	   by	  
scraping	  into	  SPG	  buffer	  and	  homogenised	  by	  flushing	  through	  23	  gauge	  needle	  to	  lyse	  
cells	   and	   release	   the	   bacteria.	   Bacterial	   stocks	   were	   checked	   for	   Mycoplasma	  
contamination	   by	   polymerase	   chain	   reaction	   (PCR)	   following	   DNA	   extraction	   using	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QIAamp	   DNA	   minikit	   (Qiagen,	   Hilden,	   Germany)	   according	   to	   manufacturer’s	  
instructions.	  For	  primers	  see	  Appendix	  1.	  For	  PCR	  parameters	  see	  Table	  2.6.	  
2.2.3.a	  Chlamydia	  trachomatis	  serovar	  LGV2	  	  
Stocks	  of	  C.trachomatis	  LGV2	  were	  collected	  at	  approximately	  50hpi,	   stock	   IFU	  
concentration	  was	  then	  determined	  at	  24hpi.	  	  
2.2.3.b	  Chlamydia	  trachomatis	  serovar	  D	  	  
Stocks	   of	   C.trachomatis	   D	   were	   collected	   at	   approximately	   96hpi,	   stock	   IFU	  
concentration	  was	  then	  determined	  at	  48hpi.	  
2.2.3.c	  Chlamydia	  muridarum	  	  
Stocks	   of	   C.muridarum	   were	   collected	   at	   approximately	   30hpi,	   stock	   IFU	  
concentration	  was	  then	  determined	  at	  18hpi.	  
2.2.4	  Heat	  inactivation	  of	  C.trachomatis	  LGV2	  
C.trachomatis	  LGV2	   from	   frozen	  stock	  were	  diluted	   in	  DMEM	  and	   incubated	  at	  56°C	  
for	  30min.	  Bacteria	  were	  then	  diluted	  to	  the	  same	  titre	  as	  live	  bacteria	  (MOI=1)	  prior	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2.3	  Drug	  treatments	  
2.3.1	  Drugs	  
Unless	   otherwise	   stated	   all	   compounds	  were	   obtained	   from	   Sigma	  Aldrich	   (St	   Louis,	  
MO,	  USA).	  For	  ionophore	  structures	  see	  Appendix	  2.	  
2.3.1.a	  Nigericin	  
5mg	   nigericin	   sodium	   salt	   was	   reconstituted	   in	   6.7ml	   dimethyl	   sulphoxide	  
(DMSO)	  to	  yield	  a	  1mM	  stock	  solution.	  
2.3.1.b	  Monensin	  
5mg	  monensin	   sodium	   salt	   was	   reconstituted	   in	   7.2ml	   DMSO	   to	   yield	   a	   1mM	  
stock	  solution.	  
2.3.1.c	  Ionomycin	  
1mg	   ionomycin	   calcium	   salt	  was	   reconstituted	   in	   1.3ml	  DMSO	   to	   yield	   a	   1mM	  
stock	  solution.	  
2.3.1.d	  Chloride	  ionophore	  I	  (c)	  Selectophore	  
5mg	  Cl-­‐I	   (Fluka,	  Basel,	  Switzerland)	  was	  reconstituted	   in	  7.1ml	  DMSO	  to	  yield	  a	  
1mM	  stock	  solution.	  
2.3.1.e	  Valinomycin	  
10mg	  valinomycin	  was	  reconstituted	  in	  9ml	  DMSO	  to	  yield	  a	  1mM	  stock	  solution.	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2.3.1.f	  Glibenclamide	  
200mg	   glibenclamide	   was	   reconstituted	   in	   4ml	   DMSO	   to	   yield	   100mM	   stock	  
solution.	  	  
2.3.1.g	  Doxycycline	  
1mg	  doxycycline	  was	   reconstituted	   in	  2ml	  deionised	  water	   to	  yield	  1mM	  stock	  
solution.	  	  
2.3.1.h	  Blebbistatin	  
1mg	   blebbistatin	   was	   reconstituted	   in	   3.4ml	   DMSO	   to	   yield	   a	   1mM	   stock	  
solution.	  Cells	  were	  treated	  with	  50µM	  blebbistatin	  diluted	  in	  HeLa	  cell	  infection	  
medium	  (Hybiske	  and	  Stephens,	  2007).	  
2.3.2	  Drug	  concentrations	  	  
Optimum	   concentrations	   for	   each	   treatment	   were	   determined	   by	   subjecting	  
monolayers	   of	   cells	   at	   100%	   confluence	   to	   increasing	   concentrations	   of	   the	   drugs,	  
diluted	   in	  HeLa	   cell	   infection	  medium,	   for	   24h.	   The	  number	   of	   cells	   remaining	   in	   10	  
random	  FOVs,	  at	  63x	  magnification,	  was	  quantified	  by	  epifluorescence.	   (described	   in	  
Section	   2.5.3)	   A	   final	   working	   concentration,	   which	   more	   than	   75%	   of	   cells	   could	  
survive	  for	  24h,	  was	  selected	  and	  used	  for	  treatment	  of	  infected	  cells	  (Table	  2.2).	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   500nM	   1μM	   5μM	   10μM	  
chloride	  ionophore	  I†	   77±12	   76±14	   66±20	   40±10	  
ionomycin†	   84±14	   76±24	   70±24	   54±13	  
monensin†	   78±5	   76±7	   45±11	   30±8	  
nigericin†	   81±14	   77±14	   72±15	   45±10	  
valinomycin†	   76±19	   75±12	   64±17	   38±11	  
	  	   1μM	   5μM	   10μM	   50μM	  
glibenclamide†	   89±19	   77±12	   76±13	   48±15	  
doxycycline*	   102±4	   93±18	   83±11	   72±13	  
Table	   2.2.	   Drug	   titrations.	   Average	   percentage	   of	   cells	   from	   10	   FOVs	   remaining	   on	   a	   coverslip,	  	  	  	  	  	  	  	  	  	  	  	  
as	   a	  percentage	  of	   an	  untreated	   control	   condition,	   following	  24h	  of	   exposure	   to	   compounds	  at	   given	  
concentrations.	   *	   solubilised	   in	   dH2O,	   †	   solubilised	   in	   DMSO.	   Shaded	   figures	   indicate	   concentrations	  
used	  for	  experiments.	  
	  
2.3.3	  Treatment	  conditions	  
Cell	  monolayers,	   seeded	   at	   appropriate	   confluence	   for	   each	   experiment	   (Table	   2.1),	  
were	   infected	   as	   described	   in	   Section	   2.2.1.	   At	   appropriate	   time	   points	   infection	  
medium	   was	   removed	   and	   cells	   were	   treated	   with	   working	   concentration	   of	   drugs	  
(Table	   2.2)	  diluted	   in	  HeLa	  cell	   infection	  medium	  and,	  unless	  otherwise	  stated,	  were	  
incubated	   at	   37°C	   with	   5%	   CO2	   in	   a	   humidified	   incubator	   for	   the	   duration	   of	   the	  
experiment.	  
In	  experiments	  that	  required	  the	  removal	  of	  drugs	  from	  cells,	  treatment	  medium	  was	  
discarded	   at	   specified	   times,	   monolayers	   were	   then	   washed	   in	   excess	   DMEM	   and	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medium	   was	   replaced	   with	   HeLa	   cell	   infection	   medium	   for	   the	   remainder	   of	   the	  
experiment.	  
	  
2.4	  Labelling	  for	  Fluorescence	  microscopy	  
2.4.1	  Sample	  preparation	  for	  fixed	  microscopy	  
Where	  appropriate	  cells	  were	  fixed	  using	  the	  method	  established	  to	  produce	  the	  best	  
images	  by	  confocal	  microscopy.	  For	  antibody	  specific	  fixation	  methods	  see	  Table	  2.3.	  	  
	   2.4.1a	  Paraformaldehyde	  (PFA)	  fixation	  
Solutions:	  
• phosphate	   buffered	   saline	   (PBS)	   –	   137mM	   NaCl,	   2.7mM	   KCl,	   8mM	  
Na2HPO4,	  1.46mM	  KH2PO4	  in	  deionised	  water	  at	  pH7.4	  
• PFA	  –	  4%	  (w/v)	  PFA	  in	  PBS	  	  
• neutralisation	  buffer	  –	  50mM	  NH4Cl	  in	  PBS	  
Growth	  medium	  was	   removed	   and	   cells	   were	   fixed	   in	   PFA	   for	   30min	   at	   room	  
temperature	  (RT)	  before	  addition	  of	  an	  equal	  volume	  of	  neutralisation	  buffer	  and	  
incubated	   at	   4°C	   for	   1h.	   Cells	   were	   then	   washed	   in	   excess	   PBS	   prior	   to	  
permeabilisation	  either	  in	  a	  1:1	  (v/v)	  mix	  of	  methanol:ethanol	  at	  4°C	  for	  5min	  or	  
0.5%	  (v/v)	  Triton	  X-­‐100	  (Sigma	  Aldrich,	  St	  Louis,	  MO,	  USA)	  in	  PBS	  for	  15min	  at	  RT	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prior	  to	  all	  antibody	  labelling	  (for	  antibody	  specific	  permeabilisation	  methods	  see	  
Table	  2.3).	  	  
2.4.1.b	  Methanol	  fixation	  
After	   removal	  of	   growth	  medium	  cells	  were	   incubated	  with	  methanol	   at	   -­‐20°C	  
for	   10min	   prior	   to	   washing	   in	   PBS.	   Methanol	   fixed	   cells	   do	   not	   require	   a	  
permeabilisation	  step.	  
2.4.1.c	  Methanol:Ethanol	  fixation	  
After	   removal	   of	   growth	   medium	   cells	   were	   incubated	   with	   an	   equal	   mix	   of	  
methanol:ethanol	   (v/v)	   at	   4°C	   for	   5min	   prior	   to	   washing	   in	   PBS.	  
Methanol:ethanol	  fixed	  cells	  do	  not	  require	  a	  permeabilisation	  step.	  
2.4.2	  Inside/outside	  labelling	  of	  bacteria	  
To	  differentiate	  between	   internal	  and	  external	  bacteria	  PFA	   fixed	  cells	  were	   labelled	  
using	   fluorescein	   isothiocyanate	   (FITC)	   conjugated	   anti-­‐Chlamydia	   spp.	   primary	  
antibody	  (Table	  2.3)	  before	  permeabilisation	  using	  methanol:ethanol.	  A	  second	  round	  
of	   antibody	   labelling,	   using	   anti-­‐Chlamydia	   spp.	   antibody	   (Table	   2.3)	   and	   an	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2.4.3	  Sample	  preparation	  for	  live	  microscopy	  
Solutions:	  
• live	   microscopy	   medium	   –	   high	   glucose	   Dulbecco’s	   modified	   eagle	   medium	  
without	   phenol	   red	   (DMEM-­‐PR),	   1x	   GlutaMAX	   supplement,	   10%	   FBS	   (All	   from	  
Gibco,	  Invitrogen,	  Carlsband,	  CA,	  USA)	  
Following	  experiments,	  growth	  medium	  was	  removed	  from	  cells	  that	  had	  been	  seeded	  
in	   either	   LabTek	   chambers	   or	   glass	   bottomed	   petri	   dishes.	   Cells	   were	   washed	   with	  
DMEM-­‐PR	  to	  remove	  any	  traces	  of	  phenol	   red,	  which	  could	  otherwise	   interfere	  with	  
fluorescence	   emissions.	   Media	   was	   replaced	   with	   live	   microscopy	   media	   for	   all	  
labelling	  steps.	  
2.4.4	  Antibody	  labelling	  
• blocking	  buffer	  –	  1%	  (w/v)	  bovine	  serum	  albumin	  (BSA)	  (Sigma	  Aldrich	  St	  Louis,	  
MO,	  USA)	  in	  PBS	  	  
• washing	  buffer	  –	  0.1%	  (w/v)	  BSA	  in	  PBS	  
All	  primary	  antibodies	  were	  diluted	   in	  blocking	  buffer	  and	   incubated	  with	  cells	  using	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target	   host	   source	   fixation/	  permeabilisation	  
stock	  
(mg/ml)	   dilution	  








4%	  PFA	  /	  
methanol:ethanol	   -­‐	   1:200	  
Chlamydia	  




4%	  PFA	  /	  
methanol:ethanol	   -­‐	   1:200	  
giantin	   rabbit	   Covance	   methanol	  	   -­‐	   1:500	  
calreticulin	   rabbit	   Thermo	  Scientific	  
4%	  PFA	  /	  
methanol:ethanol	   -­‐	   1:150	  
Table	  2.3.	  Primary	  antibodies.	  Asterisk	  (*)	  indicates	  antibodies	  discontinued	  by	  the	  manufacturer.	  	  
	  
An	  antibody	   isotype	  control	   for	  Chlamydia	  spp.	  MOMP/LPS	  antibody	  was	  carried	  out	  
using	  mouse	  Immunoglobulin	  G	  (IgG)	  isolated	  from	  normal	  mouse	  serum	  (described	  in	  
Section	   2.4.4).	   IgG	   was	   diluted	   in	   blocking	   buffer	   and	   incubated	   with	   infected	   cells	  
according	   to	   the	   conditions	   used	  with	   anti	  Chlamydia	   spp	   antibody,	   as	   described	   in	  
Table	   2.3.	  Cells	  were	   then	  washed	   in	  PBS	   followed	  by	  washing	  buffer	  and	   incubated	  
with	  appropriate	  secondary	  antibody	  for	  1h	  at	  RT,	  washed	  in	  PBS	  followed	  by	  washing	  
buffer	  and	  then	  mounted	  (Figure	  2.1	  A-­‐B).	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Following	   primary	   antibody	   incubation	   coverslips	   were	   washed	   in	   PBS	   followed	   by	  
washing	   buffer	   and	   allowed	   to	   dry	   before	   application	   of	   secondary	   antibodies.	   All	  
AlexaFluor®	  secondary	  antibodies	  were	  purchased	  from	  Molecular	  Probes	  (Invitrogen,	  
Carlsband,	  CA,	  USA).	  For	  fluorescene	  excitation	  and	  emission	  information	  see	  Table2.4.	  
All	   secondary	   antibodies	   were	   checked	   for	   cross	   reactivity	   by	   incubating	   with	   fixed	  
cells	  in	  the	  absence	  of	  any	  primary	  antisera	  (Figure	  2.1	  C).	  
2.4.5	  Isolation	  of	  mouse	  IgG	  from	  serum	  
Solutions:	  
• binding	  buffer	  -­‐	  20mM	  sodium	  phosphate	  pH8.0	  
• elution	  buffers	   (at	   decreasing	  pH	   from	  7.5	   [1]	   to	   3.0	   [10]	   at	   intervals	   of	   0.5)	   –	  
0.1M	  sodium	  citrate	  pH7.5(1)	  -­‐	  3.0	  (10)	  
• neutralisation	  buffer	  –	  1M	  Tris(hydroxymethyl)aminomethane	  (Tris)-­‐HCl	  pH9.0	  
Specificity	   of	   Argene	   anti	   Chlamydia	   spp.	   for	   each	   serovar	   and	   cell	   line	   used	   was	  
assayed	   using	   IgG	   isolated	   from	   mouse	   serum.	   Normal	   mouse	   serum	   (Invitrogen,	  
Carlsbad,	  CA,	  USA)	  was	  added	  at	  a	  ratio	  of	  2:1	  to	  binding	  buffer	  and	  adjusted	  to	  pH8.1.	  
A	   HiTrap	   protein	   A	   column	   (GE	   Healthcare,	   Buckinghamshire,	   UK)	   was	   prepared	   by	  
equilibrating	   the	   column	  with	  10ml	  binding	  buffer	   at	  1ml/minute	  before	   loading	   the	  
serum.	   The	   column	   was	   then	   flushed	   through	   with	   10ml	   binding	   buffer	   until	   no	  
material	   was	   visible	   in	   effluent.	   The	   column	   was	   then	   washed	   with	   1.5ml	   of	   each	  
elution	   buffer	  with	   increasing	   acidity.	   Flow	   through	  was	   collected	   in	   250µl	   fractions	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Figure	  2.1.	  Antibody	   labelling	   controls.	   (A-­‐C)	  Confocal	   xy-­‐sections	  of	  C.trachomatis	  
LGV2	  infected	  HeLa	  cells	  fixed	  at	  24hpi	  with	  methanol:ethanol	  (v/v)	  prior	  to	  DRAQ-­‐5	  
DNA	   labelling	   (blue)	   and	   co-­‐stained	   with	   (A)	   Chlamydia	   spp.	   MOMP/LPS	   specific	  
antibody	   and	   AlexaFluor®568	   conjugated	   secondary	   antibody	   (red)	   (B)	  
AlexaFluor®568	   conjugated	   secondary	   antibody	   only	   (C)	   mouse	   IgG	   purified	   from	  
serum	  followed	  by	  AlexaFluor®568	  conjugated	  secondary	  antibody.	  Scale	  bars,	  10µm.	  
(D)	  Mouse	   IgG	  purified	  from	  normal	  mouse	  serum	  identified	  by	  Western	  blot	  using	  
goat	  anti-­‐mouse	   horseradish	   peroxidase-­‐conjugated	   secondary	   antibody.	  Molecular	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and	   neutralised	   before	   being	   assayed	   for	   protein	   content	   using	   a	   Nanodrop	   2000	  
spectrophotometer	   (Thermo-­‐Fischer,	   Leicestershire,	   UK).	   All	   immunoglobulin	  
containing	   samples	   eluted	   at	   the	   same	   pH	   were	   pooled	   and	   all	   fractions	   without	  
detectable	  protein	  were	  discarded.	  IgG	  eluted	  at	  pH	  4.5	  (elution	  buffer	  7)	  were	  pooled	  
and	   tested	   for	  quality	  using	  a	  Western	  blot	   (described	  below	   in	  Section	   2.10.	   Figure	  
2.1D).	  	  
2.4.6.	  Mounting	  fixed	  samples	  
Solutions:	  
• MOWIOL	  mounting	  medium	   (MOWIOL)	   -­‐	  PBS,	  20%	   (w/v)	  MOWIOL	  4-­‐88	   (Sigma	  
Aldrich,	  St	  Louis,	  MO,	  USA),	  30%	  (v/v)	  glycerol	  
Glass	  microscope	  slides	  were	  washed	  in	  excess	  ethanol	  to	  remove	  any	  residual	  dirt	  or	  
grease	   and	   allowed	   to	   dry.	   Once	   fixed	   cells	   were	   appropriately	   labelled,	   coverslips	  
were	  washed	   in	   PBS	   and	   allowed	   to	   air	   dry	   for	   10min.	  A	   10µl	   drop	  of	  MOWIOL	  per	  
coverslip	  was	  applied	   to	   clean	  glass	   slides	   and	  dried	   coverslips	  were	  placed	   cell	   side	  
down	  into	  the	  MOWIOL.	  This	  was	  then	  allowed	  to	  polymerise	  at	  RT	  for	  30min	  prior	  to	  
storage	  at	  4°C.	  	  
2.4.7	  Fluorescent	  probes	  
For	   emission	   and	   excitation	  wavelengths	   for	   each	   fluorescent	   probe	   used	   see	  Table	  
2.4.	  
	  	   70	  
2.4.7.a	   Asante	   potassium	   green-­‐2	   acetoxymethyl	   ester	   (AM	   ester)	   (APG-­‐2)	  
(TEFLabs,	  Austin,	  TX,	  USA)	  	  
50µg	  of	  APG-­‐2	  was	  reconstituted	  in	  45µl	  DMSO	  to	  yield	  a	  1M	  stock	  solution.	  A	  
working	   solution	   of	   1mM	   was	   achieved	   by	   diluting	   stock	   in	   live	   microscopy	  
medium	   before	   addition	   to	   live	   cells.	   Cells	   were	   then	   incubated	   at	   37°C	   for	  
30min	  before	  washing	  with	  DMEM-­‐PR.	  Fresh	  live	  microscopy	  medium	  was	  then	  
added	  for	  the	  duration	  of	  the	  imaging	  experiment.	  
2.4.7.b	  BODIPY®	  Texas	  Red	  (TR)	  Glibenclamide	  (Molecular	  Probes,	  Invitrogen,	  
Carlsband,	  CA,	  USA)	  
100µg	  of	  BODIPY	  TR	  Glibenclamide	  was	  diluted	  in	  110µl	  DMSO	  to	  yield	  a	  1mM	  
stock	  solution.	  A	  working	  solution	  of	  500nM	  was	  achieved	  by	  diluting	  stock	  in	  
live	  microscopy	  medium	  before	  addition	  to	  live	  cells.	  Cells	  were	  then	  incubated	  
at	   37°C	   for	   30min	   before	   washing	   with	   DMEM-­‐PR.	   Fresh	   live	   microscopy	  
medium	  was	  then	  added	  for	  the	  duration	  of	  the	  imaging	  experiment.	  
2.4.7.c	  4’,6-­‐diamidine-­‐2’-­‐phenylindole	  (DAPI)	  (Roche,	  Indianpolis,	  IN,	  USA)	  
10mg	   of	   DAPI	   was	   diluted	   in	   10ml	   deionized	   water	   to	   yield	   a	   1mg/ml	   stock	  
solution.	  A	  working	   solution	  of	   1µg/ml	  was	   achieved	  by	  diluting	   stock	   in	   PBS	  
before	   addition	   to	   fixed,	   permeabilised	   cells,	   either	   alone	   or	   in	   combination	  
with	   antibodies.	   Cells	   were	   incubated	   for	   15min	   at	   RT	   protected	   from	   light	  
before	  washing	  in	  excess	  PBS.	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2.4.7.d	   1,5-­‐bis{[2-­‐(di-­‐methylamino)ethyl]amino}-­‐4,8-­‐dihydroxyanthracene-­‐9,	  
10-­‐dione	  (DRAQ-­‐5)	  (Abcam,	  Cambridge,	  UK)	  	  
5mM	   stock	   solution	   of	   DRAQ-­‐5	   was	   diluted	   to	   5µM	  working	   solution	   in	   PBS	  
before	  addition	  to	  fixed	  cells	  and	  incubated	  at	  RT	  for	  30min	  before	  washing	  in	  
excess	   PBS.	   For	   live	  microscopy	   a	   25µM	  working	   solution	   was	   added	   to	   live	  
cells.	  Cells	  were	  then	  incubated	  at	  37°C	  for	  30min	  before	  washing	  with	  DMEM-­‐
PR.	   Fresh	   live	   microscopy	   medium	   was	   then	   added	   for	   the	   duration	   of	   the	  
imaging	  experiment.	  
2.4.7.e	   BisBenzimide	   H	   33342	   trihydrochloride	   (Hoechst)	   (Sigma-­‐Aldrich,	   St	  
Louis,	  MO,	  USA)	  
100mg	  of	  Hoechst	  was	  diluted	  in	  10ml	  deionised	  water	  to	  yield	  a	  stock	  solution	  
of	  10mg/ml.	  A	  working	  solution	  of	  1µg/ml	  was	  achieved	  by	  diluting	  stock	  in	  live	  
microscopy	  medium	  before	  addition	  to	  live	  cells.	  Cells	  were	  then	  incubated	  at	  
37°C	  for	  30min	  before	  washing	  with	  DMEM-­‐PR.	  Fresh	  live	  microscopy	  medium	  
was	  then	  added	  for	  the	  duration	  of	  the	  imaging	  experiment.	  
2.4.7.f	   MitoTracker®	   orange	   (Molecular	   probes,	   Invitrogen,	   Carlsband,	   CA,	  
USA)	  	  
50µg	  of	  Mitotracker	  Orange	  was	  reconstituted	  in	  DMSO	  to	  yield	  a	  1mM	  stock	  
solution.	  A	  working	  solution	  of	  50nM	  was	  achieved	  by	  diluting	  stock	  in	  DMEM	  
before	  addition	  to	  live	  cells	  and	  incubation	  at	  37°C	  for	  45min.	  Cells	  were	  then	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washed	  with	  DMEM	  before	  fixation	  with	  warm	  4%	  PFA	  in	  DMEM	  for	  20min	  at	  
37°C.	  
2.4.7.g	  Wheat	  germ	  agglutinin	  AlexaFluor®	  594	  conjugate	   (WGA)	   (Molecular	  
Probes,	  Invitrogen,	  Carlsband,	  CA,	  USA)	  
5mg	   of	  WGA	  was	   diluted	   in	   5ml	   of	   PBS	   to	   yield	   a	   1mg/ml	   stock	   solution.	   A	  
working	  concentration	  of	  5µg/ml	  was	  achieved	  by	  diluting	  stock	  in	  PBS	  before	  
addition	  to	  fixed	  cells	  prior	  to	  permeabilisation.	  Cells	  were	  incubated	  at	  RT	  for	  
15min	   protected	   from	   light.	   Cells	   were	   then	   washed	   3	   times	   in	   excess	   PBS	  
before	  permesabilisation	  and	  further	  labelling.	  
2.4.8	  Transfection	  
Transfection	  medium	  was	   prepared	   by	   adding	   0.7µl	   Turbofect	   (Fermentas,	   Thermo-­‐
Fischer,	   Leicestershire,	   UK)	   to	   DMEM	   followed	   by	   150ng	   DNA	   (For	   plasmids	   see	  
Appendix	   3).	  Medium	  was	  vortexed	   thoroughly	  and	   incubated	  at	  RT	   for	  15min.	  50µl	  
transfection	  medium	  was	  added	  per	  500µl	  media	  to	  adherent	  cells	  at	  70%	  confluence.	  
When	   transfecting	   infected	   cells,	   Chlamydiaceae	   infection	   protocol	   was	   carried	   out,	  
and	  transfection	  media	  was	  prepared	  during	  infection	  incubation	  period	  in	  order	  to	  be	  
added	  to	  cells	  when	  medium	  was	  changed	  after	  90min	  incubation.	  	  
	  
	  
	  	   73	  





AlexaFluor	  488	  	   	  	   Molecular	  Probes	  	   499	   519	  
AlexaFluor	  568	  	   	  	   Molecular	  Probes	  	   579	   603	  







Probes	  	   589	   615	  
Chlamydia	  spp.	  
FITC	  conjugate*	   Chlamydia	  
Argene	  (Now	  
BioMérieux)	   495	   519	  
DAPI	   DNA	   Roche	   345	   455	  
DRAQ-­‐5	   DNA	   Abcam	   647	   681-­‐697	  
GFP	   	  	   	  	   488	   507	  
Hoechst	  33342	   DNA	   Sigma-­‐Aldrich	   345	   478	  
MitoTracker	  
orange	   mitochondria	  
Molecular	  
Probes	  	   554	  	   	  576	  






Probes	  	   591	   618	  
Table	   2.4.	   Fluorescence	   excitation	   and	   emission	  wavelengths.	  *indicates	  products	  discontinued	  by	  
manufacturer.	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2.5	  Microscopy	  
2.5.1	  Fixed	  confocal	  microscopy	  
All	   confocal	  microscopy	  of	   fixed	   samples	  was	  undertaken	  using	   a	   Leica	   Sp5	   confocal	  
microscope	   (Leica,	  Mannheim,	   Germany)	   equipped	  with	   a	   65mW	  Argon	   laser,	   1mW	  
HeNe	   543	   laser	   and	   a	   10mW	   HeNe	   633	   laser	   with	   Acousto	   optical	   beam	   splitting	  
between	  400nm	  and	  800nm.	  Unless	  otherwise	  stated,	  all	  images	  were	  obtained	  using	  
a	   63x	   oil	   emersion	   objective	   and	   z-­‐stack	   slices	   were	   taken	   at	   0.33µm	   intervals	   at	  
1024x1024	  resolution	  with	  400Hz	  scanning	  speed.	  All	   images	  were	  obtained	  from	  a	  3	  
frame	  average.	  
2.5.2	  Live	  confocal	  microscopy	  
All	  live	  microscopy	  experiments	  were	  undertaken	  on	  cells	  seeded	  to	  30%	  confluence	  in	  
4	  well	  Labtek	  chambers	  (Nunc,	  Thermo-­‐Fischer,	  Leicestershire,	  UK)	  (Table	  2.1).	  Images	  
were	   recorded	   manually	   at	   appropriate	   timepoints	   using	   the	   Leica	   Sp5	   described	  
above.	  	  
2.5.3	  Epifluorescence	  microscopy	  
DAPI	   labelled	   samples	   were	   imaged	   using	   the	   Leica	   Sp5	   confocal	   microscope	  
(described	  above)	  using	  a	  mercury	  lamp	  and	  an	  appropriate	  excitation	  filter.	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2.5.4	  Time-­‐lapse	  microscopy	  
All	   time-­‐lapse	   experiments	   were	   imaged	   using	   an	   Olympus	   Total	   Internal	   Reflection	  
1X81	  confocal	  microscope,	  which	  has	  a	  UV	  laser	  for	  405nm	  excitation	  and	  SIM	  scanner	  
to	   allow	   simultaneous	   excitation	   and	   detection	   with	   FV10-­‐ASW	   viewer.	   Time-­‐lapse	  
experiments	  were	  undertaken	  over	  6h	  periods	  with	  images	  taken	  every	  10min	  at	  63x	  
magnification.	  Cells,	   seeded	  to	  30%	  confluence	   in	  35mm	  glass	  bottomed	  petri	  dishes	  
(See	  Table	  2.1),	  were	  maintained	  at	  5%	  CO2	  on	  a	  stage	  heated	  to	  37°C.	  The	  microscope	  
was	  fitted	  with	  vertical	  drift	  compensation.	  	  
2.5.5	  Fluorescence	  recovery	  after	  photobleaching	  (FRAP)	  
Cells	   for	   FRAP	   analysis	   were	   seeded	   at	   30%	   confluence	   in	   glass	   bottomed	   LabTek	  
chambers	  (Nunc,	  Thermo-­‐Fischer,	  Leicestershire,	  UK).	  Cells	  were	  infected	  and	  labelled	  
with	  APG-­‐2.	  Using	  the	  Leica	  FRAP	  wizard,	  points	  of	  interest	  were	  bleached	  with	  argon	  
and	  488	  lasers	  set	  at	  100%.	  Images	  were	  taken	  at	  with	  a	  scanning	  speed	  of	  1000Hz	  for	  
minimised	   intervals	   for	   10	   frames	   and	   then	   at	   20s	   intervals	   for	   20	   frames	   (for	   FRAP	  
wizard	  settings	  see	  Appendix	  5).	   Images	  were	  obtained	  at	  a	  resolution	  of	  1024x1024	  
from	  a	  3	  frame	  average.	  
2.5.6	  Fluorescence	  intensity	  comparisons	  
For	   timelapse	   and	   FRAP	   experiments	   fluorescence	   intensity	   was	   measured	   using	  
ImageJ	   (for	   macro	   used	   see	   Appendix	   4).	   Average	   pixel	   intensities	   for	   regions	   of	  
interest	   (ROIs)	   were	   calculated	   for	   each	   frame	   and	   corrected	   for	   background	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fluorescence	  using	  an	  area	  within	  the	  FOV	  with	  no	  cells	  present,	  and	  photobleaching,	  




Equation	   3.	   Fluorescence	   intensity	   calculation.	   (averageROI)	   mean	   pixel	   intensity	   of	   ROI	   area.	  
(averagebackground)	   mean	   pixel	   intensity	   of	   background	   area.	   (averageNI)	   mean	   pixel	   intensity	   of	   non	  
infected	  cell	  nucleus.	  
	  
2.6	  Bacteria	  infectivity	  assay	  
Chlamydia	   is	   an	   obligate	   intracellular	   bacterium,	   which	   makes	   quantification	   of	  
infectious	   bacterial	   progeny	   very	   difficult.	   Similar	   to	   IFU	   calculations	   described	  
previously,	   an	   approximate	   IFU/ml	   value	   was	   calculated	   based	   on	   the	   number	   of	  
inclusions	   observed	   in	   a	   monolayer	   of	   cells	   infected	   with	   bacteria	   collected	   from	  
treated	  cells	  at	  appropriate	  time	  points	  (Figure	  2.2).	  
2.6.1	  Sample	  preparation	  
Cells	   were	   plated	   to	   100%	   confluence	   and	   infected	   following	   Chlamydiae	   infection	  
protocol	   (2.2.1).	   Following	   treatments,	   infection	   medium	   was	   removed	   before	   cells	  
and	  bacteria	  were	   collected	  by	   scraping	   into	   SPG	  buffer.	   Cells	  were	   then	   frozen	  at	   -­‐
80°C.	  
	  	   77	   	  










Figure	   2.2.	   Schematic	   representation	   of	   bacterial	   infectivity	   assay.	   HeLa	   cell	  
monolayers	  were	   infected	  (1)	  prior	  to	  drug	  treatments	   for	  appropriate	  duration	  (2).	  
Cells	  were	  then	  collected	  by	  scraping	  and	  frozen	  at	   -­‐80°C	  (3).	  Cells	  were	  then	   lysed	  
into	  fresh	  infection	  medium,	  to	  release	  bacteria,	  and	  used	  to	  infect	  a	  new	  monolayer	  
of	  HeLa	  cells	  (4).	  Second	  round	  infection	  was	  then	  allowed	  to	  proceed	  for	  24h	  before	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2.6.2	  Second	  round	  infection	  
HeLa	   cells	   were	   seeded	   to	   70%	   confluence	   on	   glass	   coverslips.	   Collected	   cells	   were	  
defrosted	   on	   ice	   and	   diluted	   1:100	   in	   HeLa	   cell	   infection	   medium.	   Bacteria	   were	  
released	   by	   flushing	   medium	   repeatedly	   through	   a	   23g	   needle.	   Bacteria	   were	   then	  
centrifuged	   onto	   cells	   at	   900rpm	   using	   a	   Rotina	   420R	   centrifuge	   (Hettich	   Lab,	  
Technology,	   Tuttlingen,	   Germany)	   for	   10min.	   Cells	   were	   then	   incubated	   at	   37°C	   5%	  
CO2	   in	   a	   humidified	   incubator	   for	   90min	   before	   replacing	   the	   infection	   medium	   to	  
prevent	  reinfection.	  Cells	  were	  then	  incubated	  for	  24h	  and	  fixed	  with	  4%	  PFA.	  
2.6.3	  IFU	  quantification	  
Fixed	   HeLa	   cells	   were	   labelled	   with	   DAPI	   and	   FITC	   conjugated	   anti	   Chlamydia	   spp.	  
antibody	  and	  observed	  by	  epifluorescence.	  IFU/ml	  was	  quantified	  using	  Equation	  2.	  By	  
counting	   the	   number	   of	   cells	   and	   the	   number	   of	   inclusions	   in	   10	   FOVs	   an	   average	  
number	  of	  infections	  across	  the	  coverslip	  can	  be	  calculated.	  This	  can	  be	  multiplied	  by	  
the	  original	  dilution	  factor	  to	  obtain	  the	  IFU/ml	  from	  the	  inclusions	  collected	  from	  the	  
treated	  inclusions.	  
2.6.4	  Statistical	  analysis	  
For	  each	  experiment,	  the	  IFU	  was	  quantified	  using	  an	  average	  obtained	  from	  counting	  
nuclei	  and	  inclusions	  from	  10	  FOVs.	  Statistical	  significance	  was	  determined,	  using	  the	  
IFU	   calculated	   from	  each	   individual	   FOV,	  using	   the	  Mann-­‐Whitney	  non-­‐parametric	  U	  
test.	  Each	  condition	  (group	  2)	  was	  compared	  against	  an	  appropriate	  control	  condition	  
(group	  1).	  Individual	  IFU	  values	  were	  ranked	  (the	  lowest	  value	  was	  given	  a	  ranking	  of	  1,	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the	  next	  lowest	  a	  ranking	  of	  2	  etc.).	  Where	  values	  were	  identical,	  a	  mean	  ranking	  value	  
was	   given	   to	   each.	   	   Rank	   totals	   for	   each	   group	  were	   tallied	   and	   calculated	  U	   values	  
were	   obtained	   (Equation	   4).	   Critical	   values	   for	   U	   are	   given	   in	   Appendix	   6,	   and	  




Equation	  4.	  Mann-­‐Whitney	  U	  test.	  (U)	  calculated	  U.	  (N1)	  Number	  of	  values	  in	  group	  1.	  (N2)	  Number	  of	  
values	  in	  group	  2.	  (Nx)	  Number	  of	  values	  in	  the	  group	  that	  gave	  the	  largest	  rank	  total.	  (Tx)	  largest	  rank	  
total.	  
	  
2.7	  Flame	  Photometry	  
2.7.1	  Photometer	  calibration	  
Changes	   in	   intracellular	   potassium	   concentrations	   following	   drug	   treatments	   were	  
determined	  using	  flame	  photometry.	  Dr	  Anselm	  Zdebik	  (Department	  of	  Neuroscience	  
at	   the	   Royal	   Free	   Hospital,	   London)	   kindly	   allowed	   us	   to	   use	   his	   Corning	   400	   flame	  
photometer	  (Sherwood	  Scientific	  Ltd,	  Cambridge,	  UK).	  To	  determine	  the	  accuracy	  and	  
range	  of	  the	  flame	  photometer,	  calibration	  solutions	  of	  potassium	  chloride	  diluted	  in	  
deionised	  water	  were	  assayed	  by	  siphoning	  the	  sample	  into	  the	  photometer	  until	  the	  
emission	  intensity	  at	  766nm	  (Smith	  and	  Nesson,	  1971)	  stabilised	  for	  20s.	  An	  emission	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intensity	   curve	   was	   then	   constructed	   and	   a	   lower	   threshold	   and	   saturation	   point	  
established	  (Figure	  2.3).	  	  
2.7.2	  Sample	  preparation	  
700,000	  HeLa	  cells	  were	  seeded	  per	  well	  of	  a	  6	  well	  plate	  and	  allowed	  to	  adhere	  for	  
24h	   at	   37°C	   with	   5%	   CO2	   prior	   to	   treatment.	   All	   drugs	   were	   used	   at	   the	   working	  
concentrations	   shown	   in	   Table	   2.2	   and	   incubated	   with	   cells	   for	   6h.	   Following	  
treatment,	  monolayers	  were	  washed	  in	  deionised	  water	  at	  4°C	  before	  careful	  removal	  
of	   all	   liquid.	   Cells	   were	   then	   incubated	  with	   2ml	   of	   0.5%	   (v/v)	   Triton	   X-­‐100	   (Sigma,	  
Aldrich,	  St	  Louis,	  MO,	  USA),	  diluted	  in	  deionized	  water,	  on	  ice	  for	  30min.	  Supernatants	  
were	   collected	   and	   centrifuged	   at	   13,000rpm	   using	   an	   Eppendorf	   5424	   benchtop	  
centrifuge	  (Eppendorf,	  Hamburg,	  Germany)	  for	  15min	  to	  remove	  cell	  debris.	  For	  each	  
condition	   a	   second	   well	   of	   cells	   was	   seeded	   and	   treated	   on	   order	   to	   estimate	   the	  
number	  of	  cells	  lysed	  into	  the	  samples	  collected.	  All	  samples	  used	  were	  within	  1.3	  x106	  
±	  0.1x106	  cells,	  to	  enable	  appropriate	  comparison	  of	  potassium	  ion	  (K+)	  concentrations	  
in	   final	   samples.	   K+	   emission	   intensity	   was	   measured	   as	   described	   above	   and	  
percentage	  K+	  loss	  calculated	  with	  reference	  to	  an	  untreated	  control	  population	  with	  a	  
similar	  number	  of	  cells.	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Figure	  2.3.	  K+	  concentration	  calibration	  curve.	  Calibration	  solutions	  of	  KCl	  from	  100-­‐
1000µM	  were	   assayed	   using	   flame	  photometry.	   Percentage	  emission	   intensity	  was	  
recorded	  to	  determine	  the	  sensitivity	  of	  the	  assay	  and	  establish	  a	  saturation	  point.	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2.8	  Electron	  microscopy	  
2.8.1	  Sample	  preparation	  
Solutions:	  
• fixation	   buffer	   –	   0.1M	   sodium	   cacodylate	   trihydrate	   (caco)	   ,	   2.5%	   (w/v)	  
gluteraldehyde,	  0.05%	  malachite	  green	  in	  deionized	  water	  
• osmium	  tetroxide	  solution	  –	  0.1M	  caco,	  0.5%	  (w/v)	  OsO4,	  0.8%	  (w/v)	  potassium	  
ferricyanide	  
• tannic	  acid	  –	  0.05M	  caco,	  1%	  (w/v)	  tannic	  acid	  
• uranyl	  acetate	  solution	  –	  1%	  (w/v)	  uranyl	  acetate	  
• resin	  -­‐	  agar,	  DDSA	  hardener,	  MNA	  hardner	  
HeLa	  cells	  were	  seeded	  on	  glass	  coverslips	  at	  70%	  confluencey	  onto	  glass	  coverslips.	  
Following	   C.trachomatis	   infection	   cells	   were	   fixed	   in	   fixation	   buffer	   for	   2h	   at	   RT.	  
Fixation	  buffer	  was	  then	  removed	  by	  washing	  3	  times	  in	  0.1M	  caco	  before	  incubating	  
for	  30min	  with	  osmium	  tetroxide	   to	   increase	  contrast	  of	   final	   images.	   Samples	  were	  
then	  post	  fixed	  in	  tannic	  acid	  for	  1h,	  with	  a	  change	  of	  tannic	  acid	  solution	  after	  10min	  
in	   case	  of	  osmium	  precipitation.	  Samples	  were	   then	  washed	   twice	   in	  0.1M	  caco	  and	  
then	   twice	   in	   deionised	   water	   before	   negative	   staining	   with	   uranyl	   acetate	   for	   1h,	  
protected	  from	  light.	  Samples	  were	  then	  dehydrated	  and	  embedded	  using	  ethanol	  and	  
resin	   dilution	   series	   (see	   Table	   2.5)	   Samples	   were	   then	   incubated	   at	   60°C	   for	   the	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EtOH	  (%	  in	  H2O)	   Incubation	  
25%	   2x	  2m	  
50%	   2x	  2m	  
70%	   2x	  2m	  
100%	   4x	  2m	  
embedding	  
EtOH:resin	   Incubation	  
3:1	   15m	  
2:2	   15m	  
1:3	   15m	  
pure	  resin	   overnight	  
Table	  2.5.	   TEM	  sample	  dehydration	  and	  embedding	  dilution	  series.	  TEM	  samples	  were	  dehydrated	  
using	   an	   increasing	   concentration	   of	   ethanol	   diluted	   in	   water.	   Samples	   were	   then	   embedded	   in	  
increasing	  concentrations	  of	  resin	  diluted	  in	  100%	  ethanol.	  
	  
2.8.2	  Sectioning	  
Hardened	  samples	  were	  sectioned	  using	  a	  Leica	  UC7	  microtome.	  Blocks	  were	  trimmed	  
using	  a	  cryotrim	  45	  diamond	  knife	  (Diatome,	  Hatfield,	  PA,	  USA)	  and	  100nm	  ultra	  thin	  
sections	  were	  cut	  using	  an	  Ultra	  45°	  knife	  (Diatome,	  Hatfield,	  PA,	  USA).	  Sections	  were	  
collected	  using	  a	  perfect	  loop	  (Diatome,	  Hatfield,	  PA,	  USA)	  and	  placed	  onto	  400	  square	  
mesh	  copper	  grids	  (Agar	  scientific,	  Elektron	  Technology,	  Stanstead,	  UK).	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2.8.3	  Electron	  microscopy	  
Copper	  grids	  were	   imaged	  using	  a	  Tecnai	  100kV	  electron	  microscope	  with	  a	  charged	  
coupled	  device	  (CCD)	  camera.	  
	  
2.9	  Bacterial	  viability	  assay	  
2.9.1	  Sample	  preparation	  
700,000	  HeLa	  cells	  were	  seeded	  per	  well	  of	  a	  6	  well	  plate	  and	  allowed	  to	  adhere	  for	  
24h	   at	   37°C	   with	   5%	   CO2	   prior	   to	   treatment.	   All	   compounds	   were	   used	   at	   the	  
concentrations	  shown	  in	  Table	  2.2	  and	  incubated	  with	  cells	  for	  50h.	  
2.9.2	  Ribonucleic	  acid	  (RNA)	  isolation	  	  
RNA	  was	   isolated	  using	  RNeasy	  Mini	   Kit	   (Qiagen,	  Hilden,	  Germany)	   according	   to	   the	  
manufacturers	  instructions.	  
Solutions:	  
• RLT	  –	  RNeasy	  lysis	  buffer	  
• RW1	  –	  RNeasy	  wash	  buffer	  1	  
• RPE	  –	  RNeasy	  wash	  buffer	  2,	  4	  volumes	  ethanol	  
RNA	   was	   collected	   from	   cell	   monolayers	   using	   RNeasy	   mini	   kit	   (Qiagen,	   Hilden,	  
Germany)	   according	   to	  manufacturers	   instructions.	   Cells	   were	   collected	   by	   scraping	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into	   350µl	   RLT	   and	   homogenized	   by	   flushing	   through	   a	   23	   gauge	   needle.	   An	   equal	  
volume	  of	  70%	  ethanol	  was	  added	   to	   cell	   lysate	  and	  mixed	  by	  pipetting.	   Lysate	  was	  
then	   transferred	   to	   RNeasy	   spin	   column	   and	   centrifuged	   at	   13,000rpm	   using	   an	  
Eppendorf	  5424	  benchtop	  centrifuge	  (Eppendorf,	  Hamburg,	  Germany)	  for	  15s	  and	  flow	  
through	  was	  discarded.	  Column	  was	  then	  washed	  twice	  in	  RPE	  before	  RNA	  was	  eluted	  
into	  RNase	  free	  water.	  
2.9.3	  DNase	  treatment	  
Solutions:	  
• RDD	  buffer	  –	  DNase	  1	  Digestion	  buffer	  (Quiagen,	  Hilden,	  Germany)	  
RNA	  samples	  were	   treated	   for	  DNA	  contamination	  using	  15	  units	  of	  DNase	  1	   in	  10%	  
RDD	  buffer	  (Quiagen,	  Hilden,	  Germany)	  for	  10min	  at	  RT	  before	  enzyme	  denaturation	  
at	  75°C	  for	  10min.	  Concentration	  of	  samples	  was	  then	  determined	  using	  a	  Nanodrop	  
2000	   spectrophotometer	   (Thermo-­‐Fischer,	   Leicestershire,	   UK),	   using	   an	   absorption	  
wavelength	  of	  260nm.	  	  
2.9.4	  Reverse	  transcription	  	  
Solutions:	  
• 10	  x	  AffinityScript	  reverse	  transcription	  buffer	  (ART	  buffer)	  (Agilent	  Technologies,	  
Santa	  Clara,	  CA,	  USA)	  –	  500mM	  Tris-­‐HCl	  pH8.3,	  750mM	  KCl,	  30mM	  MgCl2	  
• 100mM	  Dithiothreitol	  (DTT)	  (Agilent	  Technologies,	  Santa	  Clara,	  CA,	  USA)	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• 100mM	  dNTP	  mix	  –	  25%	  dATP,	  25%	  dCTP,	  25%	  dGTP.	  25%	  dTTP	  (Sigma	  Aldrich,	  
St	  Louis,	  MO,	  USA)	  
For	   each	   RNA	   sample,	   a	   total	   of	   500ng	   RNA	   was	   added	   to	   300ng	   random	   primers	  
(Sigma	  Aldrich,	  St	  Louis,	  MO,	  USA)	  and	  made	  up	  to	  14.2µl	  in	  RNase/DNase	  free	  water	  
(Gibco,	  Invitrogen,	  Carlsband,	  CA,	  USA).	  Samples	  were	  then	  incubated	  at	  65°C	  for	  5min	  
then	  slowly	  cooled	  to	  RT	  to	  allow	  primers	  to	  anneal	  to	  RNA.	  Once	  cooled	  ART	  buffer	  
was	  added,	   followed	  by	  a	   final	  concentration	  of	  10mM	  DTT	  and	  4mM	  dNTPs,	  before	  
addition	   of	   AffinityScript	   multiple	   temperature	   reverse	   transcriptase	   (Agilent	  
Technologies,	   Santa	   Clara,	   CA,	  USA).	  Mixture	  was	   then	   incubated	   at	   25°C	   for	   10min	  
before	  temperature	  increase	  to	  42°C	  for	  1h.	  Reaction	  was	  then	  inactivated	  at	  70°C	  for	  
15min.	  DNA	  templates	  were	  then	  stored	  at	  -­‐20°C	  until	  PCR	  amplification.	  
2.9.5	  PCR	  amplification	  
Solutions:	  
• 10x	   PCR	   buffer	   (Sigma	   Aldrich,	   St.	   Louis,	   MO,	   USA)	   –	   10mM	   Tris-­‐HCl	   pH	   8.3,	  
500mM	  KCl	  
• 10mM	  dNTP	  mix	  –	  10%	  dATP,	  10%	  dCTP,	  10%	  dGTP,	  10%	  dTTP	  (Sigma	  Aldrich,	  St.	  
Louis,	  MO,	  USA)	  
• Tris-­‐Borate-­‐EDTA	  (TBE)	  –	  90mM	  Tris-­‐base,	  90mM	  boric	  acid,	  2mM	  EDTA	  
• 2%	  agarose	  gel	  –	  TBE,	  2%	  (w/v)	  agarose,	  0.002%	  (v/v)	  ethidium	  bromide	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• DNA	  loading	  buffer	  (New	  England	  BioLabs,	  Ipswich,	  MA,	  USA)	  	  -­‐	  2.5%	  Ficoll-­‐400,	  
11mM	  EDTA,	  3.3mM	  Tris-­‐HCl	  pH8.0,	  0.017%	  SDS,	  0.015%	  bromophenol	  blue	  
For	   C.trachomatis	   16SFW/	   C.trachomatis	   16SRV	   and	   Eukaryotic	   18SFW/Eukaryotic	  
18SRV	   primers	   see	   Appendix	   1.	   RNA	   samples	   were	   checked	   for	   cellular	   DNA	  
contamination	  before	  and	  after	  DNase	   treatment	  using	   the	  16S	   forward	  and	   reverse	  
primers	   along	   side	   the	   DNA	   templates	   created	   by	   reverse	   transcription.	   For	   each	  
condition	  5µl	  DNA	  template	  was	  added	  to	  PCR	  buffer,	  3mM	  MgCl2	  (Sigma	  Aldrich,	  St.	  
Louis,	   MO,	   USA),	   200µM	   dNTP	   mix,	   2µl	   of	   both	   C.trachomatis	   16SFW	   and	  
C.trachomatis	   16SRV	   primers	   and	   made	   up	   to	   25µl	   with	   RNase/DNase	   free	   water	  
(Gibco,	   Invitrogen,	   Carlsband,	   CA,	   USA)	   before	   addition	   of	   0.25	   units	   Taq	   DNA	  
polymerase	  (Sigma	  Aldrich,	  St.	  Louis,	  MO,	  USA).	  For	  PCR	  conditions	  see	  Table	  2.6.	  This	  
was	  repeated	   for	  each	  of	   the	  samples	  using	  Eukaryotic	  18SFW	  and	  Eukaryotic	  18SRV	  
primers.	  Resultant	  DNA	  samples	  were	  loaded	  into	  2%	  agarose	  gels	  with	  a	  2:1	  ratio	  of	  
sample	   to	   DNA	   loading	   buffer.	   1.5µg	   100bp	   DNA	   ladder	   (New	   England	   BioLabs,	  
Ipswich,	  MA,	  USA)	  with	  a	  range	  of	  100-­‐1,500	  base	  pairs	  was	  also	  added	  to	  the	  gels	  in	  
DNA	   loading	  buffer.	  Gels	  were	  run	   in	  TBE	  at	  100v	   for	  45min.	  Gels	  were	  then	   imaged	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Initial	  denaturation:	   95°C	   10min	  
40	  cycles:	   	   	  
Denaturation	   95°C	   30s	  
Annealing	   60°C	   45s	  
Extension	   72°C	   45s	  
Final	  extension:	   72°C	   10min	  
Hold:	   4°C	   ∞	  
Table	   2.6.	   PCR	   amplification	   parameters.	   DNA	   was	   amplified	   using	   a	   GeneAmp	   PCR	   system	   9700	  
thermal	  cycler	  (Applied	  Biosystems,	  Invitrogen,	  Carlsband,	  CA,	  USA)	  using	  the	  parameters	  described.	  
	  
2.10	  Western	  Blot	  	  
2.10.1	  Sample	  preparation	  
Solutions:	  
• Laemmli	   buffer	   (x2)	   –	   125mM	   Tris-­‐HCl	   pH6.8,	   20%	   (v/v)	   glycerol,	   4%	   (w/v)	  
sodium	   dodecyl	   sulphate	   (SDS),	   20%	   (v/v)	   β-­‐mercaptoethanol,	   0.02%	   (w/v)	  
bromophenol	  blue	  	  
700,000	  HeLa	  cells	  were	  seeded	  per	  well	  of	  a	  6	  well	  plate	  and	  allowed	  to	  adhere	  for	  
24h	   at	   37°C	   with	   5%	   CO2.	   Cells	   were	   then	   collected	   in	   750µl	   versene	   (Gibco,	  
Invitrogen)	   and	   counted	   before	   centrifugation	   at	   13,000rpm	   for	   15min	   using	   an	  
Eppendorf	   5424	   benchtop	   centrifuge	   (Eppendorf,	   Hamburg,	   Germany).	   Pellets	   were	  
then	   resuspended	   in	   50µL	   Laemmli	   buffer	   per	   million	   cells	   and	   boiled	   at	   100°C	   for	  
10min.	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2.10.2	  SDS-­‐	  polyacrylamide	  gel	  electrophoresis	  (SDS-­‐PAGE)	  
Solutions:	  	  
• 14%	  resolving	  gel	  –	  14%	  (v/v)	  acrylamide,	  0.375mM	  Tris-­‐HCl	  pH8.8,	  0.01%	  (w/v)	  
SDS,	   0.15%	   (v/v)	   ammonium	   persulphate	   (APS),	   0.06%	   (v/v)	  
tetramethylethylenediamine	  (TEMED)	  
• 5%	  stacking	  gel	  –	  5%	  acrylamide,	  0.25mM	  Tris-­‐HCl	  pH6.8,	  0.02%	  (w/v)	  SDS,	  0.15%	  
(w/v)	  APS,	  0.1%	  (v/v)	  TEMED	  
• migration	  buffer	  –	  25mM	  Tris-­‐base,	  192mM	  glycine,	  0.1%	  (w/v)	  SDS	  
4.5ml	  resolving	  gel	  mixture	  was	  pipetted	   into	  a	  clean	  gel	  caster	  with	  1.5mm	  spacers,	  
covered	  with	  isopropanol	  and	  allowed	  to	  polymerise	  for	  20min	  at	  RT.	  Isopropanol	  was	  
then	  removed	  and	  any	  excess	  allowed	  to	  evaporate	  whilst	  stacking	  gel	  was	  prepared.	  
Stacking	   gel	   was	   then	   layered	   on	   top	   of	   the	   resolving	   gel	   and	   a	   15	   well	   comb	  was	  
inserted.	   Gel	   was	   then	   allowed	   to	   polymerise	   for	   30min	   at	   RT.	   Samples	   were	  
centrifuged	   for	   15min	   at	   13,000rpm	   using	   an	   Eppendorf	   5424	   benchtop	   centrifuge	  
(Eppendorf,	  Hamburg,	  Germany)	  prior	  to	  loading	  12µl	  of	  each	  sample	  into	  well	  of	  the	  
polymerised	   gel.	   3µL	   of	   2mg/ml	   full	   range	   (12-­‐225	   kDa)	   rainbow	  weight	  marker	   (GE	  
Healthcare,	  Buckinghamshire,	  UK)	  was	  loaded	  into	  the	  first	  well	  of	  each	  gel.	  Gels	  were	  
run	  in	  migration	  buffer	  for	  approximately	  2h	  at	  30mA	  per	  gel.	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2.10.3	  Transfer	  
Solutions:	  
• transfer	  buffer	  –	  	  3.7mM	  Tris	  base,	  192mM	  glycine,	  20%	  (v/v)	  ethanol	  
• Ponceau	  red	  -­‐	  0.1%	  (w/v)	  ponceau	  S,	  20%	  acetic	  acid	  
Gels	   were	   incubated	   in	   transfer	   buffer	   with	   6	   sheets	   of	   0.34mm	  Whatman	   blotting	  
paper	  (Fisher	  Scientific,	  Leicestershire,	  UK)	  and	  a	  piece	  of	  nitrocellulose	  membrane	  at	  
4°C	   for	   15min	   to	   equilibrate	   osmolarity	   and	   buffer	   temperature.	   Transfer	   cassettes	  
were	  assembled	  with	  a	  sponge	  followed	  by	  three	  sheets	  of	  blotting	  paper	  then	  the	  gel,	  
the	   membrane	   and	   another	   sheet	   of	   blotting	   paper.	   Air	   bubbles	   were	   removed	   by	  
rolling	   a	   falcon	   tube	   across	   the	   top	   sheet	   of	   paper.	   Another	   two	   sheets	   of	   blotting	  
paper	  were	  placed	  on	  top	  and	  rolled	  again	  to	  ensure	  there	  were	  no	  bubbles	  between	  
the	  gel	  and	  the	  membrane.	  The	  second	  sponge	  was	  placed	  on	  top	  of	  the	  stack	  and	  the	  
sandwich	  enclosed	   in	   the	   cassette.	  Protein	  was	   then	   transferred	   from	   the	  gel	   to	   the	  
membrane	  overnight	   at	   1.2W	  per	   cassette	   at	   4°C.	   Following	   transfer	   the	  membrane	  
was	   checked	   for	   protein	   bands	   with	   Ponceau	   red	   staining	   for	   5min	   at	   RT	   and	   then	  
destained	  using	  deionized	  water.	  
2.10.4	  Development	  
Solutions:	  
• Tris	   buffered	   saline	   0.05%	   (v/v)	   tween	   (TBST)	   –	   20mM	   Tris	   HCl,	   150mM	  NaCl,	  
0.05%	  tween	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• blocking	  buffer	  –	  TBST	  with	  5%	  (w/v)	  powdered	  milk	  
• ECL	  Solution	  A	  –	  luminol	  solution	  	  
• ECL	  Solution	  B	  –	  peroxide	  solution	  
Membranes	  were	  blocked	   in	  blocking	  buffer	   for	  1h	  at	  RT.	  Antibodies	  were	  diluted	   in	  
blocking	  buffer	  and	  incubated	  with	  membranes	  for	  1h	  at	  room	  RT.	  Membranes	  were	  
then	   washed	   for	   1h	   in	   TBST	   before	   preparation	   for	   detection	   using	   Amersham	   ECL	  
prime	  western	  blotting	  reagent	  (GE	  Healthcare,	  Buckinghamshire,	  UK)	  according	  to	  the	  
manufacturer’s	   instruction,	  briefly	  membranes	  were	   incubated	  with	  a	  1:1	  mixture	  of	  
solution	  A	  and	  solution	  B	  for	  2min	  at	  RT	  then	  dried	  thoroughly.	  Membranes	  were	  then	  
exposed	   to	   Amersham	   ECL	   Hyperfilm	   (GE	   Healthcare,	   Buckinghamshire,	   UK)	   for	  
appropriate	   time	   and	   film	  was	   developed	  using	   Xograph	  Compact	   X4	   film	  developer	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3.1	  Introduction	  
Replicating	   Chlamydiae	   actively	   control	   the	   environment	   within	   their	   membrane	  
bound	  intracellular	  niche,	  termed	  the	  inclusion.	  The	  inclusion	  lumen	  is	  separated	  from	  
the	  eukaryotic	  cytosol	  by	  a	  host-­‐derived	  membrane,	  which	  is	  modified	  by	  the	  insertion	  
of	  bacterial	  proteins	  (Scidmore	  et	  al.,	  2003).	  Little	  is	  known	  about	  the	  composition	  of	  
the	   intra-­‐inclusion	   environment	   or	   the	   methods	   by	   which	   the	   bacteria	   maintain	  
optimal	   growth	   conditions.	   Experiments	   using	   small	   molecule	   probes	   demonstrated	  
that	  the	   inclusion	  membrane	  is	  apparently	  impermeable	  to	  molecules	  larger	  that	  520	  
Da	   (Heinzen	   et	   al.,	   1997).	   This	   is	   in	   contrast	   to	   the	   vacuoles	   of	   other	   intracellular	  
pathogens,	   for	   example,	   the	   parasitophorus	   vacuole	   of	   the	   intracellular	   protozoa	  
Toxoplasma	   gondii,	   which	   contains	   pores	   to	   allow	   the	   exchange	   of	   small	   molecules	  
from	  1300-­‐1900	  Da	   between	   the	   host	   and	   the	   parasite	   (Schwab	  et	   al.,	  1994).	  Many	  
other	   intracellular	   organisms,	   such	   as	   Coxiella	   burnetii	   (Heinzen	   et	   al.,	   1996)	   and	  
members	   of	   the	  Mycobacterium	   genus	   (Clemens	   and	   Horwitz,	   1996;	   Halaas	   et	   al.,	  
2010),	   inhabit	  phagosomes	  and	  acquire	  nutrients	   from	  their	  host	  by	   interacting	  with	  
recycling	  endosomes.	  Chlamydial	  inclusions	  remain	  largely	  segregated	  from	  endocytic	  
compartments	   (Friis,	   1972;	   Scidmore	   et	   al.,	   2003).	   Nevertheless,	   inclusions	   actively	  
intercept	   vesicles	   containing	   cholesterol	   and	   sphingomyelin	   (Carabeo	   et	   al.,	   2003;	  
Hackstadt	  et	  al.,	  1996),	  en	  route	   from	  the	  Golgi	  apparatus	  to	  the	  plasma	  membrane,	  
and	   have	   species-­‐specific	   requirements	   for	   lysosomes	   as	   a	   method	   of	   amino	   acid	  
uptake	  (Ouellette	  et	  al.,	  2011).	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Although	  numerous	  studies	  have	  investigated	  chlamydial	  nutrient	  acquisition	  from	  the	  
host	  cell,	  very	  little	  data	  exists	  on	  the	  physical	  conditions	  within	  the	  inclusion	  and	  the	  
methods	   of	   bacteria-­‐host	   communication.	   A	   study	   by	   Grieshaber	   et	   al.	   (2002)	   used	  
fluorescent	  ratiometric	  probes	  to	  determine	  both	  the	  pH	  and	  the	  cationic	  composition	  
of	   the	   C.trachomatis	   LGV2	   inclusion	   lumen	   20h	   into	   the	   infection	   cycle.	   This	   was	  
calculated	   to	   be	   pH7.25±0.19	   using	   carboxy	   fluorescein	   diacetate	   (CFDA)	   and	  
7.25±0.26	   using	   2’,7’-­‐bis(2-­‐carboxyethyl)-­‐5,6-­‐carboxyfluorescein	   acetoxymethyl	   ester	  
(BCECF-­‐AM),	  in	  both	  cases	  this	  was	  equivalent	  to	  the	  pH	  of	  the	  cytoplasm,	  calculated	  
at	   7.29±0.07	   and	   7.28±0.11	   respectively.	   Similarly,	   the	   concentrations	   of	   the	   ions	  
tested	  within	   the	   inclusion	   lumen	  were	   not	   significantly	   different	   from	   those	   in	   the	  
host	   cytoplasm.	   Inclusion	   potassium	   ion	   (K+)	   concentration	   was	   calculated	   at	  
148±9mM	  using	  potassium-­‐binding	  benzofuran	  isophthalate	  (PBFI)	  potassium	  sensitive	  
dye,	   only	   2mM	   more	   than	   the	   calculated	   cytoplasmic	   K+.	   Sodium	   ion	   (Na+)	  
concentration	  was	  determined	  to	  be	  14±9mM	  within	  the	  inclusion	  and	  21±4mM	  in	  the	  
host	  cell	  cytoplasm	  using	  sodium-­‐binding	  benzofuran	  isophthalate	  (SBFI).	  Fura-­‐PE3-­‐AM	  
was	   used	   to	   determine	   calcium	   (Ca2+)	   ion	   concentrations	   at	   34±4nM	   within	   the	  
inclusion	  and	  42±3nM	   in	   the	  host	   cell.	   The	   similarity	  of	   the	   ionic	   composition	  of	   the	  
inclusion	   lumen	  and	  host	  cell	  cytoplasm	  led	  the	  authors	  to	  suggest	  that	  the	   lack	  of	  a	  
discernable	   ionic	   gradient	   across	   the	   inclusion	   membrane,	   and	   distortions	   of	   the	  
inclusion	   during	   incubation	   with	   hypertonic	   sucrose	   solution,	   would	   indicate	   that	  
inclusion	  turgor	  is	  maintained	  by	  osmotic	  pressure.	  	  
In	  eukaryotic	  cells	   inorganic	   ions	  not	  only	  maintain	  membrane	  potentials	  and	  pH	  but	  
also	   act	   as	   signalling	   molecules.	   For	   example,	   K+	   efflux	   from	   cells	   in	   response	   to	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pathogens	  such	  as	  Bacillus	  anthracis	  (Pétrilli	  et	  al.,	  2007)	  and	  Pseudomonas	  aeruginosa	  
(Lindestam	   Arlehamn	   et	   al.,	   2010)	   activates	   inflammasomes,	   a	   protein	   complex	  
responsible	   for	   initiation	   of	   an	   inflammatory	   response	   via	   caspase-­‐1	   processing	   of	  
interleukin	  1β.	   In	  prokaryotes,	   intracellular	   ions	  perform	  a	  diverse	  array	  of	   functions,	  
for	  example,	  Hybiske	  and	  Stephens	  (2007)	  demonstrated	  that	  inhibition	  of	  Ca2+	  fluxes	  
at	  the	  end	  of	  the	  C.trachomatis	  infection	  cycle	  caused	  a	  significant	  delay	  in	  the	  rupture	  
of	   the	   plasma	   membrane	   and	   consequent	   release	   of	   bacteria.	   The	   bacterial	   K+	  
transport	   system	   Trk	   is	   necessary	   for	   host	   cell	   invasion	   by	   Salmonella	   enterica,	  
indicating	   a	   role	   for	   K+	   in	   bacterial	   virulence	   (Su	   et	   al.,	   2009).	   Other	   intracellular	  
pathogens	   have	   been	   shown	   to	   utilise	   the	   relatively	   high	   intracellular	   K+	  
concentrations	   to	   their	   advantage,	   for	   example,	   exposing	   Plasmodium	   sporozites	   to	  
intracellular	  K+	  concentrations	  has	  been	  shown	  to	   increase	   infectivity	  between	  4	  and	  
10-­‐fold	  depending	  on	  species	  (Kumar	  et	  al.,	  2007).	  
The	   aim	   of	   this	   chapter	   is	   to	   determine	   the	   importance	   of	   inorganic	   ions	   in	   the	  
Chlamydia	   inclusion,	   and	   to	   identify	   any	   role	   for	   these	   ions	   during	   the	   bacteria	  
development	  cycle.	  	  
The	   C.trachomatis	   inclusion	   is	   easily	   damaged	   by	   physical	   manipulation,	   which	   has	  
prevented	   comprehensive	   characterisation	   of	   the	   inclusion	   environment	   (Greishaber	  
et	  al.,	  2002).	  Instead,	  to	  further	  our	  understanding	  of	  the	  ionic	  environment	  within	  the	  
inclusion,	   the	   impact	  of	   altering	   important	   ions	  during	   the	  Chlamydia	   infection	   cycle	  
was	  assessed	  using	  compounds	  to	  specifically	  alter	  selected	  ion	  concentrations.	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Ionophores	  are	  a	  class	  of	  lipid	  soluble	  molecules,	  some	  naturally	  occurring	  and	  others	  
synthetic,	  which	   transport	   charged	   ions	  across	  membranes.	  There	  are	   two	  classes	  of	  
ionophore;	   mobile	   ion	   carriers	   (Figure	   3.1	   A),	   which	   transport	   specific	   ions	   across	  
membranes,	   and	   channel	   formers,	   which	   create	   pores	   in	   membranes	   to	   allow	   the	  
movement	  of	   ions	   (Figure	   3.1	  B).	  Due	  to	   the	  need	   for	  specificity,	  mobile	   ion	  carriers	  
will	  be	  used	  in	  this	  project.	  Mobile	  ion	  carriers	  are	  either	  cyclic	  peptides,	  or	  form	  cyclic	  
complexes	  when	   bound	   to	   an	   ion,	   and	   are	   arranged	  with	   polar	   side	   chains	   directed	  
inwards,	  generating	  a	  hydrophilic	  core.	  The	  size	  of	  the	  hydrophilic	  core	   lends	  binding	  
selectivity	   to	   the	   ionophore,	   creating	   a	   ligand	  pocket	   sterically	   suited	   to	   a	   particular	  
ion.	   Outwardly,	   the	   ionophore	   complex	   presents	   a	   hydrophobic	   surface	   in	   order	   to	  
partition	   into	   biological	   membranes.	   Mobile	   ionophores	   will	   diffuse	   within	   a	   lipid	  
bilayer	  and	  sequester	  an	  ion	  at	  a	  hydrophilic	  interface,	  simultaneously	  removing	  water	  
molecules	   and	   forming	   a	   stable,	   hydrogen	   bonded	   ionophore-­‐ion	   complex.	   This	  
complex	  diffuses	  across	  the	  membrane	  to	  a	  second	  interface	  where	  the	  ion	  becomes	  
rehydrated	   and	   the	   ionophore	   diffuses	   back	   into	   the	   membrane	   (Pressman,	   1976)	  
(Figure	   3.1	   A).	  Membrane	  potential	  electrophoretically	  drives	   ionophore	  diffusion	   to	  




	  	   99	   	  









Figure	   3.1.	   Schematic	   of	   ionophore	   mechanisms.	   (A)	   Mobile	   ion	   carrier	   –	   Lipid	  
soluble	  ionophore	  (green)	  sequesters	  an	  ion	  (red)	  at	  a	  hydrophilic	  interface.	  The	  ion	  
is	   hydrogen	   bonded	   to	   the	   hydrophilic	   core	   of	   the	   ionophore,	   which	   presents	   a	  
hydrophobic	   exterior	   to	   allow	   diffusion	   through	   the	   membrane.	   At	   the	   second	  
interface	   ion	   is	   re-­‐hydrated	   ad	   released	   from	   the	   ionophore	   complex.	   (B)	  Channel	  
forming	  ionophore	  –	  Ionophore	  (green)	  inserts	  a	  hydrophilic	  pore	  into	  membranes	  to	  
allow	  diffusion	  of	  charged	  ions	  (red)	  through	  the	  hydrophobic	  membrane	  interior.	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3.2	  Reconstituting	  Chlamydia	  trachomatis	  serovar	  LGV2	  infection	  in	  vitro	  
using	  HeLa	  cells	  
Chlamydiae	  share	  a	  unique,	  biphasic	  infection	  cycle,	  much	  of	  which	  takes	  place	  within	  
the	  inclusion,	  a	  parasitophorous	  vacuole	  established	  by	  the	  bacteria	  within	  host	  cells.	  
The	  infection	  cycle,	  from	  bacteria	  entry	  to	  cell	   lysis,	  varies	  between	  serovars	  from	  36	  
to	   72h,	   and	   is	   dependent	   on	   cell	   line	   and	   culture	   conditions.	   Before	   experiments	  
designed	   to	   assay	   alterations	   in	   the	   infection	   cycle	   could	   begin,	   the	   C.trachomatis	  
LGV2	  infection	  was	  reconstituted	  in	  cultured	  HeLa	  cells	  to	  observe	  the	  serovar	  specific	  
cycle	   under	   the	   infection	   conditions	   that	   will	   be	   used	   for	   the	   remainder	   of	   the	  
experiments	  (2.2.1).	  These	  data	  will	  establish	  a	  ‘reference’	  infection	  cycle.	  	  
The	   progression	   of	   C.trachomatis	   LGV2	   infection	   was	   visualised	   in	   fixed	   cells	   by	  
fluorescence	  microscopy	  at	  6h	  intervals	  from	  1-­‐66	  hours	  post	  infection	  (hpi).	  Infected	  
cells	  were	   incubated	  with	  AlexaFluor®	  conjugated	  wheat	  germ	  agglutinin	   (WGA)	   that	  
selectively	  binds	  to	  N-­‐acetylneuraminic	  acid	  and	  N-­‐acetylglucosamine	  residues,	  which	  
prior	   to	   cell	   permeabilisation	   labels	   the	   plasma	  membrane	   (Figure	   3.2A).	   Following	  
permeabilisation	   the	   bacteria	   were	   labelled	   with	   an	   antibody	   raised	   against	  
Chlamydia-­‐specific	  major	   outer	  membrane	   protein	   (MOMP)/lipopolysaccharide	   (LPS)	  
and	  an	  AlexaFluor®-­‐conjugated	   secondary	  antibody	   (Figure	   3.2A).	   Elementary	  bodies	  
(EBs),	  the	  infectious	  form	  of	  the	  bacteria,	  are	  approximately	  0.3µm	  in	  diameter.	  At	  the	  
resolution	   achievable	   by	   light	   microscopy,	   EBs	   can	   be	   distinguished	   from	   the	  
replicative	  reticulate	  bodies	  (RBs)	  by	  size.	  RBs	  are	  approximately	  1µm	  in	  diameter	  and	  
exhibit	  a	  distinctive	  halo	  of	  MOMP	  and	  LPS	  staining,	  as	  indicated	  by	  the	  arrow	  in	  Figure	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3.2A	  12h.	  At	  the	  start	  of	  the	  infection	  EBs	  were	  observed	  in	  association	  with	  the	  HeLa	  
cell	   plasma	  membrane	   (Figure	   3.2A	  1h).	   Following	  host	   cell	   invasion,	   bacterial	   entry	  
vesicles	  are	  trafficked	  the	  perinuclear	  region	  of	  the	  host	  cell	  (Grieshaber	  et	  al.,	  2003),	  
and	  by	  12hpi	  RBs	  are	  observed	  within	  an	  established	  inclusion	  (indicated	  in	  Figure	  3.2A	  
12h).	  RBs	  can	  be	  seen	  clustered	   in	  a	   ring	   formation	  within	  the	   infected	  cell	   from	  12-­‐
18hpi	   (Figure	   3.2A	   12h	   and	   18h	   panels).	   This	   configuration	   of	   bacteria	   is	   consistent	  
with	  previous	  observations	  that	  RBs	  replicate	  in	  contact	  with	  the	  inclusion	  membrane	  
(Matsumoto,	  1981;	  Wilson	  et	  al.,	  2009).	  From	  30h	  onwards	  the	  RBs	  remain	   in	  a	  ring,	  
but	  EBs	  are	  present	  within	  the	  inclusion	  lumen	  (indicated	  by	  the	  arrow	  in	  Figure	  3.2A	  
30h),	   indicating	  that	  re-­‐differentiation	  has	   initiated.	  At	  48hpi	  the	   inclusion	  contains	  a	  
higher	   proportion	   of	   EBs,	   however	   some	   RBs	   remain	   (Figure	   3.2A	   48h).	   Once	   the	  
majority	  of	   the	  bacteria	  have	  differentiated	   into	  EBs,	  as	   shown	   in	  Figure	   3.2A	   (60h),	  
the	  bacteria	  are	   released	   from	  the	  host	  cell	  either	  by	   lysis	  or	  extrusion	   (Hybiske	  and	  
Stephens,	  2007)	  to	  propagate	  infection	  in	  new	  cells.	  
The	  point	  at	  which	  RB-­‐EB	  re-­‐differentiation	  begins	  to	  occur	  is	  difficult	  to	  determine	  by	  
fluorescence	  microscopy	   alone.	   Instead,	   using	   the	   fact	   that	   EBs	   infect	   host	   cells	   and	  
RBs	  do	  not,	   the	  number	  of	  EBs	   in	  a	   sample	  can	  be	  quantified	  by	  scoring	   the	   relative	  
number	  of	  inclusions	  observed	  in	  a	  second	  monolayer	  of	  cells	  following	  infection	  with	  
bacteria	  collected	  at	  the	  time	  of	  interest.	  The	  number	  of	  inclusions	  observed	  is	  directly	  
proportional	  to	  the	  number	  of	  infection	  forming	  units	  (IFUs)	  (i.e.	  EBs)	  that	  were	  added	  
to	  the	  monolayer	  (for	  a	  schematic	  of	  IFU	  quantification	  refer	  to	  Figure	  2.2).	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Bacteria	  collected	  at	  timepoints	  from	  1	  to	  66hpi	  were	  used	  to	   illustrate	  the	  stages	  at	  
which	  EBs	  were	  present	   in	  the	  sample	  and	  consequently	  to	  derive	  the	  time	  at	  which	  
both	  EB-­‐RB	  and	  RB-­‐EB	  differentiation	  occurred.	  At	  1hpi	  IFUs	  were	  recovered	  from	  cells,	  
indicating	   that	   EBs	   were	   still	   present	   in	   the	   sample,	   and	   therefore	   that	   EB-­‐RB	  
differentiation	  was	  yet	  to	  be	  completed	  (Figure	  3.2B).	  By	  6hpi	  there	  were	  no	  inclusions	  
observable	  in	  the	  cell	  monolayer,	  indicating	  that	  the	  bacteria	  present	  in	  samples	  at	  this	  
time	   point	   were	   exclusively	   differentiated	   into	   the	   non-­‐infectious	   RB	   form,	   and	  
therefore	   EB-­‐RB	   differentiation	  was	   complete	   by	   6hpi	   under	   these	   assay	   conditions.	  
From	  6-­‐24hpi	  there	  were	  no	  IFUs	  collected	  from	  cell	  monolayers,	  consistent	  with	  the	  
bacteria	  replicating	  as	  RBs	  during	  this	  period.	  Recovery	  of	  IFUs	  at	  30hpi	  indicated	  that	  
RB-­‐EB	  differentiation	  had	  begun,	  and	  therefore	  some	  of	  the	  bacteria	  in	  the	  inclusions	  
had	  re-­‐differentiated	  from	  RBs	  to	  EBs.	  This	  was	  consistent	  with	  the	  images	  obtained	  by	  
fluorescence,	   in	  which	  RBs	   could	   be	  observed	   around	   the	  periphery	   of	   the	   inclusion	  
and	  EBs	  within	  the	  inclusion	  lumen	  (Figure	  3.2A,	  30h).	  The	  titre	  of	  IFUs	  recovered	  from	  
cells	   increased	   between	   30-­‐54hpi	   as	   differentiation	   continued.	   Peak	   infectivity	   was	  
reached	  at	  54hpi	  when	  the	  bacteria	  existed	  predominantly	  in	  the	  EB	  form	  but	  had	  yet	  
to	  be	  released.	  IFU	  recovery	  from	  cells	  began	  to	  decrease	  from	  60hpi	  onwards	  as	  EBs	  
were	  released	  from	  mature	   inclusions	   into	  the	  extracellular	  medium	  to	   infect	  nearby	  
cells.	  	  
These	  experiments	  demonstrate	   that	   the	  C.trachomatis	  LGV2	   infection	   cycle	   in	  HeLa	  
cells	  lasts	  approximately	  54h.	  The	  inclusion	  was	  established	  and	  EB-­‐RB	  differentiation	  
was	   complete	   by	   6hpi.	   RB	   replication	   continued	   for	   24h	   until	   30hpi,	   when	   RB-­‐EB	  
differentiation	   began	   to	   occur.	   Differentiation	   continues	   for	   a	   further	   24h	   before	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Figure	   3.2.	   Reconstitution	   of	  C.trachomatis	   LGV2	   infection	   cycle	   in	  HeLa	   cells.	   (A)	  
The	   infection	   progression	   of	   C.trachomatis	   LGV2	   was	   observed	   in	   HeLa	   cells	  
(multiplicity	   of	   infection	   (MOI=1)).	   Confocal	   xy-­‐sections	   (6h-­‐48h)	   or	   confocal	   xyz-­‐
projection	   (60h)	   of	   the	   infection	   progression	   in	   cells	   fixed	   1-­‐66hpi,	   as	   indicated.	  
Plasma	  membranes	  were	  labelled	  using	  AlexaFluor®594	  conjugated	  WGA	  (red)	  prior	  
to	  permeabilisation.	  Bacteria	  were	  labelled	  with	  Chlamydia	  spp.	  MOMP/LPS	  specific	  
primary	   antibody	   followed	   by	   AlexaFluor®488	   conjugated	   secondary	   antibody	  
(green).	  White	  arrows	  indicate	  an	  RB	  (12h)	  and	  an	  EB	  (30h).	  Scale	  bar,	  10µm.	  Insets	  
show	   indicated	  areas	  at	  higher	  magnification.	   Schematic	  diagrams	  of	   the	  phases	  of	  
the	  infection	  cycle	  are	  shown	  for	  comparison.	  EBs	  are	  shown	  in	  red,	  RBs	  are	  shown	  in	  
green	   (see	   Figure	   1.4).	   (B)	   Cell	   layers	   collected	   at	   appropriate	   time	   points	   after	  
infection	   were	   diluted	   in	   fresh	   medium	   to	   infect	   a	   new	   layer	   of	   cells.	   After	   24h,	  
infected	   cells	   were	   fixed	   and	   labelled	   using	   anti-­‐Chlamydia	   spp.	   fluorescein	  
isothiocyanate	  (FITC)-­‐conjugated	  antibody	  and	  4’,	  6-­‐diamidino-­‐2-­‐phenylindole	  (DAPI)	  
DNA	   stain.	   Inclusion-­‐forming	   units	   (IFUs)	   were	   then	   quantified	   (IFU/ml).	   Error	   bars	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bacteria	   began	   to	   be	   released	   from	   host	   cells.	   These	   approaches	   allow	   both	  
quantitative	   and	   qualitative	   analysis	   of	   the	   infection	   cycle	   in	   the	   subsequent	  
experiments.	  	  
	  
3.3	  Ionophore	  treatment	  of	  HeLa	  cells	  infected	  with	  C.trachomatis	  LGV2	  
implies	  a	  critical	  role	  for	  Na+	  and	  K+	  cations	  in	  bacterial	  development	  
Having	   characterised	   the	   C.trachomatis	   LGV2	   development	   cycle	   in	   HeLa	   cells,	  
conditions	   for	   the	   treatment	   of	   uninfected	   HeLa	   cells	   with	   ionophores	   were	  
established	  and	  optimised.	   Loss	  of	   cells	  during	   treatment	  was	  minimised	  by	   titrating	  
ionophore	  dilutions	   in	  growth	  medium	  to	  a	  concentration	  that	  could	  be	  tolerated	  by	  
the	  majority	  of	  a	  population	  of	  cells	  (≥75%).	  
Ionophores,	   dissolved	   in	   dimethyl	   sulphoxide	   (DMSO),	   were	   added	   to	   confluent	  
monolayers	  of	  HeLa	  cells	  at	  increasing	  concentrations	  from	  500nM	  to	  10µM.	  Cell	  loss	  
after	   24h	  of	   treatment	  was	  determined	  by	   counting	   the	   cells	   in	   10	   random	   fields	  of	  
view	  (FOVs).	  The	  average	  number	  of	  cells	  remaining	  after	  each	  treatment,	  expressed	  
as	   a	   percentage	   of	   the	   untreated	   control,	   are	   presented	   in	  Table	   3.1.	   As	   incubation	  
with	  a	  1:1000	  dilution	  of	  DMSO	  in	  growth	  medium	  (v/v)	  for	  24h	  caused	  a	  loss	  of	  23±8%	  
of	  cells,	  DMSO-­‐diluted	  ionophores	  did	  not	  exceed	  0.1%	  to	  prevent	  excessive	  cell	  loss	  as	  
a	   result	   of	   solvent	   exposure.	   Although	   these	   data	   do	   not	   reflect	   the	   activity	   of	   the	  
compounds	   it	   is	   important	   that	   the	   treatments	   can	   be	   tolerated	   by	   the	  majority	   of	  
cells.	  The	  ionophore	  working	  dilutions	  chosen	  for	  all	  subsequent	  investigations	  was	  the	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highest	  that	  could	  be	  tolerated	  by	  at	  least	  75%	  of	  cells,	  for	  chloride	  ionophore	  I	  (Cl-­‐I),	  
ionomycin,	   monensin,	   and	   nigericin	   this	   was	   1µM	   (for	   ionophore	   structures	   see	  
Appendix	  2).	  To	  ensure	  the	  working	  dilutions	  had	  limited	  adverse	  effects	  on	  the	  cells,	  
nuclei	   were	   labelled	   using	   4’6-­‐diamino-­‐2-­‐phenylindole	   (DAPI),	   a	   DNA	   intercalating	  
fluorescent	  dye	  (Figure	  3.3).	  The	  morphology	  of	  cell	  nuclei	  was	  assessed	  to	  ensure	  that	  
ionophores	   introduced	   at	   this	   concentration	   did	   not	   damage	   host	   cells	   by	   inducing	  
apoptosis,	   indicated	   by	   condensation	   of	   the	   nucleus	   (as	   shown	   in	   Figure	   3.3	   10µM	  
nigericin	  panel).	  Following	  24h	  incubation	  with	  1µM	  of	  each	  ionophore	  there	  was	  no	  
significant	  morphological	  changes	  in	  the	  nuclei	  of	  HeLa	  cells,	  suggesting	  that	  the	  cells	  
can	  tolerate	  ionophore	  treatment	  for	  24h	  (Figure	  3.3).	  
Titrating	  ionophore	  concentrations	  to	  a	  working	  dilution	  that	  can	  be	  tolerated	  by	  more	  
than	   75%	  of	   host	   cells	   ensures	   that	   any	   changes	   observed	   during	   the	  C.trachomatis	  
LGV2	   infection	   cycle	   in	   subsequent	   experiments	   are	   the	   result	   of	   alterations	   in	   ion	  
concentrations.	  
Once	  these	  working	  concentrations	  had	  been	  established,	  the	  effect	  of	  ion	  disruption	  
on	   the	   C.trachomatis	   infection	   cycle	   could	   be	   assayed,	   both	   qualitatively	   using	  
microscopy,	  and	  by	  quantifying	  IFU	  recovery	  from	  infected	  cells.	  	  
HeLa	  cells	  were	  treated	  with	  ionophores	  at	  12hpi,	  during	  the	  replication	  phase	  of	  the	  
infection	  cycle,	  then	  fixed	  at	  24hpi	  prior	  to	  labelling	  with	  anti	  Chlamydia	  antibody	  and	  
an	  AlexaFluor®	   conjugated	   secondary	   antibody.	   DNA	  was	   then	   labelled	   using	   1,5-­‐bis	  
{[2-­‐(di-­‐methylamino)	   ethyl]	   amino}-­‐4,8-­‐dihydroxyanthracene-­‐9,	   10-­‐dione	   (DRAQ-­‐5)	   a	  
far-­‐red	   fluorescent	  DNA-­‐intercalating	  dye.	   Initially,	   infected	  cells	  were	   left	  untreated,	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Table	   3.1.	   Titrating	   ionophores	   to	   non-­‐toxic	   working	   concentrations.	   HeLa	   cells	  
were	   seeded	   at	   100%	   confluence	   and	   treated	   with	   increasing	   concentration	   of	  
ionophores.	   Toxicity	   was	   assessed	   by	   quantifying	   the	   average	   number	   of	   cells	   per	  
coverslip	   as	   a	   percentage	   of	   an	   untreated	   control	   condition.	   Selected	   working	  
concentrations	  are	  shaded	  in	  grey.	  
	  
Figure	  3.3.	  Assessment	  of	  cell	  nuclei	  following	  ionophore	  treatments.	  Fluorescence	  
micrographs	   of	   untreated	   HeLa	   cells	   (control),	   and	   HeLa	   cells	   treated	   with	   either	  
1:1000	   dilution	   of	   DMSO,	   1µM	   chloride	   ionophore	   I	   (Cl-­‐I),	   1µM	   ionomycin,	   1µM	  
monensin,	   1µM	  or	   10µM	  nigericin,	   as	   indicated,	   and	   fixed	   after	   24h	   of	   treatment.	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or	  incubated	  with	  a	  1:1000	  dilution	  of	  DMSO	  from	  12hpi.	  When	  untreated	  and	  DMSO	  
treated	  Chlamydia-­‐infected	   cells	  were	   compared	  at	   24hpi	   intracellular	   bacteria	  were	  
evident	   within	   an	   inclusion	   adjacent	   to	   the	   host	   cell	   nucleus.	   Bacteria	   exhibit	   the	  
distinctive	  halo	  of	  MOMP/LPS	   labelling	  associated	  with	  RBs,	  which	   is	   consistent	  with	  
the	   replicative	   phase	   of	   the	   infection	   cycle	   (Figure	   3.4	   compare	   control,	   and	   DMSO	  
panels).	  This	  confirms	  that	  the	  solvent	  alone	  does	  not	  have	  a	  detectable	  effect	  on	  the	  
C.trachomatis	  development	  cycle.	  
Cl-­‐I,	  a	  synthetic	  chloride	   ion	   (Cl-­‐)	   selective	  Mn(III)	  metalloporphyrin,	  which	  has	  a	  high	  
affinity	  for	  chloride	  ions	  over	  nitrite	  (NO2-­‐)	  and	  other	  monovalent	  anions	  (Huser	  et	  al.,	  
1990),	  causes	  the	  translocation	  of	  Cl-­‐	  ions	  across	  biological	  membranes	  (Garber	  et	  al.,	  
2005).	  When	   HeLa	   cells	   infected	   with	   C.trachomatis	   LGV2	   were	   treated	   with	   Cl-­‐I	   at	  
12hpi,	  no	  effect	  on	  the	  morphology	  of	  the	  bacteria	  was	  evident	  when	  fixed	  cells	  were	  
observed	   at	   24hpi,	   when	   compared	   to	   the	   control	   conditions	   (Figure	   3.4	   Cl-­‐	  panel).	  
When	   infected	   cells	   were	   equivalently	   treated	   with	   ionomycin,	   a	   calcium	   (Ca2+)	   ion	  
specific	   ionophore	  produced	  by	  Streptomyces	   conglobatus	   (Liu	   and	  Hermann,	   1978),	  
RBs	   were	   observed	   within	   an	   inclusion	   indistinguishable	   to	   those	   present	   under	  
control	   conditions	   (Figure	   3.4	   Ca2+	  panel).	   These	  data	   show	   that	   perturbation	  of	   the	  
concentration	   of	   intracellular	   Cl-­‐	   or	   Ca2+	   using	   ionophores	   at	   these	   concentrations	  
during	   C.trachomatis	   LGV2	   replication	   in	   HeLa	   cells	   has	   no	   discernible	   effect	   on	  
bacteria	  or	  inclusion	  morphology.	  
Conversely,	   when	   HeLa	   cells	   infected	   with	   C.trachomatis	   LGV2	   were	   treated	   with	  
monensin	   at	   12hpi,	   a	   Na+	   ionophore	   from	   Streptomyces	   cinnamonensis	   (Mollenhaur	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1990),	  a	  dramatic	  effect	  on	  the	  bacteria	  was	  clearly	  evident.	  The	  LPS/MOMP	  antibody	  
labelled	   abnormally	   shaped,	   large	   chlamydial	   bodies	   in	   fixed	   cells	   (Figure	   3.4	   Na+	  
panel).	   These	   bodies,	   which	   resemble	   aberrant	   bodies	   (ABs)	   observed	   during	  
chlamydial	   persistence	   (reviewed	   by	   Hogan	   et	   al.,	   2004),	   retained	   DRAQ-­‐5	   DNA	  
labelling	   and	   remained	   perinuclear,	   but	   no	   longer	   consistently	   appeared	   in	   the	   ring	  
formation	  characteristic	  of	  RBs	   replicating	  within	   the	   inclusion.	  Equivalent	   treatment	  
with	   nigericin,	   an	   ionophore	   from	   Streptomyces	   hygroscopicus	   (Heisey	   and	   Putnam,	  
1986)	  selective	  for	  K+	  over	  Na+	  (Stern,	  1977),	  also	  induced	  the	  formation	  of	  similar	  ABs	  
(Figure	   3.4	   K+	   panel).	   As	   with	   monensin	   treatment,	   the	   anti-­‐Chlamydia	   antibody	  
labelled	   bacterial	   bodies	   adjacent	   to	   the	   host	   cell	   nucleus,	   however	   they	   no	   longer	  
formed	   the	  distinctive	   spherical	   inclusions	  expected	  at	  24hpi.	  There	  were	  also	   fewer	  
bodies	   within	   inclusions	   following	   K+	   and	   Na+	   ionophore	   treatments,	   suggesting	  
replication	  had	  slowed	  or	  arrested.	  These	  data	  indicate	  that	  disruption	  of	  Na+	  or	  K+	  ion	  
gradients	  during	  the	  replicative	  phase	  of	  the	  C.trachomatis	  LGV2	  infection	  cycle	  has	  a	  
profound	  effect	  on	  the	  bacteria.	  
The	   morphological	   changes	   in	   C.trachomatis	   LGV2	   were	   observed	   during	   the	  
replicative	  phase	  of	  the	   infection	  cycle,	  when	  the	  bacteria	  are	  exclusively	   in	  the	  non-­‐
infectious	  RB	  state.	  This	  means	  that	  the	  effect	  on	  the	  number	  or	  infectivity	  of	  bacterial	  
progeny	  following	  ionophore	  treatment	  could	  not	  be	  assessed	  by	  IFU	  quantification	  at	  
an	  equivalent	  timepoint.	  Instead,	  IFU	  quantification	  was	  undertaken	  at	  the	  end	  of	  the	  
infection	  cycle,	  once	  RB-­‐EB	   re-­‐differentiation	  was	  complete.	  As	  described	  previously,	  
during	   C.trachomatis	   LGV2	   infection	   of	   HeLa	   cells	   RB-­‐EB	   differentiation	   begins	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Figure	   3.4.	  Monovalent	   cation	   specific	   ionophores	   dramatically	   alter	   intracellular	  
C.trachomatis	   LGV2	   morphology.	   Confocal	   xy-­‐sections	   of	   C.trachomatis	   LGV2	  
infected	  HeLa	  cells	   (MOI=1)	   either	   untreated	   (control)	  or	   treated	   12hpi	  with	   either	  
1:1000	   DMSO,	   1µM	   Cl-­‐I,	   1µM	   ionomycin,	   1µM	   monensin,	   or	   1µM	   nigericin,	   as	  
indicated.	  Cells	  were	  then	  fixed	  at	  24hpi.	  Bacteria	  were	  labelled	  with	  Chlamydia	  spp.	  
MOMP/LPS	   specific	   primary	   antibody	   followed	   by	   AlexaFluor®488	   conjugated	  
secondary	   antibody	   (green)	   and	   1,	   5-­‐bis	   {[2-­‐(di-­‐methylamino)	   ethyl]	   amino}-­‐	   4,	   8-­‐
dihydroxyanthracene-­‐9,	  10-­‐dione	   (DRAQ-­‐5)	  DNA	   label	   (magenta).	   Scale	  bars,	  10µm.	  
Insets	  show	  indicated	  areas	  at	  higher	  magnification.	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approximately	   30hpi	   and	   is	   completed	   by	   54hpi.	   To	   ensure	   that	   samples	   contained	  
predominantly	  EBs,	  bacteria	  were	  collected	  for	  quantification	  at	  50hpi.	  	  
HeLa	   cells	   infected	   with	   C.trachomatis	   LGV2	   were	   treated	   with	   Cl-­‐I,	   ionomycin,	  
monensin,	  nigericin,	  or	  DMSO,	  each	  at	  12hpi.	   Infection	  was	  allowed	  to	  progress	  until	  
50hpi	  when	   infected	  monolayers	  were	   collected	   (see	  Figure	   3.5A	   for	   a	   schematic	  of	  
the	   first	   round	   infection	   and	   collection	   stage	   of	   IFU	   quantification).	   IFUs	   were	  
quantified	   for	   each	   sample	   following	   infection	   of	   a	   second	   cell	   monolayer	   and	  
expressed	   as	   a	   percentage	  of	   the	   IFU/ml	   collected	   from	  untreated	   cells	   equivalently	  
infected	  with	  C.trachomatis	  (Figure	  3.5B).	  	  
Disruption	   of	   monovalent	   cations	   Na+	   or	   K+	   had	   a	   dramatic	   effect	   on	   the	   IFU	   titre.	  
Treatment	  with	  either	  monensin	  or	  nigericin	  eliminated	  all	   the	   IFU	  from	  the	  samples	  
(Figure	   3.5B	   Na+	   and	   K+).	   This	   loss	   of	   IFU	   suggests	   that	   the	   ABs	   observed	   by	  
fluorescence	   microscopy	   following	   monensin	   or	   nigericin	   treatment	   are	   either	   non-­‐
viable	  or	  incapable	  of	  maturing	  into	  infectious	  EBs,	  either	  because	  re-­‐differentiation	  is	  
arrested,	   or	   because	   released	   progeny	   are	   incapable	   of	   establishing	   subsequent	  
infections.	  	  
96±14%	  of	  control	  IFU	  was	  collected	  from	  Cl-­‐I	  treated	  cells,	  suggesting	  that	  disruption	  
of	  Cl-­‐	  gradients	  from	  12hpi	  until	  the	  end	  of	  RB-­‐EB	  differentiation	  does	  not	  significantly	  
impact	  the	  number	  of	  infectious	  progeny	  (Figure	  3.5B	  Cl-­‐).	  These	  data	  suggest	  that	  the	  
majority	   of	   C.trachomatis	   infections	   can	   tolerate	   Cl-­‐	   gradient	   disruptions,	   which	   is	  
consistent	  with	  observations	  that	  bacterial	  morphology	  is	  unaffected	  by	  Cl-­‐I	  treatment	  
during	  the	  replicative	  phase	  of	  the	  infection	  cycle.	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Similarly,	   more	   than	   92±13%	   of	   the	   control	   IFU	   was	   obtained	   following	   equivalent	  
ionomycin	  treatment	  (Figure	  3.5B	  Ca2+).	  The	  relatively	  unchanged	   IFU	  value	  together	  
with	   the	   normal	   inclusion	   morphology	   observed	   in	   fluorescent	   micrographs	  
demonstrates	  that	  ionomycin	  treatment	  during	  the	  replicative	  phase	  of	  C.trachomatis	  
LGV2	  infection	  has	  an	  insignificant	  effect	  on	  the	  developmental	  cycle	  of	  the	  bacteria.	  	  
Following	  DMSO	  treatment	  there	  was	  no	  loss	  of	   IFUs	  collected	  from	  cells,	  confirming	  
that	   prolonged	   exposure	   to	   the	   solvent	   did	   not	   cause	   excessive	   loss	   of	   cells	   (Figure	  
3.5B	  DMSO).	  This	  verifies	   that	  any	  observed	  decrease	   in	   IFU	   from	   ionophore	   treated	  
conditions	  were	  the	  result	  of	  the	  treatment,	  and	  not	  cell	   loss	  due	  to	  exposure	  to	  the	  
solvent.	  	  
As	   both	   monensin	   and	   nigericin	   collapse	   gradients	   of	   monovalent	   cations,	   the	  
observed	  alteration	  of	  bacterial	  morphology	  and	   the	  development	   cycle	   could	   result	  
from	  osmotic	  disruption	  or	  pH	  variation.	  However,	  this	  seems	  unlikely	  as	  perturbation	  
of	   either	   Ca2+	   or	   Cl-­‐	   ion	   concentrations	   had	   little	   effect	   on	   bacterial	   morphology	   or	  
infectivity,	   suggesting	   that	   bacteria	   can	   withstand	   generic	   fluctuations	   in	   osmotic	  
pressure	   and	   membrane	   potential.	   This	   implies	   that	   replicating	   Chlamydia	   have	  
specific	   requirements	   for	   monovalent	   cations	   during	   the	   developmental	   cycle,	  
however	  the	  data	  collected	  following	  nigericin	  or	  monensin	  treatments	   is	   insufficient	  
to	   determine	   whether	   the	   alterations	   observed	   in	   bacterial	   morphology	   and	  
development	   are	   the	   result	   of	   altering	  monovalent	   cation	   concentrations	   or	   if	   each	  
specific	  ion	  has	  a	  distinct	  role	  during	  chlamydial	  development.	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Figure	  3.5.	  Treatment	  of	  C.trachomatis	  LGV2	   infected	  HeLa	  cells	  with	  monovalent	  
cation	  specific	   ionophores	  significantly	  reduces	  the	  titre	  of	   infectious	  bacteria.	  (A)	  
Schematic	  representation	  of	  experiment	  timelines,	  showing	  a	  confocal	  xy-­‐section	  of	  
C.trachomatis	   (green)	   infection	   of	   HeLa	   cells	   (red)	   at	   the	   time	   of	   ionophore	  
treatment.	  (B)	  C.trachomatis	  LGV2	  infected	  HeLa	  cell	  layers	  (MOI=1),	  were	  treated	  at	  
12hpi	  and	  bacteria	  collected	  50hpi.	  Recovered	  bacteria	  were	  diluted	  in	  fresh	  medium	  
to	   infect	  a	  new	  layer	  of	  cells.	  After	  24h,	  infected	  cells	  were	  fixed	  and	  labelled	  using	  
anti-­‐Chlamydia	   spp.	   FITC-­‐conjugated	   antibody	   and	   4’,	   6-­‐diamidino-­‐2-­‐phenylindole	  
(DAPI)	  DNA	   stain.	   IFUs	  were	   then	   quantified	   (IFU/ml)	   IFU/ml	   for	   each	   treatment	   is	  
compared	   as	   a	   percentage	   of	   appropriate	   control	   conditions.	   Experiments	   were	  
repeated	   a	  minimum	  of	   three	   times,	   and	   the	   data	  presented	  are	   representative	  of	  
each	  iteration.	  Error	  bars	  show	  standard	  deviation.	  (*	  =	  p≤0.05).	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3.4	  Intracellular	  K+	  concentrations	  are	  reduced	  by	  treatment	  with	  either	  
nigericin	  or	  monensin	  	  
To	  identify	  specific	  triggers	  for	  the	  abnormal	  development	  observed	  in	  both	  nigericin	  
and	  monensin	  treated	  conditions,	  the	  effect	  of	  each	  of	  the	  treatments	  on	  host	  cells,	  at	  
the	   concentrations	  used	   in	   the	  previous	   experiments,	  must	  be	  examined.	   Eukaryotic	  
cells	  maintain	   a	   K+	   concentration	   of	   approximately	   100mM,	  dependent	   on	   cell	   type,	  
whereas	  the	  concentration	  of	  the	  extracellular	  milieu	  is	  much	  lower,	  usually	  10mM	  or	  
less	  (Su	  et	  al.,	  2009).	  Consequently,	  using	  K+	  ionophores	  such	  as	  nigericin	  to	  equilibrate	  
gradients	   across	   membranes	   reduces	   the	   concentration	   of	   available	   K+	   within	   cells.	  
Conversely,	   intracellular	   Na+	   is	   normally	  maintained	   between	   4-­‐16mM	   compared	   to	  
extracellular	  concentrations	  of	  approximately	  140mM	  (Bers	  et	  al.,	  2003),	  therefore	  Na+	  
ionophore	  treatment	  causes	  an	  influx	  of	  Na+	  into	  the	  cell.	  	  
Selectivity	  of	  an	  ionophore	  for	  a	  specific	  ion	  is	  dependent	  on	  a	  number	  of	  factors,	  the	  
most	   important	   being	   the	   respective	   sizes	   of	   the	   ion	   and	   the	   ion-­‐binding	   site	   in	   the	  
ionophore.	  Both	  sodium	  and	  potassium	  belong	  to	  the	  alkali	  metal	  group,	  meaning	  their	  
ions	   behave	   in	   a	   very	   similar	   manner.	   Sodium	   is	   smaller	   than	   potassium,	   with	  
dehydrated	   ionic	   radii	  of	  0.95Å	  and	  1.33Å	  respectively	   (Hille	  et	  al.,	  1999).	  Therefore,	  
the	  positively	  charged	  nucleus	  of	  a	  sodium	  ion	  has	   less	  shielding	  electron	  shells	   than	  
that	  of	  a	  potassium	  ion.	  Consequently,	  the	  dehydration	  of	  Na+	  requires	  a	  much	  higher	  
energy	  input,	  and	  generally	  Na+	  remains	  hydrated,	  increasing	  the	  ionic	  radius	  to	  similar	  
dimensions	  to	  K+,	  decreasing	  selectivity	  between	  Na+	  and	  K+.	  As	  a	  result,	  monensin	  is	  
only	   10-­‐fold	   more	   selective	   for	   Na+	   over	   K+	   (Mollenhauer	   et	   al.,	   1990).	   Given	   that	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nigericin	   is	   specific	   for	  K+,	   but	  monensin	   is	  much	   less	   selective	   for	  Na+,	   the	  effect	  of	  
both	  treatments	  on	  intracellular	  K+	  concentration	  was	  assayed.	  
Flame	   photometry	   detects	   K+	   concentrations	   from	   0.1-­‐1mM	   in	   solution	   (for	  
photometer	   calibration	   refer	   to	   Figure	   2.3).	   Determining	   the	   K+	   concentration	   of	   a	  
sample	  is	  achieved	  by	  measuring	  the	  emission	  intensity	  of	  a	  sample	  at	  766.5nm	  (Smith	  
and	   Nesson,	   1971),	   the	   characteristic	   emission	   wavelength	   of	   K+	   as	   it	   is	   excited	   by	  
being	  drawn	  through	  a	  flame.	  The	  emission	  intensity	  is	  directly	  proportional	  to	  the	  K+	  
concentration	   of	   the	   sample	   (Smith	   and	  Nesson,	   1971).	   This	  method	  was	   applied	   to	  
analyse	   the	   intracellular	   K+	   concentration	   of	   HeLa	   cells	   treated	   with	   monensin	   or	  
nigericin.	  1.3	  x106	  ±	  0.1x106	  cells	  were	  incubated	  with	  or	  without	  1µM	  of	  monensin	  or	  
nigericin	  as	  previously,	  and	  K+	  concentration	  was	  assayed	  using	  the	  flame	  photometer.	  
Since	  equivalent	  cell	  numbers	  were	  lysed	  into	  equal	  volumes,	  the	  K+	  concentrations	  of	  
the	  final	  solutions	  are	  comparable	  to	  one	  another.	  However,	  because	  the	  lysates	  must	  
be	  diluted	  to	  assay	  K+	  within	  the	  detection	  range	  of	  the	  flame	  photometer	  (0.1-­‐1mM	  
K+),	   an	   exact	   intracellular	   K+	  concentration	   is	   difficult	   to	   obtain	  without	   knowing	   the	  
initial	   volume	   of	   the	   cellular	   contents.	   Relative	   K+	   concentrations	   are	   therefore	  
presented	  in	  comparison	  to	  untreated	  cells	  (Figure	  3.6).	  Monensin	  treatment	  reduced	  
intracellular	   K+	   by	   25%,	   compared	   to	   a	   50%	   reduction	   following	   nigericin	   treatment.	  
This	   shows	   that,	   due	   to	   poor	   selectivity	   for	   Na+	  over	   K+,	   K+	   concentrations	   are	   also	  
affected	  in	  monensin	  treated	  samples.	  	  
To	   identify	   the	   ionic	   alteration	   responsible	   for	   abnormal	   C.trachomatis	   LGV2	  
development,	   ionophores	   with	   greater	   affinities	   for	   Na+	   and	   K+	   should	   be	   used.	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Figure	   3.6.	   Quantification	   of	   intracellular	   K+	   following	   monensin,	   nigericin,	  
valinomycin,	   and	   glibenclamide	   treatments.	   1.3x106	   ±0.1x106	   HeLa	   cells	   were	  
treated	  for	  12h	  with	  either	  1µM	  monensin,	  1µM	  nigericin,	  1µM	  valinomycin	  (Section	  
3.5),	   or	   10µM	   glibenclamide	   (Section	   3.7).	   Cells	   were	   than	   lysed	   and	   K+	  
concentrations	   were	   measured	   using	   flame	   photometer	   (emission	   intensity	   at	  
766.5nm).	  K+	  concentration	  is	  presented	  as	  a	  percentage	  of	  the	  emission	  intensity	  of	  
an	   untreated	  control	   population	  of	   cells	   and	   is	   representative	   of	   each	  of	   the	   three	  
iterations	  undertaken.	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Unfortunately	  there	  are	  currently	  no	  Na+	  specific	  ionophores	  that	  would	  not	  perturb	  K+	  
gradients	  to	  some	  extent.	  Nigericin	  is	  a	  K+/H+	  exchange	  ionophore,	  which	  means	  that	  
as	  K+	   is	  removed	  it	   is	  replaced	  with	  a	  hydrogen	  ion	  (H+)	  (Nicholls,	  2006).	  To	  ascertain	  
whether	  aberrant	  C.trachomatis	  LGV2	  development	  is	  the	  result	  of	  a	  K+	  efflux,	  and	  not	  
due	  to	  an	  increase	  in	  either	  cytosolic	  or	  luminal	  pH,	  C.trachomatis	  LGV2	  infected	  HeLa	  
cells	  were	   treated	  with	  valinomycin,	  a	  K+	  uniporter	   that	   induces	  a	  K+	  efflux	  but	  does	  
not	  affect	  H+	  (Nicholls,	  2006).	  
	  
3.5	   Depletion	   of	   intracellular	   K+	   concentration	   disrupts	   C.trachomatis	  
LGV2	  development	  
The	  experiments	  presented	  so	  far	  have	  revealed	  a	  correlation	  between	  intracellular	  K+	  
depletion	   and	   abnormal	   C.trachomatis	   LGV2	   development.	   Nigericin	   treatment	   of	  
HeLa	  cells	  12hpi	  with	  C.trachomatis	  LGV2	  induced	  the	  formation	  of	  ABs,	  which	  failed	  
to	  produce	  infectious	  progeny	  at	  the	  end	  of	  the	  infection	  cycle.	  	  
Nigericin	   is	   a	   K+/H+	   antiporter,	   and	   will	   therefore	   equilibrate	   both	   K+	   and	   H+	  
concentrations	   across	  membranes.	   Valinomycin,	   which	   only	   alters	   K+	   concentrations	  
without	  altering	  cellular	  H+	   concentrations,	  was	  used	   to	  assess	  whether	  K+	  depletion	  
alone	  has	  an	  equivalent	  impact	  on	  C.trachomatis	  LGV2	  development.	  Valinomycin	  is	  a	  
cyclic	  dodecadepsipeptide	  produced	  by	  Streptomyces	  fulvissimus	  (Ristow	  et	  al.,	  1974),	  
which	   is	  400	   times	  more	   selective	   for	  K+	  over	  H+	  and	  Na+	   (Mueller	  and	  Rudin,	  1967)	  
(For	  chemical	  structure	  see	  Appendix	  2).	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A	   working	   concentration	   of	   valinomycin	   was	   obtained	   by	   treating	   confluent	  
monolayers	   of	   HeLa	   cells	   with	   a	   range	   of	   valinomycin	   concentrations	   from	   500nM-­‐
10µM	  and	  comparing	  cell	  numbers	  to	  an	  equivalent	  control	  monolayer.	  Following	  1µM	  
valinomycin	  treatment	  75%	  of	  cells	  remained	  on	  coverslips	  (Table	  2.2),	  therefore	  1µM	  
was	   selected	   as	   a	   working	   concentration.	   This	   concentration,	   when	   assayed	   using	  
flame	  photometry,	   reduced	   intracellular	  K+	  by	  more	  than	  70%	  when	  compared	  to	  an	  
equivalent	  control	  sample	  (Figure	  3.6),	  demonstrating	  that,	  at	  the	  concentrations	  used	  
in	  these	  assays,	  it	  is	  more	  efficient	  at	  reducing	  intracellular	  K+	  than	  either	  monensin	  or	  
nigericin.	  	  
HeLa	   cells	   were	   infected	   with	   C.trachomatis	   LGV2	   and	   treated	   with	   valinomycin	   at	  
12hpi,	  a	   timepoint	  at	  which	  bacterial	   replication	   is	  occurring.	  When	   these	  cells	  were	  
fixed	  at	  24hpi,	  large	  perinuclear	  bodies	  were	  observed.	  These	  bodies	  were	  recognised	  
by	   Chlamydia	   specific	  MOMP/LPS	   antibody,	   and	   were	   much	   larger	   than	   RBs	   in	   the	  
equivalent	   control	   this	   time	   point	   (Figure	   3.7A	   compare	   control	   and	   valinomycin	  
panels).	   ABs	  were	  universally	   observed	   in	   all	  C.trachomatis	   LGV2	   infected	  HeLa	   cells	  
treated	   with	   1µM	   valinomycin	   at	   this	   timepoint.	   These	   ABs	   were	   similar	   to	   the	  
phenotype	   previously	   observed	   in	   HeLa	   cells	   infected	   with	   C.trachomatis	   LGV2	  
following	   equivalent	   treatment	   with	   nigericin.	   These	   data	   show	   that	   abnormal	  
development	  occurs	  as	  a	  result	  of	  K+	  efflux,	  independently	  of	  an	  associated	  H+	  influx.	  
HeLa	   cells	   that	   were	   infected	   with	   C.trachomatis	   LGV2	   and	   treated	   12hpi	   with	  
valinomycin	  were	  collected	  50hpi	  for	   IFU	  quantification.	  No	   infectivity	  was	  recovered	  
from	   valinomycin	   treated	   cells,	   which	   demonstrates	   that	   valinomycin-­‐induced	   ABs	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Figure	  3.7.	  Valinomycin	  induced	  K+	  efflux	  during	  C.trachomatis	  LGV2	  replication	  in	  
HeLa	   cells	   causes	   persistence-­‐like	   non-­‐infectious	   ABs.	   (A)	   Confocal	   xy-­‐sections	   of	  
C.trachomatis	   LGV2	   infected	   HeLa	   cells	   (MOI=1)	   treated	   with	   1µM	   valinomycin	   at	  
12hpi	   and	   fixed	   at	   24hpi.	   Bacteria	   were	   labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	  
specific	   primary	   antibody	   followed	   by	   AlexaFluor®488	   conjugated	   secondary	  
antibody	   (green)	   and	  DRAQ-­‐5	  DNA	   label	   (magenta).	   Scale	   bars,	   10µm.	   Insets	   show	  
indicated	  areas	  at	  higher	  magnification.	  (B)	  Cell	  layers	  treated	  with	  1µM	  valinomycin	  
at	  12hpi	  and	  collected	  at	  50hpi	  were	  diluted	  in	  fresh	  media	  to	  infect	  a	  new	  layer	  of	  
cells.	  After	  24h,	  infected	  cells	  were	  fixed	  and	  labelled	  using	  anti-­‐Chlamydia	  spp.	  FITC-­‐
conjugated	  antibody	  and	  DAPI	  DNA	  stain.	   IFUs	  were	  then	  quantified	   (IFU/ml).	   Each	  
experiment	   was	   repeated	   a	   minimum	   of	   three	   times,	   and	   the	   data	   presented	   are	  
representative	  of	  each	  iteration.	  Error	  bars	  show	  standard	  deviation	  (*p≤0.05).	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were	  subsequently	  unable	  to	  form	  infectious	  EBs	  (Figure	  3.7B).	  Again,	  this	  is	  analogous	  
to	  the	  non-­‐infectious	  nigericin-­‐induced	  ABs.	  These	  data	  demonstrate	  that	  treatment	  of	  
HeLa	  cells	   infected	  with	  C.trachomatis	  LGV2	  with	  K+	  ionophores	  during	  RB	  replication	  
has	  an	  adverse	  effect	  on	  the	  bacterial	  development	  cycle,	  which	  shows	  that	  K+	  has	  a	  
critical	  role	  in	  the	  C.trachomatis	  lifecycle.	  
Although	  ionophore	  concentrations	  were	  titrated	  to	  reduce	  cell	  loss,	  K+	  performs	  many	  
vital	   functions	   within	   eukaryotic	   cells,	   which	   would	   be	   interrupted	   by	   ionophore	  
treatment.	  This	  could	  potentially	  cause	  stress	  to	  the	  eukaryotic	  cell	  without	  resulting	  in	  
cell	   death.	   To	   further	   understand	   the	   impact	   of	   ionophore	   treatment	   during	  
C.trachomatis	   development,	   the	   potential	   consequences	   of	   cellular	   K+	   depletion	  
require	  further	  investigation.	  	  
	  
3.6	  K+	   ionophore	   treatment	  disrupts	  mitochondria	  but	  not	  Golgi	   stacks	  
or	  endoplasmic	  reticulum	  
Both	   valinomycin	   and	   nigericin	   concentrations	   were	   titrated	   to	   concentrations	   that	  
had	  a	  minimal	   impact	  on	  host	  cells,	  however	  a	  significant	  decrease	   in	   intracellular	  K+	  
can	  still	  be	  observed	  following	  treatment	  (Figure	  3.6).	  The	  cellular	  implications	  of	  this	  
efflux	  must	  be	  explored	  to	  determine	  the	  cause	  of	  the	  abnormal	  C.trachomatis	  LGV2	  
development	   observed	   in	   HeLa	   cells	   treated	   with	   K+	   ionophores.	   To	   assess	   the	  
physiological	   changes	   in	   cellular	   components	   due	   to	   K+	   efflux,	   the	   morphology	   of	  
mitrochondria,	   which	   are	   sensitive	   to	   K+	   fluctuations	   (Nicholls,	   2006),	   was	   assessed.	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Additionally	  the	  effect	  of	  nigericin	  treatment	  on	  endoplasmic	  reticulum	  (ER)	  and	  Golgi,	  
which	   are	   both	   known	   to	   participate	   in	   the	   C.trachomatis	   infection	   cycle,	   will	   be	  
evaluated.	  
Although	   the	  mitochondrial	   outer	  membrane	   is	   freely	   permeable	   to	   ions,	   the	   inner	  
membrane	  is	  rich	  in	  potassium	  channels	  (Shi	  et	  al.,	  2005;	  Szabò	  et	  al.,	  2012).	  Nigericin	  
causes	  mitochondrial	  hyperpolarisation	  (Nicholls,	  2006),	  presumably	  due	  to	  the	  high	  K+	  
concentration	  within	  the	  mitochondrial	  matrix,	  which	  in	  some	  cell	  types	  is	  thought	  to	  
be	   as	   high	   as	   180mM	   (Kozoriz	   et	   al.,	   2010).	   Mitotracker	   orange,	   a	   probe	   that	  
accumulates	   in	   active	   mitochondria	   in	   live	   cells,	   was	   used	   to	   label	   both	   nigericin	  
treated	  and	  untreated	  HeLa	  cells.	  Control	  cells	  contain	  an	   interconnected	  network	  of	  
mitochondria	   throughout	   the	   cell.	   In	   contrast,	  mitochondria	   in	   cells	   treated	   for	   12h	  
with	  nigericin	  are	  less	  evenly	  distributed	  throughout	  the	  cell	  and	  form	  a	  less	  organised	  
network.	   (Figure	   3.8A).	   Although	   nigericin-­‐induced	   K+	   efflux	   appears	   to	   alter	   the	  
morphology	  of	  the	  mitochondrial	  network,	  the	  remaining	  mitochondria	  continue	  to	  be	  
active,	  as	  demonstrated	  by	  the	  uptake	  of	  the	  mitotracker	  probe.	  	  
C.trachomatis	   sequesters	   vesicles	   from	   the	   host	   secretory	   pathway	   to	   obtain	  
important	  nutrients	  such	  as	  cholesterol	  and	  sphingolipids	   (Carabeo	  et	  al.,	  2003).	  The	  
uptake	  of	  these	  nutrients	  is	  dependent	  on	  functioning	  Golgi	  apparatus	  (Carabeo	  et	  al.,	  
2003)	   and	  C.trachomatis	   inclusions	   co-­‐opt	   Golgi	   stacks,	   presumably	   to	   facilitate	   this	  
nutrient	  uptake	   (Heuer	  et	  al.,	  2009).	  To	  establish	  whether	  nigericin	   induced	  K+	  efflux	  
disrupts	   the	   Golgi	   apparatus,	   a	   specific	   antibody	   against	   giantin,	   a	   Golgi	   membrane	  
protein	   (Sonnichsen	  et	   al.,	  1998),	  was	   used	   to	   label	   cis-­‐	  and	  medial	  Golgi.	  Nigericin-­‐
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induced	  K+	  efflux	  did	  not	  induce	  any	  significant	  morphological	  changes	  in	  Golgi	  stacks	  
(Figure	   3.8B),	   and	   therefore	   it	   seems	   unlikely	   that	   the	   ABs	   observed	   following	   K+	  
ionophore	  treatment	  are	  generated	  as	  a	  result	  of	  disrupted	  cis-­‐	  or	  medial	  Golgi	  stacks.	  
Recently	  in	  our	  lab,	  Dumoux	  et	  al.	  (2012)	  showed	  that	  ER	  is	  recruited	  to	  the	  chlamydial	  
inclusion.	  This	   interaction	  is	  critical	  for	  early	   inclusion	  biogenesis,	  but	  was	  unaffected	  
by	   ionophore	   treatment	   (Dumoux	  et	   al.,	   2012),	   however,	   K+	   efflux	   induced	  by	   pore-­‐
forming	   toxin,	   aerolysin,	   was	   shown	   to	   cause	   vacuolation	   of	   the	   ER	   (Abrami	   et	   al.,	  
1998).	  Morphology	   of	   the	   ER	   in	  HeLa	   cells	   following	   12h	   of	   nigericin	   treatment	  was	  
assessed	  using	  a	  specific	  antibody	  against	  calreticulin,	  a	  glycoprotein	  chaperone	  in	  the	  
ER	  (Molinari	  et	  al.,	  2004).	  Consistent	  with	  the	  findings	  of	  Dumoux	  et	  al.,	  there	  appears	  
to	   be	   no	   difference	   between	   nigericin	   treated	   and	   control	   ER,	   which	   indicates	   that	  
abnormal	  C.trachomatis	  LGV2	  development	  following	  nigericin	  treatment	  was	  not	  the	  
result	  of	  disrupted	  ER	  (Figure	  3.8C).	  	  
These	  data	  show	  that	  the	  only	  significant	  disruption	  of	  observed	  organelles	  following	  
nigericin-­‐induced	  K+	  efflux	  is	  alteration	  of	  the	  active	  mitochondria	  network	  in	  treated	  
HeLa	   cells.	   This	   could	   imply	   that	   mitochondrial	   hyperpolarization	   has	   a	   detrimental	  
effect	  on	  C.trachomatis	  LGV2	  infection	  of	  HeLa	  cells.	  However,	  this	  could	  just	  be	  a	  side	  
effect	   of	   the	   nigericin	   treatment,	   and	   not	   the	   cause	   of	   disrupted	   bacterial	  
development.	  To	  determine	  if	  this	  is	  the	  case,	  cells	  infected	  with	  C.trachomatis	  will	  be	  
observed	   following	   K+	   depletion	   using	   a	   method	   that	   does	   not	   directly	   affect	  
mitochondrial	  activity.	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Figure	  3.8.	  Ionophore	  induced	  K+	  efflux	  disrupts	  HeLa	  mitochondria	  but	  not	  Golgi	  or	  
endoplasmic	  reticulum.	  Confocal	  xy-­‐sections	  of	  HeLa	  cells	  treated	  with	  1µM	  nigericin	  
for	  24h.	   (A)	  Live	  cells	  were	   labelled	  using	  mitotracker	  orange	  (red)	  prior	  to	  fixation.	  
(B)	   Fixed	   cells	   were	   labelled	   using	   anti-­‐giantin	   antibody	   and	   AlexaFluor®568	  
conjugated	   secondary	   antibody	   (red).	   (C)	   Fixed	   cells	   were	   labelled	   using	   anti-­‐
calreticulin	   antibody	   and	   AlexaFluor®488	   conjugated	   secondary	   antibody	   (green).	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3.7	   Restriction	   of	   cellular	   K+	   uptake	   has	   a	   detrimental	   effect	   on	  
C.trachomatis	  LGV2	  infection	  
Nigericin-­‐induced	  AB	  formation	  could	  imply	  that	  replicating	  bacteria	  have	  a	  nutritional	  
requirement	   for	  K+,	  however	  other	  contributing	   factors	  must	  also	  be	  considered.	  For	  
example,	   mitochondria	   in	   nigericin	   treated	   cells	   appear	   to	   be	   disrupted	   by	   the	   K+	  
efflux,	  which	   could	  have	  an	   impact	  on	  C.trachomatis	  development.	   Equally,	  nigericin	  
treatment	  could	  activate	  cellular	  signalling	  pathways,	  usually	   triggered	  by	  a	  decrease	  
in	   intracellular	   K+.	   For	   example,	   K+	   efflux	   from	   eukaryotic	   cells	   has	   been	   shown	   to	  
stimulate	  the	  production	  of	  reactive	  oxygen	  species	  and	  consequently	  acts	  as	  a	  trigger	  
for	   the	  NLRP3	   inflammasome	   leading	   to	   caspase-­‐1	   cytokine	  production	   to	   initiate	   an	  
innate	   immune	   response	   (Muñoz-­‐Planillo	   et	   al.,	   2013).	   Restricting	   K+	   concentrations	  
without	  inducing	  an	  efflux	  or	  disrupting	  mitochondria,	  by	  inhibiting	  inwardly	  rectifying	  
K+	  channels	  (Kir),	  will	  illustrate	  whether	  replicating	  bacteria	  require	  a	  constant	  influx	  of	  
K+	  for	  successful	  intracellular	  development.	  Adenosine	  triphosphate	  (ATP)-­‐sensitive	  Kir	  
channels	  are	  located	  in	  both	  the	  plasma	  membrane	  and	  organelles,	  including	  the	  inner	  
mitochondrial	  membrane	  (Shi	  et	  al.,	  2005).	  Kir	  channels	  are	  comprised	  of	  two	  distinct	  
subunits,	  a	  pore	  forming	  subunit	  of	  the	  Kir6.x	  family	  and	  an	  ATP	  binding	  sulphonylurea	  
receptor	  (SUR)	  subunit	  (Bryan	  and	  Aguilar-­‐Bryan,	  1999).	  SUR	  domains	  are	  sensitive	  to	  
glibenclamide,	  which	  reduces	  Kir	  activity	  by	  50-­‐60%	  (Bryan	  and	  Aguilar-­‐Bryan,	  1999).	  	  
Glibenclamide	   concentration	  was	   titrated	   to	  a	   level	   that	   could	  be	   tolerated	  by	  more	  
that	   75%	  of	  HeLa	   cells.	   Treatment	  of	   cells	  with	   10µM	  glibenclamide	   caused	   the	   loss	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less	  than	  25%	  of	  HeLa	  cells	  (Table	  2.2),	  and	  did	  not	  reduce	  the	  initial	  K+	  concentration	  
within	  the	  cells,	  as	  verified	  using	  flame	  photometry	  (Figure	  3.6).	  
When	  HeLa	  cells	  infected	  with	  C.trachomatis	  LGV2	  were	  treated	  with	  glibenclamide	  at	  
12hpi,	   ABs	   morphologically	   similar	   to	   those	   generated	   following	   K+	   ionophore	  
treatment	   were	   observed	   at	   24hpi	   (Figure	   3.9A).	   When	   bacterial	   infectivity	   was	  
quantified	   at	   50hpi,	   following	   treatment	   of	   the	   cells	  with	   glibenclamide	   from	  12hpi,	  
only	   33%	   of	   the	   bacteria	   had	   differentiated	   into	   EBs	   in	   comparison	   to	   control	  
conditions.	  The	  infectious	  titre	  was	  significantly	  reduced	  (p≤	  0.05)	  when	  compared	  to	  
the	   control	   (Figure	   3.9B).	   These	   data	   would	   suggest	   that	   ABs,	   induced	   following	  
glibenclamide	   treatment,	   were	   unable	   to	   differentiate	   into	   EBs,	   but	   the	   bacteria	  
observed	   with	   normal	   RB	   morphology	   successfully	   completed	   RB-­‐EB	   differentiation	  
and	  were	  unaffected	  by	  glibenclamide	  inhibition	  of	  Kir	  channels.	  
Interestingly,	   glibenclamide	   treated	   cells	   contained	   a	  mixed	   population	   of	   inclusions	  
containing	  either	  RBs	  (Figure	  3.10	  glibenclamide	  panel,	  indicated	  by	  *)	  or	  ABs	  (Figure	  
3.10	   glibenclamide	  panel,	   indicated	  by	  †),	  whereas	   treatment	  with	  nigericin	   induced	  
ABs	   in	   every	   observed	   inclusion	   (Figure	   3.10	  nigericin	   panel).	   This	   is	   consistent	  with	  
infectivity	  data,	  where	  nigericin	  treatment	  prevented	  the	  formation	  of	  any	   infectious	  
EBs	   (Figure	   3.5B)	   but	   approximately	   30%	   of	   bacteria	   in	   glibenclamide	   treated	   cells	  
successfully	  completed	  RB-­‐EB	  redifferentiation	  (Figure	  3.9B).	  These	  data	  could	  appear	  
contradictory	  to	  the	  hypothesis	  that	  a	  decrease	  in	  intracellular	  K+	  during	  C.trachomatis	  
replication	  induces	  the	  formation	  of	  ABs.	  Quantification	  of	  intracellular	  K+	  using	  flame	  
photometry	   showed	   that	   glibenclamide	   treatment	   did	   not	   reduce	   intracellular	   K+,	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Figure	  3.9.	  Restricting	  K+	  uptake	  by	  HeLa	  cells	  causes	  persistence-­‐like	  development	  
during	   C.trachomatis	   LGV2	   replication.	   (A)	   Confocal	   xy-­‐sections	   of	   C.trachomatis	  
LGV2	   infected	   HeLa	   cells	   (MOI=1)	   treated	   with	   10µM	   glibenclamide	   at	   12hpi	   and	  
fixed	   at	   24hpi.	   Bacteria	   were	   labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	   specific	  
primary	  antibody	  followed	  by	  AlexaFluor®488	  conjugated	  secondary	  antibody	  (green)	  
and	  DRAQ-­‐5	  DNA	  label	  (magenta).	  Scale	  bars,	  10µm.	  Insets	  show	  indicated	  areas	  at	  
higher	  magnification.	   (B)	  C.trachomatis	  LGV2	   infected	  cell	   layers	  treated	  with	  10µM	  
glibenclamide	  at	  12hpi	  and	  collected	  at	  50hpi	  were	  diluted	  in	  fresh	  media	  to	  infect	  a	  
new	   layer	   of	   cells.	   After	   24h,	   infected	   cells	   were	   fixed	   and	   labelled	   using	   anti-­‐
Chlamydia	  spp.	  FITC-­‐conjugated	  antibody	  and	  DAPI	  DNA	  stain.	  IFUs	  were	  quantified	  
(IFU/ml).	   Each	   experiment	   was	   repeated	   a	  minimum	   of	   three	   times,	   and	   the	   data	  
presented	   are	   representative	   of	   each	   iteration.	   Error	  bars	   show	  standard	  deviation	  
(*=p≤0.05).	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Figure	  3.10.	  Glibenclamide	   inhibition	  of	  Kir	  channels	   induces	  ABs	   in	  most,	  but	  not	  
all,	   C.trachomatis	   LGV2	   infected	   HeLa	   cells.	   Confocal	   xy-­‐sections	   of	   C.trachomatis	  
LGV2	   infected	   HeLa	   cells	   either	   (A)	   untreated,	   (B)	   treated	   with	   1µM	   nigericin	   at	  
12hpi,	   or	   (C)	   treated	  with	   10µM	  glibenclamide	   at	   12hpi.	   Cells	  were	   fixed	   at	  24hpi.	  
Bacteria	   were	   labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	   specific	   primary	   antibody	  
followed	  by	  AlexaFluor®488	  conjugated	  secondary	  antibody	  (green)	  and	  DRAQ-­‐5	  DNA	  
label	  (magenta).	  Asterisk	   (*)	  indicates	  inclusions	  that	  appear	  to	  contain	  RBs.	  Dagger	  
(†)	   indicates	   inclusions	   that	   appear	   to	   contain	   ABs.	   Scale	   bars,	   50µm.	   Insets	   show	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compared	   to	   control	   cells	   (Figure	   3.6),	   and	   yet	   AB	   formation	   was	   still	   induced	   in	   a	  
significant	   number	   of	   glibenclamide	   treated	   cells.	   When	   analysing	   intracellular	   K+	  
concentration	  using	  a	  potassium	  specific	  ratiometric	  fluorescent	  dye,	  Grieshaber	  et	  al.	  
(2002)	   demonstrated	   a	   deviation	   of	   28mM	   in	   K+	   concentration	   across	   24	   Vero	   cells,	  
which	   would	   suggest	   a	   natural	   variation	   in	   K+	   concentrations	   between	   cells.	   This	  
variation	   could	   indicate	   that	   the	   cells	   containing	   RBs	   following	   glibenclamide	  
treatment	   contained	   sufficient	   intracellular	   K+	   to	   support	   C.trachomatis	   replication,	  
without	  the	  need	  for	  inwardly	  rectifying	  K+	  channels.	  	  
These	  data	  show	  that	  AB	  formation	  is	  induced	  in	  intracellular	  C.trachomatis	  LGV2	  in	  K+	  
restricted	   environments	   without	   the	   need	   for	   a	   K+	   efflux.	   This	   suggests	   that	   AB	  
formation	   is	   not	   the	   result	   of	   a	   host-­‐induced	   response	   to	   intracellular	   bacteria,	   and	  
instead,	   demonstrates	   a	   link	   between	   K+	   availability	   during	   RB	   replication	   and	  
abnormal	   bacterial	   development.	   The	   significant	   proportion	   of	   bacteria	   disrupted	  
following	  glibenclamide	  treatment	  suggests	  that	  replicating	  C.trachomatis	  LGV2,	  in	  the	  
majority	   of	   HeLa	   cells,	   require	   more	   K+	   than	   is	   readily	   available	   in	   intracellular	   K+	  
stores.	  
K+	   starvation	   from	   12hpi,	   during	  C.trachomatis	   LGV2	   replication,	   is	   characterised	   by	  
the	  formation	  of	  ABs	  with	  reduced	  capacity	  to	  produce	  infectious	  EBs.	  The	  large,	  non-­‐
infectious	   bodies	   observed	   in	   K+	   ionophore	   treated	   cells	   and	   Kir	   inhibited	   cells	   are	  
consistent	  with	  previously	  described	  persistence	  phenotypes,	   induced	  during	   in	   vitro	  
chlamydial	  infections	  in	  response	  to	  a	  number	  of	  environmental	  stressors	  (reviewed	  by	  
Hogan	  et	  al.,	  2004).	  C.trachomatis	  persistence	   is	  defined	  by	  enlarged	  ABs,	  which	  are	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transcriptionally	   active	  but	  non-­‐replicative,	   that	  will	   resume	   their	  development	   cycle	  
on	   restoration	   of	   favourable	   conditions	   (Hogan	   et	   al.,	   2004;	   Schoborg,	   2011).	   To	  
conclude	  that	  restriction	  of	  K+	  during	  C.trachomatis	  replication	  results	   in	  persistence,	  
ultrastructural	   observation	   of	   K+	   starvation-­‐induced	   ABs	   was	   undertaken,	   and	  
continued	  transcription	  and	  AB	  recovery	  investigated.	  
	  
3.8	   Restriction	   of	   K+	   during	   C.trachomatis	   LGV2	   replication	   induces	  
persistence	  
C.trachomatis	   can	   enter	   a	   persistent	   state	   in	   response	   to	   a	   number	   of	   stressors,	  
including	  exposure	  to	  cytokines,	  such	  as	  interferon-­‐γ	  (Pantoja	  et	  al.,	  2001),	  heat	  shock	  
(Kahane	   and	   Friedman,	   1992),	   and	   various	   nutrient	   deficiencies,	   for	   example	   iron	  
starvation	   (Raulston,	   1997)	   and	   amino	   acid	   deprivation	   (Coles	   et	   al.,	   1993).	   Each	  
trigger	   produces	   slightly	   different	   persistence	   phenotypes,	   but	   share	   certain	  
identifying	  features.	  	  
Restriction	  of	  intracellular	  K+	  during	  C.trachomatis	  LGV2	  replication	  appears	  to	  induce	  
the	   formation	   of	   ABs,	   similar	   to	   those	   observed	   during	   recognised	   persistence	  
conditions.	   These	   ABs	   are	   situated	   in	   the	   perinuclear	   region	   of	   the	   cell,	   however	  
fluorescence	  microscopy	  images	  do	  not	  provide	  any	  structural	  detail	  on	  the	  effects	  of	  
K+	  starvation	  on	  bacterial	  morphology.	  Transmission	  electron	  microscopy	  (TEM)	  of	  thin	  
sections	  of	  C.trachomatis	  LGV	   infected	  HeLa	  cells	  allowed	  ultrastructural	   comparison	  
of	  nigericin	  treatment-­‐induced	  ABs	  and	  RBs	  under	  normal	  infection	  conditions.	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HeLa	   cells	   infected	   with	   C.trachomatis	   LGV2	   were	   treated	   with	   nigericin	   12hpi	   and	  
fixed	   at	   24hpi,	   prior	   to	   embedding	   and	   preparation	   for	   transmission	   electron	  
microscopy.	   Electron	   micrographs	   of	   K+	   starved	   inclusions	   contain	   large	   bodies,	  
consistent	  with	  the	  morphology	  of	  the	  bacteria	  observed	  by	  fluorescence	  microscopy.	  
The	   ABs	   contain	   several	   membrane	   fragments,	   which	   possibly	   result	   from	   arrested	  
replication	  (Figure	  3.11	  nigericin	  panel,	   indicated	  by	  *).	  After	  nigericin	  treatment	  the	  
inclusion	  membrane	  remains	   intact	  as	  a	  distinction	  can	  clearly	  be	  made	  between	  the	  
host	  cell	  cytosol	  and	  the	  inclusion	  lumen,	  and	  ABs	  still	  appear	  to	  contact	  the	  inclusion	  
membrane.	   There	   is	   also	   an	   increase	   in	   electron-­‐dense	  material	  within	   the	   inclusion	  
(indicated	   by	   arrows	   in	   Figure	   3.11),	   which	   resembles	   glycogen	   (Gordon	   and	   Quan,	  
1965;	   Chiappino	   et	   al.,1995).	   These	   data	   show	   that	   the	   ABs,	   observed	   following	   K+	  
efflux	  during	  C.trachomatis	  LGV2	  replication,	  remain	  inside	  an	  intact	  inclusion	  but	  are	  
morphologically	  distinct	  from	  RBs	  observed	  in	  untreated	  cells.	  To	  establish	  persistence	  
in	  K+	  deficient	  bacteria,	  ABs	  must	  be	  shown	  to	  be	  viable	  and	  capable	  of	  recovery	  once	  
optimal	  K+	  conditions	  have	  been	  restored.	  
Expression	  of	   bacterial	   16S	   rRNA	  was	  used	   to	   assay	   the	   viability	   of	   K+	   deficient	  ABs.	  
Ribosomal	  RNA	  precursors	  are	  essential	  to	  bacteria;	  therefore	  the	  absence	  of	  16S	  rRNA	  
transcription	   is	   a	   strong	   indication	   that	   bacterial	   cells	   are	   non-­‐viable.	   To	   establish	   a	  
negative	   control	   for	   this	   assay,	   conditions	   that	   will	   eliminate	   bacteria,	   but	   are	   non-­‐
toxic	   to	   host	   cells	   are	   required.	   Chlamydial	   infections	   are	   sensitive	   to	   tetracycline	  
antibiotics,	  with	  doxycycline	  being	  one	  of	  the	  most	  common	  therapeutic	  agents	  (Senn	  
et	  al.,	  2005).	  Doxycycline	  concentrations	  were	  titrated	  using	  HeLa	  cells,	  and	  5µM	  was	  
selected	  as	  a	  working	  concentration	  (Table	  2.2).	  HeLa	  cells	  infected	  with	  C.trachomatis	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Figure	  3.11.	  Ultrastructure	  of	  K+	  starved	  ABs	   in	  HeLa	  cells.	  HeLa	  cells	  infected	  with	  
C.trachomatis	   LGV2	   (MOI=1)	   were	   either	   left	   untreated	   (control)	   or	   treated	   12hpi	  
with	  1µM	  nigericin	  (nigericin).	  Cells	  were	  fixed	  at	  24hpi	  prior	  to	  embedding.	  Asterisk	  
(*)	   indicates	   ABs	   that	   contain	   a	   number	   of	  membrane	   fragments.	   Arrows	   indicate	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LGV2	  were	  treated	  with	  5µM	  doxycycline	  at	  12hpi.	  At	  24hpi	   individual	  bacteria	  were	  
no	   longer	   visible	   and	   anti	   Chlamydia	  MOMP/LPS	   antibody	   labelling	   became	   diffuse	  
throughout	  the	  host	  cell	   (Figure	  3.12A).	   Infectivity	  collected	  from	  HeLa	  cells	   infected	  
with	  C.trachomatis	  LGV2	  and	   treated	  with	  5µM	  doxycycline	  at	  12hpi,	  was	  quantified	  
50hpi	  after	  either	   incubation	  with	  doxycycline	   for	   the	  duration	  of	   the	  experiment	  or	  
having	  had	  the	  doxycycline	  washed	  out	  after	  1h	  (for	  schematic	  representation	  of	  the	  
experiment	   see	   Figure	   3.12B).	   The	   infectivity	   assay	   confirmed	   that	   that	   doxycycline	  
treatment	  had	  prevented	  the	  formation	  of	  infectious	  EBs	  (Figure	  3.12C),	  and	  bacterial	  
infectivity	   could	   not	   be	   recovered	   when	   doxycycline	   was	   removed	   after	   1h	   of	  
treatment	   (Figure	   3.12C).	   This	   absence	   of	   bacterial	   recovery	   following	   doxycycline	  
removal	   indicates	   that	   the	   bacteria	   are	   no	   longer	   viable,	   which	   demonstrates	   that	  
doxycycline	   treatment	   is	   effective	   at	   killing	  C.trachomatis	   LGV2,	   and	   is	   therefore	   an	  
appropriate	  control	  treatment	  for	  16S	  rRNA	  viability	  assays.	  
HeLa	   cells	   infected	   with	   C.trachomatis	   LGV2	   for	   12h	   were	   either	   treated	   with	   5µM	  
doxycycline	   to	   clear	   bacterial	   infection,	   1µM	   nigericin	   to	   induce	   K+	   deficient	   AB	  
formation,	  or	  left	  untreated,	  before	  RNA	  isolation	  at	  50hpi.	  RNA	  samples	  were	  treated	  
with	  DNase	   I	   to	   remove	  DNA	  contaminants	  prior	   to	  reverse	  transcription	  and	  PCR	  to	  
amplify	  prokaryotic	  16S	  (product	  207bp,	  for	  primers	  see	  Appendix	  1),	  and	  eukaryotic	  
18S	  (product	  217bp,	  for	  primers	  see	  Appendix	  1).	  For	  each	  condition	  RNA,	  both	  before	  
(Figure	  3.13A	  -­‐DNase)	  and	  after	  (Figure	  3.13A	  +DNase)	  DNase	  treatment,	  was	  used	  for	  
PCR,	  employing	  16S	  primers	  to	  ensure	  that	  any	  cellular	  DNA	  contamination	  had	  been	  
removed.	   Untreated	   controls	   showed	   amplification	   of	   both	   prokaryotic	   16S	   and	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Figure	   3.12.	   Doxycycline	   clears	  C.trachomatis	   LGV2	   infection	   from	  HeLa	   cells.	   (A)	  
Confocal	   xy-­‐sections	   of	   C.trachomatis	   LGV2	   infected	   HeLa	   cells	   (MOI=1)	   either	  
untreated	   (control),	   or	   treated	  with	   5µM	  doxycycline	   at	   12hpi	   (doxycycline),	   were	  
fixed	   at	   24hpi.	   Bacteria	   were	   labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	   specific	  
primary	  antibody	  followed	  by	  AlexaFluor®488	  conjugated	  secondary	  antibody	  (green)	  
and	  DRAQ-­‐5	  DNA	  label	   (magenta).	  Scale	  bars,	  10µm.	  Insets	  show	  indicated	  areas	  at	  
higher	  magnification.	  (B)	  Schematic	  representation	  of	  experiment	  timelines,	  showing	  
confocal	  xy-­‐section	  of	  C.trachomatis	  (green)	  infection	  of	  HeLa	  cells	  (red)	  at	  the	  time	  
of	   doxycycline	   treatment	   and	   indicating	   when	   treatment	   was	   washed	   out,	   where	  
appropriate.	   (C)	   C.trachomatis	   LGV2	   infected	   HeLa	   cell	   layers	   either	   untreated,	  
treated	  12hpi	  with	  5µM	  doxycycline	   for	  the	  duration	  of	  the	  experiment,	  or	  treated	  
12hpi	  with	  5µM	  doxycycline	  for	  1h	  before	  doxycycline	  media	  was	  replaced	  with	  fresh	  
growth	  media,	   were	   collected	   at	   50hpi	   and	   diluted	   in	   fresh	  media	   to	   infect	   a	   new	  
layer	  of	  cells.	  After	  24h,	   infected	  cells	  were	  fixed	  and	   labelled	  using	  anti-­‐Chlamydia	  
spp.	  FITC-­‐conjugated	  antibody	  and	  DAPI	  DNA	  stain.	   IFUs	  were	  then	  quantified.	  Each	  
experiment	   was	   repeated	   a	   minimum	   of	   three	   times,	   and	   the	   data	   presented	   are	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eukaryotic	  18S	  complementary	  DNA	  (Figure	  3.13A	  control	  panel),	  indicating	  viability	  of	  
both	   bacteria	   and	   host	   cells	   respectively.	   18S	   products	   were	   still	   amplified	   from	  
doxycycline	  treated	  cells	  after	  bacterial	  infection,	  but	  no	  amplification	  of	  16S	  product	  
was	  observed,	  confirming	  that	  the	  host	  cell	  is	  viable	  but	  the	  bacteria	  were	  not	  (Figure	  
3.13A	   doxycycline	   panel).	   K+	   starved	   bacteria,	   resulting	   from	   nigericin	   treatment	   of	  
infected	   cells,	   show	   amplification	   of	   18S	   product	   at	   a	   comparable	   level	   to	   the	  
untreated	   control	   and	   a	   feint	   band	   of	   amplified	   16S	   product	   (Figure	   3.13A	   nigericin	  
panel).	   The	  presence	  of	   the	   16S	  product	   illustrates	   that	   bacteria	   remain	   viable	   after	  
nigericin	   treatment.	   As	   this	   assay	   was	   not	   undertaken	   using	   quantitative	   PCR	   it	   is	  
difficult	   to	   assess	   the	   levels	   of	   16S	   product,	   but	   the	   amplification	   of	   18S	   product	   in	  
each	  sample	  allows	  semi-­‐quantitative	  analysis.	  By	  measuring	  the	  mean	  pixel	  intensities	  
from	  the	  fluorescent	  bands	  produced	  following	  ethidium	  bromide	  intercalation	  of	  the	  
DNA	  present	   in	   gels,	   the	  quantity	  of	  16S	  product	   in	   relation	   to	   the	  18S	  product	  was	  
obtained.	  In	  control	  conditions	  the	  16S	  pixel	  intensity	  was	  76%	  of	  the	  18S,	  whereas	  the	  
intensity	   of	   the	   16S	   band	   obtained	   from	   nigericin	   treated	   cells	   was	   29%	   of	   the	  
corresponding	  18S	  band	   (Figure	   3.13B).	   This	   difference	   could	  be	   the	   result	   of	   either	  
reduced	   transcription,	   or	   fewer	   bacteria	   present	   in	   the	   sample,	   which	   would	   be	  
consistent	  with	  disrupted	  replication	  following	  the	  induction	  of	  ABs.	  	  
Having	   established	   that	   K+	   deficient	   C.trachomatis	  ABs	   are	   capable	   of	   transcription,	  
despite	  being	  non-­‐cultivable,	   recovery	  upon	  restoration	  of	  optimal	  K+	  concentrations	  
must	  be	  demonstrated	  before	  persistence	  can	  be	  confirmed.	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Figure	   3.13.	   K+	   starved	   ABs	   remain	   viable	   but	   non-­‐infectious.	   (A)	  HeLa	  cells	  were	  
infected	   with	   C.trachomatis	   LGV2	   (MOI=1)	   and	   were	   either	   untreated	   (control),	  
treated	  at	  12hpi	  with	  5µM	  doxycycline	  (doxycycline),	  or	  treated	  at	  12hpi	  with	  1µM	  
nigericin	   (nigericin).	  RNA	  was	   then	  collected	  at	   50hpi	   prior	   to	   reverse	   transcription	  
before	  PCR	  using	  specific	  primers	  for	  C.trachomatis	  16S	  (16S)	  or	  eukaryotic	  18S	  (18S)	  
complementary	   DNA.	   RNA	   samples	   were	   shown	   to	   be	   free	   from	   cellular	   DNA	  
contamination	   before	   (-­‐DNase)	   or	   after	   (+DNase)	  DNase	   treatment.	   (B)	  Mean	  pixel	  
intensity	  of	  16S	  product	  expressed	  as	  a	  percentage	  of	  the	  equivalent	  18S	  product.	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HeLa	   cells	   were	   treated	   with	   nigericin	   12hpi,	   and	   remained	   in	   nigericin-­‐containing	  
medium	   for	   the	   duration	  of	   the	   experiment	   or	   had	   the	   nigericin-­‐containing	  medium	  
removed	  either	  after	  1h	  or	  12h	  of	  treatment	  to	  allow	  K+	  gradients	  to	  be	  restored	  (for	  a	  
schematic	  of	  infection,	  treatment	  and	  washing-­‐out	  times	  for	  each	  condition	  see	  Figure	  
3.14A).	   At	   50hpi,	   a	   timepoint	   when	   bacteria	   under	   control	   conditions	   had	  
differentiated	   into	   EBs,	   bacteria	   were	   collected	   and	   infectivity	   quantified.	   When	  
nigericin	  was	  present	  for	  the	  duration	  of	  the	  experiment	  no	  infection	  was	  recovered.	  
Strikingly,	  nigericin	  removal	  allowed	  bacteria	  to	  recover	   infectivity	   irrespective	  of	  the	  
duration	  of	  nigericin	  treatment	  (Figure	  3.14B).	  
These	  data	  confirm	  that	  K+	  starvation	  during	  the	  replicative	  phase	  of	  the	  C.trachomatis	  
infection	   cycle	   induces	   classical	   persistence.	   Persistent	   ABs	   remained	   viable	   and	   the	  
infection	   cycle	   recovered	   to	   complete	   RB-­‐EB	   differentiation	   when	   physiological	   K+	  
concentrations	   were	   restored.	   This	   demonstrates	   an	   essential	   role	   for	   K+	   during	  
C.trachomatis	  LGV2	  replication	  in	  HeLa	  cells.	  However,	  due	  to	  the	  wide-­‐ranging	  tissue	  
tropism	   of	   the	   Chlamydiaceae,	   and	   the	   close	   relationship	   between	   these	   different	  
hosts	  and	  the	  specific	  pathogenic	  species,	  the	  essential	  role	  for	  K+	  during	  C.trachomatis	  
LGV2	  infection	  of	  HeLa	  cells	  could	  be	  unique	  to	  this	  cell	   line-­‐serovar	  combination.	  To	  
assess	   the	   wider	   implications	   of	   these	   observations,	   different	   host-­‐Chlamydiae	  
combinations	   were	   assayed	   to	   ascertain	   whether	   K+	   is	   critical	   to	   all	   Chlamydiae	  
irrespective	  of	  host	  cell	  line.	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Figure	  3.14.	  K+	  starvation-­‐induced	  C.trachomatis	  LGV2	  ABs	  can	  recover	  to	  complete	  
the	   infection	   cycle	   when	   K+	   concentrations	   are	   restored.	   (A)	   Schematic	  
representation	   of	   experiment	   timelines,	   showing	   confocal	   xy-­‐sections	   of	  
C.trachomatis	  (green)	  infection	  of	  HeLa	  cells	  (red)	  at	  the	  time	  of	  nigericin	  treatment,	  
and	  indicating	  when	  treatment	  was	  washed	  out	  where	  appropriate.	  (B)	  C.trachomatis	  
LGV2	  infected	  HeLa	  cell	   layers	  (MOI=1)	  either	  untreated,	  treated	  at	  12hpi	  with	  1µM	  
nigericin	  for	  the	  duration	  of	  the	  experiment,	  treated	  at	  12hpi	  with	  1µM	  nigericin	  for	  
1h	  before	  nigericin	  media	  was	  replaced	  with	  fresh	  growth	  media,	  or	  treated	  at	  12hpi	  
with	   1µM	   nigericin	   for	   1h	   before	   nigericin	   media	  was	   replaced	   with	   fresh	   growth	  
media.	  Cells	  were	  collected	  at	  50hpi	  and	  diluted	  in	  fresh	  media	  to	  infect	  a	  new	  layer	  
of	   cells.	   After	   24h,	   infected	   cells	  were	   fixed	  and	   labelled	   using	   anti-­‐Chlamydia	  spp.	  
FITC-­‐conjugated	   antibody	   and	  DAPI	  DNA	  stain.	   IFUs	  were	   then	   quantified	   (IFU/ml).	  
Each	  experiment	  was	   repeated	   a	  minimum	  of	   three	   times,	  and	   the	   data	  presented	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3.9	   K+	   starvation	   of	  Chlamydiae	  during	   replication	   induces	   persistence,	  
regardless	  of	  serovar,	  species	  or	  host	  
This	  chapter	  has	  demonstrated	  that	  reducing	  intracellular	  K+,	  either	  by	  inducing	  efflux	  
using	   ionophores	   or	   inhibiting	   Kir	   channels,	   causes	   persistence	   during	   C.trachomatis	  
LGV2	   replication	   in	   HeLa	   cells.	   It	   is	   important	   to	   ascertain	   whether	   bacterial	  
dependence	  on	  K+	  is	  unique	  to	  this	  serovar-­‐cell	  line	  combination,	  or	  if	  K+	  starvation	  will	  
induce	  persistence	  in	  other	  Chlamydiae	  strains	  or	  C.trachomatis	  serovars	  in	  other	  host	  
cell	  lines.	  
Bacteria	  from	  the	  Chlamydiaceae	  family	  infect	  a	  wide	  range	  of	  hosts,	  and	  demonstrate	  
diverse	  tissue	  tropism	  (Figure	  1.1)	  (Everett	  et	  al,	  2000;	  Abdelsamed	  et	  al.,	  2013).	  Due	  
to	   the	   obligate	   intracellular	   nature	   of	   the	   Chlamydiaceae	   each	   strain	   has	   evolved	  
closely	  with	   its	   host,	   and	  will	   therefore	   encounter	   differing	   environmental	   pressures	  
and	  have	  different	  nutritional	   requirements.	  For	  example,	  C.suis	  strain	  S-­‐45	   infection	  
of	   swine	   differentiated	   luminal	   epithelial	   cells	   displayed	   an	   active	   infection	   cycle,	  
however	  infection	  of	  swine	  glandular	  epithelial	  cells	  with	  the	  same	  bacteria	  resulted	  in	  
persistent	   infection	   (Guseva	   et	   al.,	   2003).	   Allan	   and	   Pearce	   (1983)	   investigated	   the	  
differing	  amino	  acid	  requirements	  of	  Chlamydiae	  strains	  and	  serovars	  and	  found	  that	  
four	  strains	  of	  C.psittaci	  did	  not	  require	  histidine	  for	  successful	  infection	  development,	  
however	   intracellular	   development	   of	   eleven	   serovars	   of	   C.trachomatis,	   including	  
ocular,	   LGV,	   and	   genital	   biovars,	   was	   inhibited	   by	   omission	   of	   histidine	   from	   the	  
growth	   medium.	   Furthermore,	   only	   ocular	   serovars	   A-­‐C	   were	   shown	   to	   require	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tryptophan,	   and	   LGV2	   was	   shown	   to	   require	   methionine,	   unlike	   ocular	   and	   genital	  
biovars	  (Allan	  and	  Pearce,	  1983).	  	  
RL95-­‐2	   cells,	   first	   immortalized	   and	   characterised	   by	  Way	   et	   al.	   (1983),	   are	   human	  
endometrial	  carcinoma	  cells,	  and	  are	  therefore	  physiologically	  relevant	  to	  chlamydial	  
infection.	   RL95-­‐2	   cells	   were	   used	   to	   observe	   the	   effect	   of	   K+	   starvation	   during	  
C.trachomatis	  LGV2	  replication	  in	  an	  alternative	  cell	   line.	  As	  the	  infection	  cycle	   is	  cell	  
line	  specific,	  the	  normal	  development	  cycle	  of	  C.trachomatis	  LGV2	  in	  RL95-­‐2	  cells	  was	  
initially	  reconstituted.	  
RL95-­‐2	   cells	   infected	   with	   C.trachomatis	   LGV2	   contained	   EB-­‐filled	   inclusions	   6hpi	  
(Figure	   3.15A/B	  6h),	  which	  begin	   to	  differentiate	   into	  RBs	  at	  12hpi,	   (Figure	   3.15A/B	  
12h).	   Mature	   inclusions	   began	   to	   lyse	   at	   48hpi,	   demonstrated	   by	   a	   decrease	   in	  
infectivity	  collected	  from	  cells	  from	  48	  to	  60hpi	  (Figure	  3.15A	  48h).	  These	  data	  show	  
that	  C.trachomatis	  LGV2	  development	  occurs	  more	  rapidly	  in	  RL95-­‐2	  cells	  than	  in	  HeLa	  
cells,	  and	  therefore,	  to	  investigate	  the	  effects	  of	  K+	  starvation	  during	  replication,	  cells	  
were	   treated	  with	   nigericin	   6hpi	   and	   fixed	   18hpi.	   Nigericin	   induced	   K+	   efflux	   during	  
C.trachomatis	   LGV2	   infection	   caused	   the	   formation	   of	   ABs	   in	   RL95-­‐2	   cells	   (Figure	  
3.15C).	  RL95-­‐2	  cells	   infected	  with	  C.trachomatis	  LGV2	  were	  treated	  12hpi	  with	  either	  
nigericin,	  to	  induce	  a	  K+	  efflux,	  glibenclamide,	  to	  restrict	  host	  cell	  K+	  uptake,	  or	  chloride	  
ionophore	  I,	  to	  disrupt	  Cl-­‐	  gradients	  and	  act	  as	  a	  control	  for	  disrupted	  pH,	  osmolarity,	  
and	   membrane	   potentials,	   before	   IFU	   quantification	   48hpi.	   Nigericin	   treatment	  
prevented	  bacteria	  differentiation	  into	  infectious	  EBs	  at	  the	  end	  of	  the	  infection	  cycle,	  
as	  demonstrated	  by	  the	  lack	  of	  infectivity	  (Figure	  3.15D).	  Glibenclamide	  treatment	  also	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Figure	  3.15.	  K+	  starvation	  induces	  persistence	  during	  C.trachomatis	  LGV2	  replication	  
in	  RL95-­‐2	  cells.	  (A)	  The	  infection	  progression	  of	  C.trachomatis	  LGV2	  was	  observed	  in	  
RL95-­‐2	   cells	   (MOI=1).	   Cell	   layers	   collected	   at	   appropriate	   time	  points	   from	  1-­‐60hpi	  
were	  diluted	  in	  fresh	  media	  to	  infect	  a	  new	  layer	  of	  cells.	  At	  appropriate	  timepoints	  
secondary	   infected	   cells	   were	   fixed	   and	   labelled	   using	   anti-­‐Chlamydia	   spp.	   FITC-­‐
conjugated	  antibody	  and	  DAPI	  DNA	  stain.	   IFUs	  were	  then	  quantified	  (IFU/ml).	  Error	  
bars	  show	  standard	  deviation.	  (B)	  Confocal	  xy-­‐sections	  of	  the	  infection	  progression	  in	  
cells	   fixed	   6,	   24,	   or	   36hpi,	   as	   indicated.	   Plasma	   membranes	   were	   labelled	   using	  
AlexaFluor®594	   conjugated	   WGA	   (red)	   prior	   to	   permeabilisation.	   Bacteria	   were	  
labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	   specific	   primary	   antibody	   followed	   by	  
AlexaFluor®488	   conjugated	   secondary	   antibody	   (green).	   Scale	   bars,	   10µm.	   (C)	  
Confocal	   xy-­‐sections	   of	   C.trachomatis	   LGV2	   infected	   RL95-­‐2	   cells	   (MOI=1)	   either	  
untreated	   (control),	   or	   treated	  with	   1µM	  nigericin	   at	   6hpi	   (nigericin),	   and	   fixed	   at	  
18hpi.	  Plasma	  membranes	  were	  labelled	  using	  AlexaFluor®594	  conjugated	  WGA	  (red)	  
prior	   to	   permeabilisation.	   Bacteria	   were	   labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	  
specific	   primary	   antibody	   followed	   by	   AlexaFluor®488	   conjugated	   secondary	  
antibody	   (green).	   Scale	   bars,	   10µm.	   (D)	   C.trachomatis	   LGV2	   infected	   RL95-­‐2	   cell	  
layers	  were	  either	  left	  untreated	  or	  treated	  with	  either	  1:1000	  DMSO,	  1µM	  nigericin,	  
10µM	   glibenclamide,	   or	   1µM	   chloride	   ionophore	   I,	   at	   6hpi	   and	   collected	   at	   48hpi	  
were	   diluted	   in	   fresh	  media	   to	   infect	   a	   new	   layer	   of	   cells.	   After	   24h,	   infected	  cells	  
were	  fixed	  and	  labelled	  using	  anti-­‐Chlamydia	  spp.	  FITC-­‐conjugated	  antibody	  and	  DAPI	  
DNA	  stain.	  Inclusion-­‐forming	  units	  (IFUs)	  were	  quantified	  (*p≤0.05).	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significantly	   reduced	   infectivity	   at	   the	   end	   of	   the	   infection	   cycle.	   This	   suggests	   that,	  
similar	   to	   the	   effects	   observed	   during	   C.trachomatis	   LGV2	   infection	   of	   HeLa	   cells,	  
bacteria	  require	  a	  ready	  supply	  of	  K+,	  above	  that	  which	  is	  available	  within	  most	  resting	  
host	  cells.	  Chloride	  ionophore	  I	  treatment	  had	  very	  little	  impact	  on	  the	  infectious	  EBs	  
recoverable	  when	  compared	  to	  control	  conditions,	   indicating	  that	  disrupting	  chloride	  
ion	   gradients	   during	   RB	   replication	   does	   not	   affect	   the	   progression	   of	  C.trachomatis	  
LGV2	   infection	   (Figure	   3.15D).	   These	   data	   demonstrate	   that	   K+	   starvation	   induces	  
persistence	  in	  C.trachomatis	  LGV2,	  irrespective	  of	  host	  cell	  type.	  	  
C.trachomatis	   serovar	   D	   infection	   of	   HeLa	   cells	   was	   used	   to	   determine	   whether	   K+	  
starvation	  induced	  persistence	  is	  serovar	  specific.	  Reconstitution	  of	  the	  infection	  cycle	  
in	  HeLa	  cells	  showed	  that	  RB	  replication	  occurred	  between	  6	  and	  30h	  (Figure	  3.16A/B).	  
RB-­‐EB	  differentiation	  began	  42hpi	  and	  continued	  until	  78hpi	  when	  inclusions	  began	  to	  
lyse,	   as	   infectivity	   began	   to	   decrease.	   This	   demonstrates	   that	   the	   intracellular	  
development	   of	   C.trachomatis	   D	   in	   HeLa	   cells	   is	   much	   slower	   than	   that	   of	  
C.trachomatis	  LGV2.	  
HeLa	   cells	   infected	   with	   C.trachomatis	  D	   were	   treated	   with	   nigericin	   at	   12hpi.	   This	  
resulted	   in	  ABs	   similar	   to	   those	  observed	  during	  K+	   starvation-­‐induced	  C.trachomatis	  
LGV2	  persistence	   (Figure	   3.16C).	  When	   infectivity	  was	  quantified	   at	   78hpi,	   following	  
nigericin	   treatment	   at	   12hpi,	   the	   induced	   ABs	   were	   observed	   to	   be	   non-­‐infectious	  
(Figure	  3.16D).	  Interestingly,	  glibenclamide	  treatment	  during	  RB	  replication	  eliminated	  
the	   infectivity	   of	  C.trachomatis	  D	   released	   from	  HeLa	   cells.	   This	  would	   suggest	   that	  
C.trachomatis	  D	  has	  a	  greater	  requirement	   for	  K+	  during	  development	  than	  the	  LGV2	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Figure	  3.16.	  K+	  starvation	  induces	  persistence	  during	  C.trachomatis	  D	  replication	  in	  
HeLa	   cells.	   (A)	   The	   infection	   progression	   of	  C.trachomatis	  D	  was	   observed	   in	  HeLa	  
cells	   (MOI=1).	   Cell	   layers	   collected	   at	   appropriate	   time	  points	   from	   1-­‐102hpi	   were	  
diluted	   in	   fresh	   media	   to	   infect	   a	   new	   layer	   of	   cells.	   At	   appropriate	   timepoints	  
secondary	   infected	   cells	   were	   fixed	   and	   labelled	   using	   anti-­‐Chlamydia	   spp.	   FITC-­‐
conjugated	  antibody	  and	  DAPI	  DNA	  stain.	   IFUs	  were	  then	  quantified	  (IFU/ml).	  Error	  
bars	  show	  standard	  deviation.	  (B)	  Confocal	  xy-­‐sections	  of	  the	  infection	  progression	  in	  
cells	   fixed	   12,	   54,	   or	   78hpi,	   as	   indicated.	   Plasma	   membranes	   were	   labelled	   using	  
AlexaFluor®594	   conjugated	   WGA	   (red)	   prior	   to	   permeabilisation.	   Bacteria	   were	  
labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	   specific	   primary	   antibody	   followed	   by	  
AlexaFluor®488	   conjugated	   secondary	   antibody	   (green).	   Scale	   bars,	   10µm.	   (C)	  
Confocal	  xy-­‐sections	  of	  C.trachomatis	  D	  infected	  HeLa	  cells	  (MOI=1)	  either	  untreated	  
(control),	   or	   treated	  with	   1µM	  nigericin	   12hpi	   (nigericin),	   and	   fixed	   30hpi.	   Plasma	  
membranes	   were	   labelled	   using	   AlexaFluor®594	   conjugated	   WGA	   (red)	   prior	   to	  
permeabilisation.	   Bacteria	   were	   labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	   specific	  
primary	   antibody	   followed	   by	   AlexaFluor®488	   conjugated	   secondary	   antibody	  
(green).	  Scale	  bars,	  10µm.	  (D)	  C.trachomatis	  D	  infected	  HeLa	  cell	   layers	  were	  either	  
left	   untreated	   or	   treated	   with	   either	   1:1000	   DMSO,	   1µM	   nigericin,	   10µM	  
glibenclamide,	   or	   1µM	   ionomycin,	   at	   12hpi	   and	   collected	   at	   78hpi	   were	   diluted	   in	  
fresh	  media	   to	   infect	   a	   new	   layer	   of	   cells.	   After	   30h,	   infected	   cells	  were	   fixed	   and	  
labelled	   using	   anti-­‐Chlamydia	   spp.	   FITC-­‐conjugated	   antibody	   and	   DAPI	   DNA	   stain.	  
IFUs	  were	  quantified	  (*p≤0.05).	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strain,	   possibly	   due	   to	   the	   fact	   that	   the	   replicative	   phase	   of	   C.trachomatis	   D	   lasts	  
longer.	   Equivalent	   ionomycin	   treatment	   during	   C.trachomatis	   D	   replication	   had	   no	  
significant	  impact	  on	  infectivity,	  indicating	  that	  persistence	  is	  induced	  by	  K+	  starvation	  
specifically,	  and	  is	  not	  limited	  to	  C.trachomatis	  LGV2	  serovar.	  
To	   determine	   whether	   K+	   starvation-­‐induced	   persistence	   is	   unique	   to	   C.trachomatis	  
the	  effects	  of	  an	  ionophore-­‐induced	  K+	  efflux	  and	  inhibition	  of	  Kir	  channels	  were	  tested	  
on	  C.muridarum	  infected	  HeLa	  cells.	  	  
Reconstitution	  of	  the	  C.muridarum	   infection	  in	  HeLa	  cells	  demonstrated	  that	  bacteria	  
exist	   in	   the	   RB	   form	   between	   6	   and	   12hpi	   (Figure	   3.17A/B),	   RB-­‐EB	   differentiation	  
began	   to	   occur	   18hpi	   and	   continued	   until	   30hpi	  when	   less	   infectivity	   is	   recoverable	  
from	   cells,	   demonstrating	   that	   inclusions	   have	  begun	   to	   lyse.	   This	   indicates	   that	   the	  
infection	  cycle	  of	  C.muridarum	  in	  HeLa	  cells	  is	  faster	  than	  that	  of	  C.trachomatis	  LGV2.	  
When	  C.muridarum	  infected	  HeLa	  cells	  were	  treated	  with	  nigericin	  at	  12hpi,	  large	  ABs	  
were	   formed	   within	   inclusions	   when	   samples	   were	   fixed	   24hpi	   (Figure	   3.17C),	  
suggesting	  persistence	  was	  again	  induced	  following	  K+	  efflux.	  Bacteria	  collected	  at	  the	  
end	   of	   the	   infection	   cycle,	   30hpi,	   from	  nigericin	   treated	   conditions	  were	   completely	  
non-­‐infectious,	   and	   a	   significantly	   reduced	   number	   of	   infectious	   EBs	   were	   collected	  
from	  glibenclamide	  treated	  cells,	   indicating	  that	  Chlamydiae	  require	  K+	   for	  successful	  
infection.	   Using	   ionomycin	   as	   a	   control	   for	   other	   ion-­‐disrupted	   conditions	  
demonstrated	  that	  disruption	  of	  Ca2+	  gradients	  during	  replication	  of	  C.muridarum	  did	  
not	   have	   a	   significant	   effect	   on	   resultant	   infectivity,	   and	   therefore	   shows	   that	   ionic	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Figure	   3.17.	   K+	   starvation	   induces	   persistence	   during	   C.muridarum	   replication	   in	  
HeLa	  cells.	   (A)	  The	  infection	  progression	  of	  C.muridarum	  was	  observed	  in	  HeLa	  cells	  
(MOI=1).	  Cell	  layers	  collected	  at	  appropriate	  time	  points	  from	  1-­‐66hpi	  were	  diluted	  in	  
fresh	   media	   to	   infect	   a	   new	   layer	   of	   cells.	   At	   appropriate	   timepoints	   secondary	  
infected	   cells	   were	   fixed	   and	   labelled	   using	   anti-­‐Chlamydia	   spp.	   FITC-­‐conjugated	  
antibody	  and	  DAPI	  DNA	   stain.	   IFUs	  were	   then	   quantified	   (IFU/ml).	   Error	  bars	   show	  
standard	  deviation.	  (B)	  Confocal	  xy-­‐sections	  of	  the	  infection	  progression	  in	  cells	  fixed	  
at	   12,	   30,	   or	   54hpi,	   as	   indicated.	   Plasma	   membranes	   were	   labelled	   using	  
AlexaFluor®594	   conjugated	   WGA	   (red)	   prior	   to	   permeabilisation.	   Bacteria	   were	  
labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	   specific	   primary	   antibody	   followed	   by	  
AlexaFluor®488	   conjugated	   secondary	   antibody	   (green).	   Scale	   bars,	   10µm.	   (C)	  
Confocal	   xy-­‐sections	   of	   C.muridarum	   infected	   HeLa	   cells	   (MOI=1)	   either	   untreated	  
(control),	  or	  treated	  with	  1µM	  nigericin	  12hpi	  (nigericin),	  and	  fixed	  at	  24hpi.	  Plasma	  
membranes	   were	   labelled	   using	   AlexaFluor®594	   conjugated	   WGA	   (red)	   prior	   to	  
permeabilisation.	   Bacteria	   were	   labelled	   with	   Chlamydia	   spp.	   MOMP/LPS	   specific	  
primary	   antibody	   followed	   by	   AlexaFluor®488	   conjugated	   secondary	   antibody	  
(green).	  Scale	  bars,	  10µm.	  (D)	  C.muridarum	  infected	  HeLa	  cell	  layers	  were	  either	  left	  
untreated	  or	  treated	  with	  either	  1:1000	  DMSO,	  1µM	  nigericin,	  10µM	  glibenclamide,	  
or	  1µM	  ionomycin,	  at	   12hpi	   and	   collected	   at	  30hpi	  were	   diluted	   in	   fresh	  media	   to	  
infect	  a	  new	  layer	  of	  cells.	  After	  24h,	  infected	  cells	  were	  fixed	  and	  labelled	  using	  anti-­‐
Chlamydia	   spp.	   FITC-­‐conjugated	   antibody	   and	   DAPI	   DNA	   stain.	   IFUs	   were	   then	  
quantified	  (*p≤0.05).	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balance	   during	  C.muridarum	   infection	   does	   not	   generally	   induce	   persistence	   (Figure	  
3.17D).	  	  
These	   data	   show	   that	   K+	   starvation	   during	   replication,	   either	   as	   a	   result	   of	   an	  
ionophore-­‐induced	   efflux	   or	   by	   inhibiting	   inwardly	   rectifying	   K+	   channels,	   induces	  
persistence	  in	  Chlamydiae,	  independent	  of	  host,	  serovar,	  or	  species.	  This	  also	  supports	  
the	   theory	   that	   replicating	   bacteria	   require	   a	   supply	   of	   K+,	   beyond	   that	   which	   is	  
available	  in	  the	  host	  cell,	  as	  persistence	  appears	  to	  be	  induced	  in	  a	  significant	  number	  
of	  bacteria	  following	  inhibition	  of	  inwardly	  rectifying	  potassium	  channels.	  	  
3.10	  Discussion	  
The	   data	   presented	   in	   this	   chapter	   establish	   a	   clear	   and	   novel	   link	   between	  
intracellular	  K+	  concentration	  during	  chlamydial	  replication	  and	  infection	  progression.	  
It	   has	   been	   shown	   that	   reducing	   intracellular	   K+,	   either	   by	   inducing	   an	   efflux	   or	  
inhibiting	  Kir	  channels,	  causes	  persistence	  in	  Chlamydiae.	  
Using	  ionophores	  to	  selectively	  disrupt	  Ca2+	  or	  Cl-­‐	  gradients	  in	  HeLa	  cells	  infected	  with	  
C.trachomatis	  LGV2	  during	  replication	  at	  12hpi,	  had	  no	  effect	  on	  bacterial	  morphology	  
and	  an	  insignificant	  impact	  on	  the	  quantity	  of	  infectious	  bacteria	  produced	  at	  the	  end	  
of	   the	   infection	  cycle.	   	   Treatment	  with	  nigericin,	   to	  equilibrate	  K+	  gradients,	   induced	  
aberrant	  bodies	  (ABs)	  within	  the	  C.trachomatis	  inclusion	  and	  prevented	  the	  formation	  
of	   infectious	   EBs	  when	   bacteria	  were	   collected	   50hpi.	   A	   similar	   infection	   phenotype	  
was	  observed	   following	   treatment	  with	  monensin,	   intended	   to	  disrupt	  Na+	  gradients	  
(Figures	   3.4,	   3.5).	   As	  Na+	   retain	  water	  molecules	   they	   are	   very	   similar	   in	   size	   to	   K+,	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which	   reduces	   the	   steric	   selectivity	   of	   sodium	   ionophores.	   As	   a	   result,	   monensin	  
ionophore	   treatment	   disrupts	   K+	   as	   well	   as	   Na+	   concentrations	   (Figure	   3.6).	   In	   the	  
absence	   of	   a	   higher	   specificity	   Na	   +	   ionophore	   infected	   cells	   were	   treated	   with	  
valinomycin,	   a	   high	   affinity	   K+	   uniport	   ionophore	   (Nicholls,	   2006),	   to	   verify	   a	   link	  
between	  abnormal	  development	  and	  disrupted	  K+	  gradients	  (Figure	  3.6).	  As	  eukaryotic	  
cells	   maintain	   a	   high	   K+	   concentration,	   compared	   to	   the	   extracellular	   environment,	  
treatment	   with	   nigericin,	   which	   equilibrates	   K+	   concentration	   across	   biological	  
membranes,	  will	  effectively	  reduce	  the	  concentration	  of	  K+	  available	  within	  a	  cell.	  To	  
determine	  whether	  this	  abnormal	  bacteria	  development	  was	  the	  result	  of	  K+	  starvation	  
of	   bacteria,	   and	   not	   a	   due	   to	   any	   side	   effects	   of	   ionophore	   treatment,	   host	   cell	   K+	  
uptake	   was	   restricted.	   Glibenclamide,	   a	   specific	   inhibitor	   of	   SUR	   in	   Kir	   channels,	  
prevents	  K+	  influx	  into	  host	  cells	  (Bryan	  and	  Aguilar-­‐Bryan,	  1999),	  effectively	  fixing	  the	  
K+	   concentration	   within	   the	   cells.	   Glibenclamide	   treatment	   of	   C.trachomatis	   LGV2	  
infected	   HeLa	   cells	   caused	   the	   formation	   of	   ABs	   during	   replication,	   similar	   to	   those	  
observed	   during	   nigericin-­‐induced	   K+	   starvation	   (Figure	   3.9).	   This	   effect	   was	   not	  
universal,	  unlike	  in	  ionophore	  treated	  conditions	  (Figure	  3.10),	  which	  is	  reflected	  in	  the	  
infectivity	   recovered	   from	   glibenclamide	   treated	   cells.	   Although	   the	   IFUs	   recovered	  
were	  significantly	  less	  than	  could	  be	  collected	  under	  control	  conditions,	  infectivity	  was	  
not	  entirely	  eradicated	  (Figure	  3.9).	  This	  suggests	  that	  bacteria	  scavenge	  host	  K+	  during	  
replication	   and,	   in	   a	   significant	   number	   of	   infections,	   bacteria	   require	   inward	  
rectification	  of	  K+	  concentrations	  to	  supplement	  host	  cell	  K+	  stores.	  
Development	   of	   ABs	   within	   chlamydial	   inclusions	   is	   considered	   a	   characteristic	  
hallmark	  of	  persistent	   infection	  (Hogan	  et	  al.,	  2004).	  Persistence	   is	  a	  term	  applied	  to	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changes	   in	   the	   progression	   of	   chlamydial	   infection	   in	   response	   to	   a	   wide	   range	   of	  
external	   pressures,	   including	   heat	   shock	   (Kahanne	   and	   Friedman,	   1992),	   amino	   acid	  
starvation	   (Coles	   et	   al.,	   1993),	   and	   interferon-­‐γ	   treatment	   (Pantoja	   et	   al.,	   2001).	  
Persistent	   states	   are	   identified	   by	   ABs	   that	   are	   viable	   but	   non-­‐replicating,	   and	   are	  
capable	   of	   recovery	   once	   favourable	   conditions	   have	   been	   restored.	   Observing	   K+	  
starvation-­‐induced	  ABs	  at	  a	  higher	  resolution	  using	  transmission	  electron	  microscopy	  
showed	   a	   significant	   increase	   in	   dense,	   granular	   material	   within	   the	   inclusion.	   The	  
large	   ABs	   observed	   by	   fluorescence	   in	   K+-­‐starved	   conditions	   appear	   to	   contain	   a	  
number	   of	   different	  membranes,	   suggestive	   of	   bacteria	   that	   have	   either	   aggregated	  
together	   or	   failed	   to	   separate	   during	   replication	   (Figure	   3.11).	   Following	   nigericin	  
treatment	   the	   inclusion	   lumen	   remains	   clearly	   distinguishable	   from	   the	   host	   cell	  
cytosol.	   This	   indicates	   that	   nigericin	   treatment	   does	   not	   permeabilise	   the	   inclusion	  
membrane,	  and	  that	  persistence	  is	  the	  result	  of	  K+	  deficiency	  specifically,	  and	  not	  the	  
result	  of	  a	  loss	  of	  inclusion	  integrity.	  	  
Persistence	  was	  established	  in	  K+	  starved	  ABs	  using	  bacterial	  16S	  RNA	  transcription	  as	  
a	   marker	   for	   viability.	   K+	   starved	   ABs,	   treated	   with	   nigericin	   during	   replication,	  
remained	   viable	   although	   they	   were	   non	   infectious	   (Figure	   3.13).	   Abnormal	   bodies	  
were	  shown	  to	  be	  capable	  of	  recovering	  the	  normal	  infection	  cycle,	  once	  K+	  gradients	  
were	   restored,	   irrespective	   of	   how	   long	   the	   bacteria	   had	   been	   starved	  of	   K+	   (Figure	  
3.14).	   These	   data	   demonstrate	   that	   K+	   starvation	   of	   C.trachomatis	   during	   RB	  
replication	   induces	   persistence,	   and	   that	   ABs	   are	   capable	   of	   completing	   the	   normal	  
infection	  cycle	  once	  sufficient	  K+	  is	  available	  to	  them.	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Persistence	   was	   observed	   following	   K+	   starvation,	   both	   by	   restricting	   K+	   uptake	   by	  
inhibiting	   Kir	   channels,	   and	   inducing	   an	   efflux	   with	   K+	   ionophores,	   in	   C.trachomatis	  
LGV2	   infection	   of	   RL95-­‐2	   endometrial	   cells	   and	   in	   HeLa	   cells	   infected	   with	  
C.trachomatis	  D	  and	  C.muridarum.	  This	  demonstrates	  that	  Chlamydiae	  are	  dependent	  
on	  K+,	  beyond	  that	  which	  is	  available	  in	  host	  cells,	  during	  RB	  replication	  independent	  of	  
host,	  serovar,	  or	  species.	  	  
These	  data	  clearly	  demonstrate	  an	  essential	  role	  for	  K+	  during	  Chlamydiae	  replication,	  
as	   restricting	   K+	   during	   the	   RB	   phase	   of	   the	   infection	   cycle	   induces	   persistence.	  
Persistence	   inducers	   can	   be	   used	   to	   explore	  Chlamydia-­‐host	   interactions	   (Schoborg,	  
2011).	  Observing	  changes	   to	  bacteria	  and	   inclusion	  morphology,	   cellular	   response	   to	  
the	  bacteria,	  and	  changes	  to	  the	  bacterial	  cell	  cycle	  following	  persistence	  induction	  can	  
provide	   insight	   into	  the	  biochemistry	  of	  chlamydial	   infection.	   Identifying	  the	  function	  
of	  K+	  during	   replication	   could	  provide	   insight	   into	   intracellular	   survival	   techniques	  of	  
C.trachomatis.	  	  
K+	  efflux	  has	  been	  implicated	  in	  host	  responses	  to	  pathogen	  invasion	  by	  activation	  of	  
the	  NLRP3	   inflammasome	  and	   consequently	   caspase-­‐1	  production	   (Muñoz-­‐Planillo	   et	  
al.,	  2013).	  The	  data	  presented	  in	  this	  chapter	  demonstrate	  that	  a	  K+	  efflux	  in	  response	  
to	   chlamydial	   infection	   would	   cause	   persistence,	   which	   would	   suggest	   that	   the	  
bacteria	  must	  have	  some	  strategy	  in	  place	  to	  prevent	  this	  efflux.	  Indeed,	  the	  inhibition	  
of	   NLRP3	   activation	   is	   a	   strategy	   employed	   by	   pathogens	   such	   as	   Pseudomonas	  
aeruginosa	  (Galle	  et	  al.,	  2008)	  and	  Yersinia	  (Schotte,	  2004)	  to	  avoid	  detection	  by	  host	  
cells.	   Chang	   and	   Moulder	   (1978)	   reported	   that	   infection	   of	   L-­‐cells	   with	   high	  
	  	   165	  
multiplicities	   of	   C.psittaci	   (multiplicity	   of	   infection	   (MOI)=100	   or	   higher)	   caused	   a	  
significant	  loss	  of	  K+,	  determined	  using	  flame	  photometry	  of	  lysed	  cells.	  However	  both	  
HeLa	   and	   L-­‐cells	   infected	  with	  more	  physiological	   bacterial	   titres	   (MOI=10)	   lost	   little	  
intracellular	   K+	   until	   48hpi,	   when	   a	   significant	   loss	   was	   demonstrated.	   These	  
observations	  would	  appear	  to	  conflict	  with	  results	  from	  two	  studies	  by	  Abdul-­‐Sater	  et	  
al.	   (2010a;	   2010b)	  which	   show	   that	   K+	   efflux-­‐induced	   reactive	   oxygen	   species	   (ROS)	  
production	  and	  consequent	  caspase-­‐1	  production,	  via	  NLRP3	  activation,	  is	  essential	  for	  
Chlamydiae	  infection	  of	  THP-­‐1	  cells.	  However,	  ROS	  production	  appeared	  to	  increase	  as	  
infection	  progressed,	  with	  the	  most	  significant	  increase	  between	  20-­‐24hpi.	  This	  could	  
suggest	   that,	   although	  a	  K+	  efflux	  during	   replication	   induces	  persistence,	  Chlamydiae	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4.1	  Introduction	  
The	   data	   presented	   in	   chapter	   3	   demonstrate	   that	   reducing	   the	   concentration	   of	  
intracellular	   potassium	   ions	   (K+),	   either	   by	   inducing	   an	   efflux	   using	   K+	   specific	  
ionophores	  or	  inhibiting	  inward	  rectifying	  K+	  (Kir)	  channels,	  during	  bacterial	  replication	  
induces	  persistence.	  These	  data	  would	  suggest	  that	  high	  intracellular	  K+	  concentration	  
plays	  an	  essential	  role	  in	  the	  chlamydial	  infection	  cycle.	  	  
K+	  efflux	  from	  cells	  in	  response	  to	  bacterial	  invasion	  is	  a	  common	  trigger	  of	  an	  innate	  
immune	  response	  (Franchi	  et	  al.,	  2012;	  Muñoz-­‐Planillo	  et	  al.,	  2013).	  Our	  data	  indicate	  
that,	   if	   this	   were	   to	   occur	   during	   chlamydial	   invasion,	   the	   bacteria	   would	   enter	   a	  
persistent	  state	  and	  infection	  would	  not	  progress.	  This	  could	  suggest	  that	  Chlamydiae	  
have	  some	  strategy	  in	  place	  to	  sidestep	  this	  K+	  efflux.	  For	  example,	  some	  intracellular	  
pathogens,	  such	  as	  Pseudomonas	  aeruginosa	  (Galle	  et	  al.,	  2008)	  and	  Yersinia	  (Schotte,	  
2004),	  inhibit	  the	  activation	  of	  inflammasomes	  during	  cell	  entry	  to	  avoid	  detection	  by	  
the	   host.	  Host	   cell	   response	   to	   chlamydial	   infection	   via	   the	  NLRP3	   inflammasome,	   a	  
complex	  responsible	  for	  caspase-­‐1	  activation	  and	  interleukin-­‐1β	  production,	  has	  been	  
extensively	   studied,	   and	   caspase-­‐1	   has	   been	   shown	   to	   be	   activated	   during	  
C.trachomatis	   infection	   (Lu	   et	   al.,	   2000;	   Gervassi	   et	   al.,	   2004;	   Cheng	   et	   al.,	   2008;	  
Prantner	  et	  al.,	   2009;	   and	  Abdul-­‐Sater	  et	   al.,	   2009;	   2010a;	   2010b).	   Interestingly,	   the	  
activation	  of	  caspase-­‐1	  following	  C.trachomatis	  LGV2	  infection	  appears	  to	  occur	   later	  
in	   the	   infection	   cycle,	   from	   36-­‐48	   hours	   post	   infection	   (hpi)	   (Lu	   et	   al.,	   2000),	   as	  
opposed	  to	  an	  immediate	  response	  to	  bacterial	  invasion.	  This	  would	  suggest	  that,	  if	  a	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K+	  efflux	  is	  the	  trigger	  for	  caspase-­‐1	  activation	  in	  this	   instance,	  then	  the	  efflux	  occurs	  
later	  in	  the	  infection	  cycle	  than	  we	  have	  so	  far	  observed.	  	  
Our	  data	  have	  established	  that	  a	  K+	  efflux	  is	  detrimental	  to	  bacteria	  during	  replication	  
(12hpi	   in	   HeLa	   cells).	   As	   Chlamydiae	   exist	   in	   two	   different	   forms,	   with	   distinct	  
nutritional	   and	  metabolic	   requirements,	   the	   effect	   of	   a	   K+	   efflux	   at	   different	   points	  
during	  the	  bacterial	  development	  cycle	  was	  assayed.	  	  
	  
4.2	   An	   induced	   K+	   efflux	   after	   RB-­‐EB	   differentiation	   does	   not	   affect	  
chlamydial	  infectivity	  
To	  determine	  whether	  Chlamydiae	  have	  differing	  requirements	  for	  K+	  throughout	  the	  
development	  cycle,	  intracellular	  K+	  was	  depleted	  using	  nigericin	  at	  different	  phases	  of	  
the	  infection	  cycle.	  
C.trachomatis	  LGV2	  inclusions	   in	  HeLa	  cells	  contain	  RBs	  between	  6	  and	  24hpi	  (Figure	  
3.3B),	   after	   which	   RB-­‐EB	   differentiation	   occurs	   and	   the	   inclusion	   lumen	   fills	   with	   a	  
mixed	   population	   of	   RBs	   and	   EBs.	   At	   approximately	   50hpi,	   the	   EBs	   are	   released.	   To	  
determine	   whether	   K+	   availability	   is	   vital	   throughout	   the	   cycle,	   or	   just	   during	  
replication	  of	  RBs,	  nigericin	  was	  used	  to	  treat	  inclusions	  at	  different	  timepoints	  during	  
C.trachomatis	  LGV2	  infection	  of	  HeLa	  cells.	  Infectivity	  was	  quantified	  at	  the	  end	  of	  the	  
development	  cycle,	  when	  the	  bacteria	  should	  have	  undergone	  RB-­‐EB	  re-­‐differentiation	  
(as	  described	  in	  Figure	  3.2).	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Infected	   cells	   were	   treated	   with	   1µM	   nigericin	   before	   inclusion	   formation	   (1hpi),	  
during	   RB	   replication	   (12hpi),	   as	   re-­‐differentiation	   begins	   to	   occur	   (24hpi),	   once	   the	  
inclusion	   contains	   a	  mixed	   population	   of	   EBs	   and	   RBs	   (36hpi),	   and	   prior	   to	   cell	   lysis	  
when	   the	   inclusion	   contains	   predominantly	   EBs	   (48hpi)	   (Figure	   4.1A).	   All	   infections	  
were	  then	  allowed	  to	  progress	  until	  50hpi	  before	  cells	  were	  collected.	  Infectivity	  was	  
then	   quantified,	   as	   inclusion-­‐forming	   units	   (IFUs),	   following	   the	   infection	   of	   a	   new	  
monolayer	   of	   cells.	   No	   infectious	   bacteria	   were	   collected	   from	   cells	   treated	   with	  
nigericin	  prior	  to	  RB-­‐EB	  differentiation,	   from	  1-­‐12hpi.	   Infectivity	  was	  recovered	  when	  
K+	   concentrations	  were	   disrupted	   at	   and	   subsequent	   to	   24hpi	   (Figure	   4.1B).	   Limited	  
infectivity	  was	  evident	  when	  cells	  were	  treated	  24hpi,	  a	  timepoint	  at	  which	  the	  RB-­‐EB	  
differentiation	   had	   begun.	   This	   suggests	   that	   intracellular	   K+	   depletion	   causes	  
persistence	   in	   RBs,	   as	   described	   in	   Section	   3.8,	   but	   that	   EBs	   are	   unaffected.	   This	   is	  
supported	  by	  the	  observation	  that	  the	  later	  in	  the	  C.trachomatis	  LGV2	  infection	  cycle	  
HeLa	   cells	   are	   treated	   with	   nigericin,	   and	   consequently	   the	   greater	   the	   number	   of	  
bacteria	   that	   were	   present	   as	   EBs	   at	   the	   time	   of	   K+	   efflux,	   the	   greater	   the	   titre	   of	  
infectious	  bacteria.	  However,	  treatment	  of	  EBs	  at	  the	  beginning	  of	  the	  infection	  cycle,	  
i.e.	   at	   1hpi,	   abolished	   detectable	   infectivity	   at	   the	   end	   of	   the	   infection	   cycle,	   50hpi	  
(Figure	   4.1B).	   This	   could	   indicate	   that	   an	   ionophore	   induced	   K+	   efflux	   disrupts	   early	  
events	  in	  the	  infection	  cycle,	  or	  alternatively,	  could	  reflect	  early	  EB	  differentiation	  into	  
K+	  starvation-­‐sensitive	  RBs.	  	  
To	   monitor	   any	   changes	   in	   early	   inclusion	   biogenesis,	   HeLa	   cells	   infected	   with	  
C.trachomatis	  LGV2	  were	  treated	  with	  nigericin	  1hpi,	  fixed	  at	  24hpi	  and	  labelled	  using	  
anti-­‐Chlamydia	   antibodies.	   The	   bacteria	   were	   not	   arranged	   in	   the	   conventional	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Figure	   4.1.	   Ionophore-­‐induced	  K+	   efflux	   causes	   persistence	   in	  C.trachomatis	   LGV2	  
RBs,	   however	   EBs	   are	   unaffected.	   (A)	   Schematic	   representation	   of	   experiment	  
timelines,	  showing	  confocal	  xy-­‐sections	  of	  C.trachomatis	   (green)	   infected	  HeLa	  cells	  
(red)	   at	   the	   time	   of	   nigericin	   treatment.	   (B)	   HeLa	   cell	   layers	   were	   infected	   with	  
C.trachomatis	   LGV2	   (multiplicity	  of	   infection	   (MOI)	  =1)	  and	  either	   left	  untreated	  or	  
treated	  with	  1µM	  nigericin	  at	  either	  1hpi,	  12hpi,	  24hpi,	  36hpi,	  or	  48hpi.	  Cells	  were	  
collected	  at	  50hpi	  and	  diluted	  in	  fresh	  media	  to	  infect	  a	  new	  layer	  of	  cells.	  After	  24h,	  
the	  second	   layer	  of	   infected	  cells	  were	  fixed	  and	   labelled	  using	  anti-­‐Chlamydia	  spp.	  
FITC-­‐conjugated	   antibody	   and	   DAPI	   DNA	   stain.	   Inclusion-­‐forming	   units	   (IFUs)	   were	  
then	  quantified	  (IFU/ml).	  Each	  experiment	  was	  repeated	  a	  minimum	  of	  three	  times,	  
and	   the	   data	   presented	   are	   representative	   of	   each	   iteration.	   Error	   bars	   show	  
standard	  deviation.	  (*	  =	  p≤0.05).	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inclusion	  structure,	  as	  observed	  in	  the	  control	  condition	  (Figure	  4.2A).	  The	  resolution	  
of	   confocal	   xy-­‐sections	   is	   insufficient	   to	   differentiate	   between	   internalised	   bacteria	  
and	  those	  at	  the	  cell	  periphery.	  Differentiation	  between	  internal	  and	  external	  bacteria	  
can	   nevertheless	   be	   achieved	   by	   immunolabelling.	   To	   determine	   if	   the	   dispersed	  
bacteria	   observed	   in	   cells	   treated	   1hpi	   with	   nigericin	   were	   intracellular,	   or	   if	   they	  
remain	   on	   the	   cell	   periphery,	   cells	   were	   labelled	   both	   before	   and	   after	  
permeabilisation	   using	   two	   different	   fluorophores.	   External	   bacteria	   were	   labelled	  
prior	   to	   permeabilisation	   then,	   following	   permeabilisation,	   both	   intracellular	   and	  
extracellular	  bacteria	  were	  labelled.	  Under	  these	  conditions,	  intracellular	  bacteria	  are	  
labelled	  by	  a	  single	  fluorophore,	  whereas	  extracellular	  bacteria	  are	  dual	  labelled.	  HeLa	  
cells	  infected	  with	  C.trachomatis	  LGV2	  exclusively	  contained	  singly	  labelled	  bacteria	  at	  
24hpi,	   arranged	   in	   a	   ring	   consistent	   with	   a	   normal	   inclusion	   at	   this	   time	   point,	  
demonstrating	   that	   they	   are	   intracellular	   (Figure	   4.2B	   control).	   Heat	   inactivated	  
bacteria,	  which	  were	  introduced	  to	  HeLa	  cells	  as	  a	  control	  for	  external	  bacteria,	  were	  
dual	   labelled	   at	   24hpi	   (Figure	   4.2B	   heat	   inactivated	   bacteria).	   In	   HeLa	   cells	   infected	  
with	  C.trachomatis	  LGV2	  and	  treated	  at	  1hpi	  with	  nigericin,	  bacteria	  were	  larger	  than	  
EBs	   at	   24hpi,	   the	  majority	   of	   which	   were	   single	   labelled	   and	   therefore	   intracellular	  
(Figure	   4.2B	   nigericin.	   Intracellular	   bacteria	   indicated	   by	   white	   arrows	   in	   increased	  
zoom	  panel).	  However,	  replication	  did	  not	  appear	  to	  have	  occurred	  under	  K+-­‐starved	  
conditions	  and	  the	  bacteria	  were	  dispersed	  throughout	  the	  cell,	  and	  are	  maybe	  even	  
cytosolic,	   as	   opposed	   to	   contained	  within	   a	   single	   inclusion.	   This	   demonstrates	   that	  
when	  K+	  efflux	  is	  induced	  at	  1hpi,	  bacteria	  remain	  inside	  the	  host	  cell,	  but	  initial	  steps	  
in	   inclusion	   biogenesis	   and	   chlamydial	   replication	   are	   apparently	   disrupted.	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Figure	   4.2.	   Ionophore-­‐induced	   K+	   efflux	   disrupts	   early	   inclusion	   biogenesis.	   (A)	  
Confocal	   xy-­‐sections	  of	  HeLa	  cells	   infected	  with	   C.trachomatis	  LGV2	   (MOI=1)	  either	  
untreated	  or	   treated	  1hpi	  with	  1µM	  nigericin.	  Cells	  were	  then	  fixed	  24hpi.	  Bacteria	  
were	   labelled	   with	   anti-­‐Chlamydia	   spp.	   MOMP/LPS	   specific	   primary	   antibody	  
followed	   by	   AlexaFluor®488	   conjugated	   secondary	   antibody	   (green).	   Scale	   bars,	  
10µm.	   (B)	   Confocal	   xy-­‐sections,	   and	   bright-­‐field	  micrographs	   of	   HeLa	   cells	   infected	  
with	   either	   heat	   inactivated	   C.trachomatis	   LGV2	   (MOI=1),	   or	   infected	   with	  
C.trachomatis	  LGV2	  (MOI=1)	  and	  left	  untreated,	  or	  infected	  with	  C.trachomatis	  LGV2	  
(MOI=1)	   and	   treated	   at	   1hpi	   with	   1µM	   nigericin.	   Cells	   were	   then	   fixed	   at	   24hpi.	  
Bacteria	   were	   labelled	   with	   fluorescein	   isothiocyanate	   (FITC)	   conjugated	   anti-­‐
Chlamydia	   spp.	   MOMP/LPS	   specific	   antibody	   (green)	   prior	   to	   methanol/ethanol	  
permeabilization,	   anti-­‐Chlamydia	   spp.	   MOMP/LPS	   primary	   antibody	   and	  
AlexaFluor®568	   conjugated	   secondary	   antibody	   (red).	   Bacteria	   labelled	   with	  
AlexaFluor®568	  only	  were	  inside	  the	  cell,	  and	  those	  that	  dual	  labelled	  (yellow)	  were	  
external.	  Scale	  bars,	  10µm.	  Insets	  show	  indicated	  areas	  at	  higher	  magnification.	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Chlamydial	   infections	   progress	   at	   different	   rates,	   dependent	   on	   host,	   serovar	   and	  
strain.	   If	   nigericin	   treatment	  at	   similar	  points	   in	   the	  development	   cycle	  has	  a	   similar	  
effect	  i.e.	  there	  is	  a	  significant	  impact	  of	  K+	  starvation	  on	  RBs,	  but	  progressively	  less	  of	  
an	  effect	  as	  RB-­‐EB	  differentiation	  advances,	  then	  a	  clearer	  link	  between	  K+	  availability	  
and	  the	  infection	  cycle	  can	  be	  established.	  
RL95-­‐2	   cells	   infected	   with	   C.trachomatis	   LGV2	   and	   HeLa	   cells	   infected	   with	   either	  
C.trachomatis	  D	  or	  C.muridarum	  were	  treated	  with	  nigericin	  at	  specific	  phases	   in	  the	  
infection	   cycle	   i.e.	   following	   internalisation,	   during	   RB	   replication,	   as	   RB-­‐EB	  
differentiation	  began	  to	  occur,	  or	  once	  the	  majority	  of	  the	  bacteria	  had	  differentiated	  
into	  EBs	  (see	  Table	  4.1	  for	  treatment	  times	  for	  each	  bacteria-­‐host	  combination).	  	  
	  









EB	  prior	  to	  
release	  
C.trachomatis	  
LGV2	   RL95-­‐2	   1hpi	   6hpi	   12hpi	   24hpi	  
C.trachomatis	  
D	   HeLa	   1hpi	   24hpi	   48hpi	   72hpi	  
C.muridarum	   HeLa	   1hpi	   12hpi	   24hpi	   36hpi	  
Table	  4.1.	  Time	  of	  nigericin	  addition	  to	  target	  specific	  phases	  in	  the	  infection	  cycle	  for	  each	  bacteria-­‐
host	   interaction.	  Phases	  of	   the	   infection	  cycle	  were	  determined	  using	   the	  data	  collected	   in	  chapter	  3	  
(Section	  3.9).	  
	  
RL95-­‐2	   cells	   were	   infected	   with	   C.trachomatis	   LGV2	   and	   treated	   with	   nigericin	   at	  
appropriate	   timepoints	   during	   the	   infection	   cycle	   (Table	   4.1).	   Infectivity	   was	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monitored	  at	  the	  end	  of	  the	  infection	  cycle	  at	  40hpi.	  By	  40hpi	  bacteria	  in	  control	  cells	  
are	  present	  as	  infectious	  EBs	  (Figure	  4.3A	  control),	  therefore	  a	  decrease	  in	  infectivity	  
at	  this	  point	  as	  a	  result	  of	  an	  ionophore-­‐induced	  K+	  efflux	  indicates	  disruption	  in	  RB-­‐EB	  
re-­‐differentiation,	   resulting	   in	   non-­‐infectious	   bacteria.	   No	   infectivity	   was	   recovered	  
from	   cells	   treated	  prior	   to	  RB-­‐EB	  differentiation,	   however	   cells	   treated	   at	   12hpi	   and	  
later	   contained	   infectious	   bacteria	   despite	   the	   nigericin-­‐induced	   K+	   efflux	   (Figure	  
4.3A).	  Cells	   treated	  early	   in	   the	  RB-­‐EB	  transition	  contained	  fewer	   infectious	  EBs	  than	  
those	   treated	   later,	  when	   a	   greater	   proportion	  of	   the	  bacteria	  were	  present	   as	   EBs.	  
This	  shows	  that	  K+	  starvation	  only	  disrupts	  RBs	  irrespective	  of	  the	  host	  cell	  line.	  	  
HeLa	   cells	   infected	  with	  C.trachomatis	  D	   contained	   EBs	   at	   90hpi	   (Figure	   4.3B).	  HeLa	  
cells	   infected	   with	   C.trachomatis	  D,	   treated	   at	   similar	   phases	   of	   the	   infection	   cycle	  
(Table	  4.1),	  were	  collected	  for	  quantification	  of	  infectivity	  at	  90hpi.	  Bacteria	  collected	  
from	  cells	  treated	  before	  RB-­‐EB	  differentiation	  had	  begun	  were	  non-­‐infectious	  (Figure	  
4.3B),	  but	  infectivity	  could	  be	  recovered	  from	  cells	  treated	  after	  RB-­‐EB	  differentiation,	  
suggesting	   that	   K+	   availability	   is	   essential	   during	   the	   period	   of	   RB	   replication	   only,	  
regardless	  of	  serovar.	  	  
Finally,	   HeLa	   cells	   infected	  with	  C.muridarum	   contained	   infectious	   EBs	   36hpi	   (Figure	  
4.3C	   control).	   HeLa	   cells	   infected	   with	   C.muridarum	   and	   equivalently	   treated	   with	  
nigericin	   (Table	   4.1)	   were	   assayed	   for	   infectivity	   at	   40hpi.	   Once	   again,	   K+	   efflux	  
prevented	  infectivity	  in	  cells	  treated	  before	  RB-­‐EB	  differentiation	  but	  had	  progressively	  
less	  of	   an	  effect	   as	   treatment	  occurred	  at	   later	   timepoints	   (Figure	   4.3C).	   This	   shows	  
that	   Chlamydiae	   are	   only	   sensitive	   to	   K+	   starvation	   during	   RB	   replication.	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Figure	   4.3.	   K+	   efflux	   during	   RB	   phase	   of	   the	   infection	   cycle	   induces	   persistence	  
irrespective	  of	  serovar,	  species	  or	  host.	  (A)	  C.trachomatis	  LGV2	  infected	  RL95-­‐2	  cells	  
(MOI=1)	  were	   either	   untreated	   or	   treated	  with	   1µM	  nigericin	   at	   either	   1hpi,	   6hpi,	  
12hpi,	  or	  24hpi,	  prior	  to	  collection	  at	  40hpi	  and	  diluted	  in	  fresh	  media	  to	  infect	  a	  new	  
layer	   of	   cells.	   (B)	   C.trachomatis	   serovar	   D	   infected	   HeLa	   cells	   (MOI=1)	   were	   either	  
untreated	  or	  treated	  with	  1µM	  nigericin	  at	  either	  1hpi,	  24hpi,	  48hpi,	  or	  72hpi,	  prior	  
to	   collection	   at	   90hpi	   and	   diluted	   in	   fresh	  media	   to	   infect	   a	   new	   layer	   of	   cells.	   (C)	  
C.muridarum	  infected	  HeLa	  cells	  (MOI=1)	  were	  either	  untreated	  or	  treated	  with	  1µM	  
nigericin	  either	  1hpi,	  12hpi,	  24hpi,	  or	  36hpi,	  prior	  to	  collection	  40hpi	  and	  diluted	   in	  
fresh	  media	  to	  infect	  a	  layer	  of	  cells	  HeLa.	  In	  all	  cases	  the	  second	  monolayer	  of	  cells	  
was	  fixed	  at	  24hpi	  and	   labelled	  using	  anti-­‐Chlamydia	  spp.	  FITC-­‐conjugated	  antibody	  
and	  DAPI	  DNA	  stain.	   IFUs	  were	   then	   quantified	   (IFU/ml).	   Error	  bars	   show	   standard	  
deviation.	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These	  data	  demonstrate	  that	  nigericin-­‐induced	  K+	  efflux	  disrupts	   inclusion	  biogenesis	  
early	  in	  the	  infection	  cycle,	  and	  causes	  persistence	  during	  RB	  replication,	  but	  a	  K+	  efflux	  
following	   RB-­‐EB	   differentiation	   does	   not	   affect	   bacterial	   infectivity.	   This	   is	  
demonstrated	   by	   a	   progressive	   increase	   in	   infectious	   bacteria	   that	   can	   be	   collected	  
from	  cells	  the	  later	  in	  the	  infection	  cycle	  the	  K+	  efflux	  occurs.	  This	  would	  suggest	  that	  
the	  different	  bacterial	  forms	  have	  different	  K+	  requirements.	  
	  
4.3	  Chlamydial	  RBs	  are	  enriched	  with	  K+	  	  
Asante	  potassium	  green	  2	  (APG-­‐2)	  is	  a	  recently	  developed	  K+-­‐specific	  fluorescent	  probe	  
for	   use	   in	   live	   cells.	   As	   there	   is	   no	   published	   data	   to	   validate	   the	   use	   of	   APG-­‐2	   for	  
observing	  K+	  distribution	  within	  cells,	  a	  labelling	  protocol	  had	  to	  be	  optimised	  in	  HeLa	  
cells.	   APG-­‐2	   labelled	   HeLa	   cells	   have	   diffuse	   cytosolic	   labelling	   with	   more	   intense	  
fluorescence	   within	   the	   mitochondria	   (Figure	   4.4A).	   The	   difference	   in	   fluorescence	  
intensity	   is	   consistent	  with	   differing	   K+	   concentrations	   in	   the	   cytosol	   and	  within	   the	  
mitochondria,	  approximately	  148mM	  (Grieshaber	  et	  al.,	  2002)	  and	  180mM	  (Kozoriz	  et	  
al.,	  2010)	  respectively.	  	  
To	   ensure	   that	   differences	   in	   fluorescence	   intensity	   are	   indicative	   of	   differing	   K+	  
concentrations,	   live	   HeLa	   cells	   were	   labelled	   with	   APG-­‐2	   and	   treated	   with	   1µM	  
nigericin,	  which	  was	  shown	  to	  reduce	  intracellular	  K+	  by	  half	  when	  assayed	  using	  flame	  
photometry	   (Figure	   3.6).	   Confocal	   xy-­‐images	   were	   taken	   every	   10	   minutes	   for	   90	  
minutes	   following	  nigericin	  addition.	  Mean	  pixel	   intensity	  measurements	  were	   taken	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for	   three	   regions	   of	   interest	   (ROIs)	   within	   the	   cells	   using	   ImageJ	   (for	   macro	   see	  
Appendix	   4).	   Measurements	   were	   corrected	   for	   background	   fluorescence	   using	  
equivalent	   pixel	   intensity	   measurements	   from	   a	   ROI	   that	   contained	   no	   cells.	  
Fluorescence	  intensity	  decreased	  rapidly	  in	  the	  30	  minutes	  following	  nigericin	  addition,	  
and	  plateaued	  at	  approximately	  half	  the	  initial	  intensity	  for	  the	  remaining	  60	  minutes	  
(Figure	  4.4B).	  It	  was	  not	  possible	  to	  correct	  for	  photobleaching	  in	  the	  sample	  because	  
all	  the	  cells	  within	  the	  sample	  were	  subjected	  to	  nigericin	  treatment.	  However,	  APG-­‐2	  
labelled	   live	   HeLa	   cells	   were	   equivalently	   imaged	   without	   the	   addition	   of	   nigericin.	  
Over	   the	   same	   period,	   three	   ROIs	   from	   the	   cytosol	   of	   APG-­‐2	   labelled	   HeLa	   cells,	  
corrected	  for	  background	  fluorescence	  using	  an	  ROI	  from	  an	  area	  containing	  no	  cells,	  
were	   assayed.	   Fluorescence	   intensity	   remained	   relatively	   constant	   throughout	   the	  
timecourse	   (Figure	   4.4C).	   These	   data	   show	   that,	   whilst	   APG-­‐2	   is	   subject	   to	   limited	  
photobleaching,	   K+	   efflux	   as	   a	   result	   of	   nigericin	   treatment	   reduced	   APG-­‐2	  
fluorescence	   intensity.	   This	   verifies	   that	   decreased	   fluorescence	   intensity	   in	   APG-­‐2	  
labelled	  micrographs	   corresponds	   to	   lower	   K+	   concentration.	   In	   addition,	   these	   data	  
show	  that	  APG-­‐2	   is	  an	  appropriate	  tool	   for	  observing	  K+	  distribution	   in	  C.trachomatis	  
infected	  cells.	  
HeLa	   cells	   infected	  with	  C.trachomatis	  LGV2	  were	   labelled	  with	  APG-­‐2	  at	  12hpi.	   Live	  
confocal	  observation	  of	  xy-­‐sections	  showed	  that	  RBs	  were	  intensely	  labelled	  with	  APG-­‐
2	  probe,	  indicative	  of	  a	  high	  K+	  concentration	  (Figure	  4.5A	  12hpi).	  There	  also	  appeared	  
to	   be	   a	   decrease	   in	   fluorescence	   in	   both	   the	   host	   cell	   cytosol	   and	   mitochondria,	  
despite	   being	   imaged	   using	   equivalent	   confocal	   settings.	   HeLa	   cells	   infected	   with	  
C.trachomatis	  LGV2	  were	  APG-­‐2	  labelled	  and	  observed	  later	   in	  the	  infection	  cycle.	  At	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Figure	   4.4.	   Nigericin	   treatment	   reduces	   APG-­‐2	   fluorescence	   by	   half	   within	   30	  
minutes.	   (A)	   Live	   confocal	   xy-­‐sections	   of	   HeLa	   cells	   labelled	   using	   APG-­‐2	   (green).	  
Scale	  bar,	  25µm.	  (B)	  Mean	  pixel	  intensity,	  corrected	  for	  background	  fluorescence,	  for	  
3	  regions	  of	  interest	  (ROIs)	  from	  HeLa	  cells	  treated	  with	  1µM	  nigericin.	  Images	  were	  
taken	  every	  10	  minutes	  for	  80	  minutes.	  Shaded	  area	  represents	  standard	  deviation.	  
(C)	   Mean	   pixel	   intensity	   from	   3	   ROIs,	   presented	   as	   a	   percentage	   of	   initial	   pixel	  
intensity,	   from	  HeLa	  cells	   labelled	  with	  APG-­‐2	  and	   imaged	  every	  10	  minutes	   for	  80	  
minutes	   to	   observe	   photobleaching,	   presented	   as	   a	   percentage	   of	   the	   average	  
intensity	  of	  the	  initial	  frame.	  Shaded	  area	  represents	  standard	  deviation.	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24hpi	   the	   infected	   cells	   contained	   intensely	   labelled	   RBs.	   APG-­‐2	   fluorescence	   had	  
reduced	  in	  the	  host	  cell	  cytosol	  and	  mitochondria	  as	  the	  infection	  progressed	  (Figure	  
4.5A	  24hpi).	   This	   implies	   that	   the	  bacteria	  use	   the	  host	   cell	   as	  a	   source	  of	  K+	  during	  
replication.	  By	  36hpi,	  once	  RB-­‐EB	  differentiation	  has	  initiated,	  APG-­‐2	  labelled	  RBs	  were	  
observed	  around	  the	  perimeter	  of	  the	  inclusion,	  however	  there	  was	  very	   little	  APG-­‐2	  
labelling	   deeper	   into	   the	   lumen	   of	   the	   inclusion	   (Figure	   4.5A	   36hpi).	   Confocal	   xy-­‐
sections	  of	  equivalently	  infected	  cells,	  fixed	  at	  36hpi	  and	  labelled	  with	  anti-­‐Chlamydia	  
spp.	   specific	   MOMP/LPS	   antibody,	   showed	   that	   the	   inclusion	   lumen	   is	   filled	   with	  
bacteria	   at	   this	   timepoint	   (Figure	   4.5B	  MOMP/LPS).	   However,	   APG-­‐2	   only	   labelled	  
bacteria	   around	   the	   periphery	   of	   the	   inclusion	   (Figure	   4.5B	   K+),	   indicating	   that	   the	  
bacteria	   that	  are	  not	   in	   contact	  with	   the	   inclusion	  membrane	  have	  a	  much	   lower	  K+	  
content.	  
These	  data	  suggest	  that	  Chlamydiaceae	  accumulate	  K+	  during	  replication,	  however	  this	  
K+	   seems	   to	   be	   lost	   once	   RB-­‐EB	   differentiation	   occurs.	   Having	   shown	   that	   K+	  
fluctuations	   can	   be	   observed	   using	   variation	   in	   APG-­‐2	   fluorescence	   intensity,	   this	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Figure	   4.5.	   K+	   sensitive	   fluorescent	   probe	   illustrates	   high	  K+	   concentration	   in	   RBs	  
but	  lower	  K+	  in	  EBs.	  (A)	  Confocal	  xy-­‐sections	  of	  live	  HeLa	  cells	  labelled	  using	  APG-­‐2	  K+	  
sensitive	   probe	   (green)	  either	  uninfected	   (panel	  1),	  or	   infected	  C.trachomatis	   LGV2	  
(MO=1)	  after	  12hpi,	  24hpi,	  or	  36hpi	  (as	  indicated).	  Scale	  bars,	  10µm.	  (B)	  Confocal	  xy-­‐
section	  of	  C.trachomatis	  LGV2	  infected	  HeLa	  cells	  36hpi	  either	  labelled	  live	  with	  APG-­‐
2	  (green;	  potassium)	  or	  fixed	  and	  labelled	  using	  Chlamydia	  spp.	  MOMP/LPS	  primary	  
antibody	   followed	   by	   AlexaFluor®568	   conjugated	   secondary	   antibody	   (red;	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4.4	  RBs	  scavenge	  host	  cell	  K+	  
Having	   shown	   that	   APG-­‐2	   can	   be	   used	   to	   detect	   changes	   in	   K+	   levels,	   fluorescence	  
recovery	   after	   photobleaching	   (FRAP)	   analysis	   was	   then	   undertaken	   to	   observe	   K+	  
dynamics	   within	   the	   infected	   cell	   and	   the	   inclusion.	   HeLa	   cells	   were	   infected	   with	  
C.trachomatis	  LGV2	  and	  labelled	  with	  APG-­‐2	  at	  24hpi.	  These	  cells	  were	  then	  subjected	  
to	  photobleaching,	  followed	  by	  image	  capture	  every	  8	  seconds	  for	  10	  frames,	  followed	  
by	  10	  frames	  every	  20	  seconds	  (for	  Leica	  FRAP	  wizard	  settings	  see	  Appendix	  5).	  Mean	  
pixel	   intensities	   from	  ROIs	  within	  the	  bacteria,	   the	   inclusion	   lumen,	  and	  the	  host	  cell	  
cytosol	   were	   measured	   using	   ImageJ	   (for	   macro	   see	   Appendix	   4).	   Mean	   pixel	  
intensities	   were	   compared	   before	   and	   after	   photobleaching	   for	   ROIs	   (Figure	   4.6A).	  
Bacteria	   partially	   recover	   fluorescence	   very	   quickly	   after	   photobleaching,	   however	  
they	   do	   not	   appear	   to	   recover	   to	   the	   original	   level	   over	   the	   observed	   time	  window	  
(Figure	   4.6B).	   The	   inclusion	   lumen	   shows	   a	   delay	   in	   fluorescence	   recovery,	   but	  
fluorescence	  does	  recover	  to	  some	  extent.	  The	  host	  cell	  cytosol	  shows	  no	  decrease	  in	  
fluorescence,	   suggesting	   that	   the	   molecules	   in	   the	   cytosol	   are	   moving	   around	   so	  
rapidly	  that	  the	  bleached	  fluorophores	  are	  replaced	  almost	  instantly.	  
These	   data	   show	   that	   bacteria	   continually	   accumulate	   K+	   during	   intracellular	  
replication.	  We	  have	  previously	  shown	  that	  while	  RBs	  are	  high	  in	  K+,	  EBs	  do	  not	  exhibit	  
any	  APG-­‐2	  fluorescence	  and	  therefore	  are	  much	  lower	  in	  K+.	  This	  would	  indicate	  that	  
K+	   is	   lost	  at	  some	  point	  during	  RB-­‐EB	  differentiation.	  Determining	  when	  this	  K+	  efflux	  
occurs	   could	  provide	   some	   insight	   into	   the	   function	  of	   K+	   during	   the	   infection	   cycle.	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Figure	   4.6.	   Bacteria	   recover	   APG-­‐2	   fluorescence	   following	   photobleaching.	   (A)	  
Confocal	  xy-­‐section	  of	  C.trachomatis	  LGV2	  infected	  HeLa	  cells	  (MOI=1)	  labelled	  with	  
APG-­‐2	   24hpi	   prior	   to	   bleaching.	   Bacteria,	   inclusion	   lumen,	   and	   cytosol	   ROIs	   circled	  
and	  indicated	  using	  white	  arrows.	  Scale	  bar,	  10µm.	  (B)	  Mean	  pixel	  intensity	  for	  ROIs	  
taken	  at	  minimized	  intervals,	  with	  a	  scanning	  speed	  of	  400Hz,	  for	  10	  frames	  the	  every	  
20	  seconds	  for	  20	  frames.	  	  
	  
	  
	  	   189	  
4.5	  K+	  are	  lost	  from	  the	  bacteria	  prior	  to	  inclusion	  expansion	  
C.trachomatis	  LGV2	  accumulate	  K+	  during	  replication.	   In	  contrast,	  EBs	  were	  shown	  to	  
contain	   less	   K+,	   and	   infectivity	   was	   unaffected	   by	   K+	   starvation.	   These	   observations	  
suggest	  that	  K+	  is	  lost	  from	  the	  bacteria	  during	  the	  transition	  from	  RB	  to	  EB.	  	  
To	   observe	   K+	   fluctuations	   during	   RB-­‐EB	   differentiation,	   HeLa	   cells	   infected	   with	  
C.trachomatis	  LGV2	  were	   labelled	  with	  APG-­‐2	  and	  Hoechst	  33342,	  a	  fluorescent	  DNA	  
intercalating	   agent	   suitable	   for	   imaging	   live	   cells,	   then	   observed	   by	   fluorescence	  
microscopy	   in	   a	  heat-­‐controlled	   chamber	   at	   5%	  CO2.	  Confocal	   xyz-­‐stacks	  were	   taken	  
every	   10	  minutes	   for	   6h	   starting	   at	   30hpi.	  Maximum	   intensity	   z-­‐projections	   at	   each	  
time	  point	  were	  compiled	  for	  the	  field	  of	  view	  (FOV)	  imaged.	  Changes	  in	  fluorescence	  
intensity	  throughout	  the	  time	  course	  were	  assayed	  for	  three	  infected	  cells	  within	  the	  
field	   of	   view	   (numbered	   in	   Figure	   4.7A).	   For	   each	   inclusion	   mean	   pixel	   intensity	  
measurements,	  in	  both	  Hoechst	  and	  APG-­‐2	  channels,	  were	  obtained	  from	  an	  ROI	  that	  
remained	  within	  the	  inclusion	  for	  the	  duration	  of	  the	  time	  course	  (ROI	  used	  for	  Figure	  
4.7	   inclusion	  1	   is	   illustrated	   in	  white	   in	  each	   frame	   in	  Figure	  4.8).	   (For	   ImageJ	  macro	  
used	   to	   obtain	   pixel	   intensity	   values	   see	  Appendix	   4).	   Each	   value	  was	   corrected	   for	  
background	   fluorescence	   by	   subtracting	   equivalent	   intensity	  measurements	   from	   an	  
ROI	   that	   did	   not	   contain	   any	   cells.	   Similarly,	   pixel	   intensity	  measurements	   obtained	  
from	  an	  ROI	  in	  an	  uninfected	  cell,	  from	  the	  same	  FOV,	  were	  used	  to	  correct	  each	  value	  
for	   photobleaching	   (see	   Section	   2.5.6,	   Equation	   3).	   Bacteria	   within	   a	   chlamydial	  
inclusion	   remain	   in	   constant	  motion	   during	   live	   imaging,	  which	   is	   problematic	  when	  
attempting	  to	  compare	  measurements	  over	  a	  time	  course.	  Comparison	  of	  fluorescence	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intensity	   is	   further	   complicated	   by	   the	   continued	   replication	   of	   the	   bacteria	   and	  
consequent	  growth	  of	  the	  inclusion.	  At	  confocal	  resolution	  it	  is	  not	  possible	  to	  follow	  a	  
single	   bacteria	   throughout	   the	   time	   course	   therefore	   the	   risk	   when	   comparing	   ROI	  
averages	  over	   time	   is	   that	   the	  quantity	  of	  bacteria	  within	   that	  ROI	  can	   fluctuate	  and	  
impact	   the	   values.	   To	   monitor	   the	   effect	   of	   bacterial	   movement	   within	   the	   ROI	  
throughout	   the	   time	   course,	   equivalent	   Hoechst	   (DNA)	   pixel	   intensities	   were	  
compared	  along	  with	  APG-­‐2	  (K+)	  values.	  Variation	  in	  DNA	  pixel	  intensity	  measurements	  
should	   correspond	   to	   fluctuations	   in	   the	   number	   of	   bacteria	   within	   the	   ROI,	   i.e.	  
increased	   pixel	   intensity	   indicates	   more	   bacteria	   and	   vice	   versa.	   Comparison	   of	  
corrected	   mean	   pixel	   intensities	   throughout	   the	   time	   course	   showed	   a	   dramatic	  
increase	   in	  APG-­‐2	   fluorescence	   intensity	  over	   the	   first	   30	  minutes	  of	   image	   capture,	  
which	  was	   independent	  of	  any	   increase	   in	  Hoechst	   fluorescence	   intensity	   (Figure	  4.7	  
B).	  Between	  30	  and	  110	  minutes,	  i.e.	  from	  30h	  30m	  to	  31h	  50m	  post	  infection,	  APG-­‐2	  
fluorescence	   intensity	   decreases,	   indicating	   decreasing	   K+	   concentrations	   within	   the	  
ROIs	  assayed	  (Figure	  4.7	  B).	  	  
Observing	  a	  single	  cell	   throughout	   this	   time	  course,	  as	  shown	   in	  Figure	   4.8	   (also	  see	  
supplementary	  movie	  S1),	  shows	  that	  from	  30-­‐36hpi	  the	  C.trachomatis	  LGV2	  inclusion	  
undergoes	  a	  number	  of	  interesting	  changes.	  Initially	  the	  chlamydial	  inclusion	  (outlined	  
in	   yellow	   in	   Figure	   4.8	   panel	   0),	   appears	   tightly	   packed	   with	   bacteria	   and	   remains	  
perinuclear	   for	   the	   first	   100	  minutes	   of	   image	   capture	   (Figure	   4.8	   panels	   0-­‐100).	   By	  
110	  minutes	   the	   inclusion	   appears	   to	   have	   expanded	   dramatically	   and	   the	   bacteria	  
appear	  more	  diffuse	  within	   the	   inclusion	   (Figure	   4.8	   panel	  110).	  Using	  Hoechst	  DNA	  
labelling	  of	  bacteria	  to	  identify	  the	  inclusion	  area,	  an	  estimate	  of	  the	  inclusion	  area,	  at	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Figure	  4.7.	  Inclusion	  K+	  concentration	  reaches	  a	  peak	  and	  is	  then	  steadily	  lost,	  with	  
the	   lowest	  point	   corresponding	  with	  a	  dramatic	   increase	   in	   inclusion	  size.	   (A)	  Live	  
confocal	  xyz-­‐projection	  of	  HeLa	  cells	   infected	  with	  C.trachomatis	  LGV2	  (MOI=1)	  and	  
labelled	  using	  APG-­‐2	   K+	  probe	   (green)	   and	  Hoechst	  DNA	   stain	   (blue).	   Confocal	   xyz-­‐
stacks	  were	  obtained	  every	  10	  minutes	   from	  30h	   to	  32h	  20m	  post	   infection	  (0-­‐140	  
minutes	  after	  the	  beginning	  of	  image	  capture).	  Numbers	  indicate	  inclusions	  assayed	  
for	   fluorescence	   intensity	   throughout	   the	   timecourse.	   Scale	   bar,	   50µm.	   (B)	   Mean	  
fluorescence	   intensity,	   corrected	   for	   photo-­‐bleaching	   (using	   an	   uninfected	   cell	  
indicated	  by	  *	  in	  A)	  and	  background	  fluorescence,	  over	  the	  time-­‐course	  was	  assayed	  
in	  both	  the	  DNA	  and	  K+	  channels	  and	  averaged	  for	  three	  inclusions	  in	  the	  field	  of	  view	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the	   largest	   point	   in	   the	   z-­‐projections,	  was	   calculated	   for	   each	   frame	   throughout	   the	  
time	   course	   (inclusion	   areas	   for	   frames	   before	   {100}	   and	   after	   {110}	   the	   inclusion	  
expansion	  outlined	  in	  yellow	  in	  Figure	  4.9	  A).	  The	  inclusion	  area	  in	  the	  xy-­‐plane,	  more	  
than	   doubled	   from	   100-­‐110	  minutes,	   i.e.	   from	   31h	   50m	   to	   32hpi,	   for	   this	   inclusion	  
(Figure	  4.9	  B),	  a	  change	  which	  is	  all	  the	  more	  evident	  in	  the	  supplementary	  movie	  S1.	  
Interestingly,	  this	  dramatic	  change	  in	  the	  size	  of	  the	  inclusion	  appears	  to	  coincide	  with	  
the	  point	  of	  lowest	  K+	  concentration.	  	  
The	   speed	   of	   the	   inclusion	   expansion,	   which	   occurs	   between	   frames	   and	   therefore	  
takes	   less	   than	  10	  minutes,	   could	   indicate	   lysis	  of	   the	   inclusion	  membrane,	  however	  
the	  bacteria	  appear	  to	  remain	  constrained	  within	  the	  host	  cell	  membrane	  beyond	  the	  
end	  of	  image	  capture	  in	  this	  experiment	  (Figure	  4.8).	  	  
These	  data	  show	  that	  the	   loss	  of	  K+	  from	  bacteria	  occurs	  gradually	   in	  the	  build	  up	  to	  
inclusion	  expansion,	  which	  coincides	  with	  the	  point	  of	  lowest	  K+	  concentration	  within	  
the	  inclusion.	  Inclusion	  membrane	  lysis	  has	  been	  illustrated	  using	  cytosolic	  GFP,	  which	  
is	   excluded	   from	   intact	   inclusions	   (Heinzen	  et	  al.,	   1997;	  Hybiske	  and	  Stevens,	   2007).	  
This	  method	  can	  be	  used	  to	  determine	   if	  K+	   loss	  corresponds	  to	   inclusion	  membrane	  
lysis.	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Figure	  4.8.	  Time-­‐lapse	  microscopy	  of	  C.trachomatis	  LGV2	   infected	  HeLa	  cells	   from	  
30hpi	   shows	   a	   dramatic	   increase	   in	   inclusion	   size.	   Live	   confocal	  xyz-­‐projections	  of	  
C.trachomatis	   LGV2	   infected	   HeLa	   cells	   (MOI=1)	   labelled	   using	   APG-­‐2	   K+	   probe	  
(green)	   and	  Hoechst	  DNA	   stain	   (blue).	   Confocal	   xyz-­‐stacks	  were	   obtained	   every	   10	  
minutes	   from	  30h	   to	  32h	  20m	  post	   infection	   (0-­‐140	  minutes	  after	   the	  beginning	  of	  
image	  capture).	  White	   line	   indicates	   the	   ROI	  analysed	   for	   this	   inclusion	   (Figure	   4.7	  




	  	   196	   	  









Figure	  4.9.	  Inclusion	  area	  more	  than	  doubles	  31h	  50m	  after	   infection.	  (A)	  Confocal	  
xyz-­‐projections	  of	   live	  HeLa	  cells	   infected	  with	  C.trachomatis	  LGV2	   (MOI-­‐1)	   labelled	  
with	  APG-­‐2	  K+	  probe	  (green)	  and	  DAPI	  DNA	  label	  (blue)	  and	  imaged	  at	  31h	  40	  m	  after	  
infection	  (100)	  and	  31h	  50m	  after	  infection	  (110).	  Inclusions	  outlined	  in	  yellow.	  Scale	  
bars,	  10µm.	  (B)	  Inclusion	  area	  (in	  pixels)	  measured	  for	  inclusion	  1	  (Figure	  4.7)	  for	  the	  
duration	  of	  the	  timecourse	  (0-­‐140	  minutes	  after	  the	  beginning	  of	  image	  capture).	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4.6	  The	  chlamydial	  inclusion	  membrane	  ruptures	  following	  a	  decrease	  in	  
K+	  concentration	  
Cytosolic	  green	   fluorescent	  protein	   (GFP)	   (26.9kDa)	   is	  excluded	   from	  the	   inclusion	   in	  
cells	   infected	  with	  C.trachomatis	   (Hybiske	  and	  Stephens,	  2007),	  however	  GFP	  cannot	  
be	   used	   in	   conjunction	   with	   the	   APG-­‐2,	   as	   they	   have	   similar	   emission	   wavelengths.	  
mCherry	  fluorescent	  protein,	  at	  28.8kDa,	  should	  be	  unable	  to	  cross	  an	  intact	  inclusion	  
membrane,	  and	  can	  be	  used	  with	  APG-­‐2.	  HeLa	  cells	  were	  infected	  with	  C.trachomatis	  
LGV2	   and	   transiently	   transfected	   with	   either	   GFP	   or	   mCherry	   and	   fixed	   30hpi.	  
Inclusions	   (outlined	   in	   yellow	   in	   Figure	   4.10)	   excluded	   both	   GFP	   (Figure	   4.10A)	   and	  
mCherry	   (Figure	  4.10B)	  at	  30hpi,	  demonstrating	  that	  mCherry	  can	  be	  used	  alongside	  
APG-­‐2	  in	  order	  to	  assess	  the	  integrity	  of	  the	  inclusion	  membrane.	  	  
HeLa	   cells	   expressing	   mCherry	   were	   infected	   with	   C.trachomatis	   LGV2	   and	   labelled	  
30hpi	   with	   Hoechst	   and	   APG-­‐2	   probes.	   Cells	   were	   then	   observed	   by	   live	   confocal	  
microscopy	  at	  37°C	  and	  5%	  CO2.	  Confocal	  xyz	  stacks	  were	  captured	  every	  10	  minutes	  
to	   observe	   changes	   in	   K+	   concentration	   and	   inclusion	   membrane	   integrity	  
simultaneously.	   Following	   a	   single	   cell	   from	   31-­‐32hpi	   shows	   that	   initially	  mCherry	   is	  
excluded	   from	   the	   inclusion,	   where	   bacteria	   can	   be	   seen	   labelled	   with	   Hoechst	  
(inclusion	  outlined	   in	  yellow	   in	  31hpi	  panels	   in	  Figure	   4.11).	  Between	  40-­‐50	  minutes	  
after	   the	   start	  of	   image	   capture,	   i.e.	  between	  30h	  40m	  and	  30h	  50m	  post	   infection,	  
mCherry	  was	  no	  longer	  excluded	  from	  the	  inclusion	  (Figure	  4.11	  +50	  minutes	  panels).	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Figure	   4.10.	  C.trachomatis	   LGV2	   inclusions	   exclude	  both	  GFP	   and	  mCherry	   36hpi.	  
Confocal	  xy-­‐sections	  of	  C.trachomatis	  LGV2	  infected	  HeLa	  cells	  (MOI=1)	  at	  24hpi.	  (A)	  
HeLa	  cells	  expressing	  cytosolic	  green	  fluorescent	  protein	  (GFP)	  (green)	  after	  infection	  
incubation	   (0hpi).	   Following	   fixation	  at	  30hpi	   cells	  were	   labelled	  with	  DRAQ-­‐5	  DNA	  
stain	   (blue).	   Inclusion	   circled	   in	  yellow.	   Scale	  bars,	   10µm.	   (B)	  HeLa	  cells	   expressing	  
cytosolic	   mCherry	   fluorescent	   protein	   (mCherry)	   (red)	   after	   infection	   incubation	  
(0hpi).	  Following	  fixation	  at	  30hpi	  cells	  were	  labelled	  with	  Hoechst	  DNA	  stain	  (blue).	  
Inclusion	  circled	  in	  yellow.	  Scale	  bars,	  10µm.	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Figure	   4.11.	   C.trachomatis	   LGV2	   inclusions	   become	   porous	   to	   mCherry.	   Live	  
confocal	   xyz-­‐projections	   of	   C.trachomatis	   LGV2	   infected	   HeLa	   cells	   (MOI=1)	  
expressing	  cytosolic	  mCherry	  (magenta)	  labelled	  using	  Hoechst	  DNA	  stain	  (cyan)	  from	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To	  observe	  the	  moment	  at	  which	  mCherry	  is	  no	  longer	  excluded	  from	  the	  inclusion	  in	  
conjunction	  with	  changes	   in	  K+	   concentration,	  mean	  pixel	   intensities	   from	  ROIs	   from	  
four	   inclusions	   within	   the	   FOV	   were	   compared	   (labelled	   1-­‐4	   in	   Figure	   4.12	   A).	  
C.trachomatis	  infections	  progress	  at	  slightly	  different	  rates	  from	  cell	  to	  cell,	  therefore	  
within	  each	  FOV	  the	  inclusion	  expansion	  occurs	  in	  different	  cells	  at	  different	  times.	  To	  
synchronise	   the	   moment	   of	   inclusion	   expansion	   the	   frames	   in	   which	   the	   inclusion	  
expansion	   occurs	   was	   identified	   (for	   each	   inclusion	   {1-­‐4}	   the	   frame	   immediately	  
following	  inclusion	  membrane	  lysis	  is	  marked	  with	  *	  in	  Figure	  4.12B).	  The	  ROI	  used	  to	  
obtain	  mean	  pixel	  intensity	  for	  inclusion	  number	  1	  (Figure	  4.12A)	  is	  illustrated	  in	  white	  
in	  Figures	   4.13.	   Similar	   to	   the	   cell	   observed	   in	  Figure	   4.11,	   the	   cell	   shown	   in	  Figure	  
4.13	   shows	   a	   loss	   of	   K+	   from	   the	   inclusion	   from	   30h	   20m,	   leading	   up	   to	  
permeabilisation	  of	  the	  inclusion	  membrane.	  Mean	  pixel	  intensity	  values	  for	  mCherry	  
and	  APG-­‐2	  channels	  from	  ROIs	  from	  the	  four	  inclusions	  were	  corrected	  for	  background	  
fluorescence	  and	  photobleaching,	  as	  described	  previously.	  DNA	  fluorescence	  intensity	  
was	  corrected	  to	  account	  for	  any	  changes	  resulting	  from	  bacterial	  movements	  within	  
the	   ROI.	   These	   data	   show	   that,	   for	   all	   the	   cells	   assayed,	   there	   was	   a	   peak	   in	   K+	  
concentration	   60	   minutes	   before	   the	   inclusion	   became	   permeable	   to	   cytosolic	  
mCherry	  (Figure	  4.14).	  The	  loss	  of	  inclusion	  membrane	  integrity	  appears	  to	  correspond	  
with	   the	   frame	   immediately	   after	   the	   lowest	   point	   in	   APG-­‐2	   fluorescence	   intensity.	  
Although	   the	   inclusion	  membrane	   appears	   to	   have	   been	   compromised,	   the	   bacteria	  
are	  still	  retained	  within	  the	  host	  cell	  at	  the	  end	  of	  image	  capture	  (Figure	  4.13	  110-­‐140).	  
This	   shows	   that,	   although	   the	   expansion	   event	   occurs	   asynchronously,	   all	   inclusions	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Figure	   4.12.	   Inclusion	  membrane	   permeabilisation	   occurs	   in	   different	   frames	   for	  
each	  inclusion	  within	  a	  50	  minute	  window.	  (A)	  Live	  confocal	  xyz-­‐projection	  of	  HeLa	  
cells	   infected	   with	   C.trachomatis	   LGV2	   (MOI=1)	   expressing	   cytosolic	   mCherry	  
fluorescent	   protein	   (magenta).	   Cells	   were	   labelled	   at	   30hpi	   using	   APG-­‐2	   K+	   probe	  
(green)	   and	  Hoechst	  DNA	   stain	   (blue).	   Confocal	   xyz-­‐stacks	  were	   obtained	   every	   10	  
minutes	   from	  30h	   to	  32h	  20m	  post	   infection	  (0-­‐140	  minutes	  after	   the	  beginning	  of	  
image	   capture).	   Numbers	   indicate	   inclusions	   assayed	   for	   fluorescence	   intensity	  
throughout	   the	   timecourse.	   Scale	  bar,	   50µm.	   (B)	  To	   observe	   fluorescence	   intensity	  
changes	  throughout	  the	  timecourse,	  the	  frame	  immediately	  following	  the	  expansion	  
were	   synchronised.	   The	   frames	   immediately	   after	   inclusion	   permeabilisation	   are	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Figure	   4.13.	  C.trachomatis	   LGV2	   inclusion	   permeabilisation	   coincides	  with	   lowest	  
APG-­‐2	   fluorescence	   intensity.	   Live	   confocal	   xyz-­‐projections	   of	   C.trachomatis	   LGV2	  
infected	  HeLa	  cells	  (MOI=1)	  expressing	  cytosolic	  mCherry	  (magenta)	  labelled	  at	  30hpi	  
with	  APG-­‐2	  K+	  probe	  (green)	  and	  Hoechst	  DNA	  stain	  (blue).	  Confocal	  xyz-­‐stacks	  were	  
obtained	  every	  10	  minutes	  from	  30h	  to	  32h	  20m	  post	  infection	  (0-­‐140	  minutes	  after	  
the	   beginning	   of	   image	   capture).	   White	   line	   indicates	   the	   ROI	   analysed	   for	   this	  
inclusion	   (Figure	   4.12	   inclusion	   1).	   Scale	   bar	   (shown	   in	   red),	   10µm.	   (Also	   see	  
Supplementary	  movie	  S1)	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Figure	   4.14.	   Inclusion	   permeabilisation	   coincides	   with	   lowest	   intracellular	   K+	  
concentration.	   C.trachomatis	   infected	   HeLa	   cells	   (MOI=1)	   expressing	   cytosolic	  
mCherry	   and	   labelled	   using	   Hoechst	   DNA	   stain	   and	   APG-­‐2	   K+	   at	   30hpi	   underwent	  
confocal	   time-­‐lapse	   imaging	  from	  30-­‐36hpi.	  Confocal	  xyz-­‐projections	  were	  compiled	  
and	   analysed	   to	  observe	   the	   frames	   in	  which	   each	   inclusion	   became	  permeable	   to	  
mCherry	   (Figure	   4.12).	   Mean	   fluorescence	   intensity	   measurements,	   corrected	   for	  
photobleaching	  and	  background	  fluorescence,	  for	  the	  synchronised	  frames	  over	  the	  
time-­‐course	  were	   assayed	   in	   the	  mCherry,	   DNA	   and	   K+	   channels	   and	   averaged	   for	  
four	   inclusions	   in	   the	   FOV	   (ROI	   for	   the	   first	   inclusion	   illustrated	   in	   Figure	   4.13).	  
Asterisk	   (*)	   indicates	   frame	   immediately	  after	  permeabilisation	  (As	   shown	   in	  Figure	  
4.12B).	  Shaded	  area	  indicates	  standard	  deviation.	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observed	  in	  this	  field	  of	  view	  exhibit	  the	  same	  pattern	  of	  K+	  loss	  followed	  by	  inclusion	  
permeabilisation.	  
These	  data	  demonstrate	  that	  the	   inclusion	  membrane	  becomes	  permeable	  when	  the	  
K+	  concentration	  reaches	  its	  lowest	  ebb,	  however	  it	  is	  insufficient	  to	  establish	  whether	  
the	   membrane	   lyses	   or	   simply	   becomes	   porous	   to	   larger	   molecules.	   To	   observe	  
changes	  to	  the	  inclusion	  membrane	  following	  K+	  loss	  by	  bacteria,	  HeLa	  cells	  were	  fixed	  
and	   embedded	   for	   EM	   sectioning	   32h	   after	   infection	   with	   C.trachomatis	   LGV2.	  
Contrast	  was	  enhanced	  using	  malachite	  green	  and	  the	  sample	  was	  negatively	  stained	  
using	  uranyl	  acetate.	  Ultra	  thin	  sections	  were	  then	  observed	  at	  low	  magnification	  using	  
an	  electron	  microscope.	  At	  32hpi	  the	  monolayer	  contained	  a	  mixed	  population	  of	  cells	  
containing	   intact	   inclusions	   (Figure	   4.15A),	   inclusions	   with	   apparently	   intact	  
membranes	  with	  less	  distinction	  between	  the	  lumen	  and	  the	  host	  cell	  cytosol	  (Figure	  
4.15B),	  cells	  that	  appeared	  to	  contain	  cytosolic	  bacteria	  (Figure	  4.15C),	  and	  cells	  that	  
had	   lysed	   to	   release	   the	   bacteria	   (Figure	   4.15D).	   These	   images	   would	   seem	   to	  
corroborate	  the	  previous	  observation	  that	  bacteria	  release	   is	  a	  two-­‐stage	  process,	  as	  
suggested	  by	  Hybiske	  and	  Stephens	  (2007).	  	  
The	   pattern	   of	   K+	   fluctuations	   exhibited	   by	   the	   cells	   observed	   in	   these	   assays,	   i.e.	  a	  
peak	  in	  K+	  concentration	  followed	  by	  a	  gradual	  efflux	  for	  60-­‐80	  minutes	  before	  lysis	  of	  
the	  inclusion	  membrane	  at	  the	  lowest	  K+	  concentration,	  could	  indicate	  a	  role	  for	  K+	  in	  
the	  late	  stages	  of	  the	  C.trachomatis	  infection	  cycle.	  The	  observation	  that	  the	  bacterial	  
K+	  concentration	  is	  lowest	  immediately	  before	  inclusion	  membrane	  lysis	  would	  suggest	  
that	  the	  efflux	  is	  involved	  in	  the	  bacterial	  release	  mechanism.	  To	  elucidate	  any	  role	  for	  
	  	   211	   	  










Figure	  4.15.	  Ultrastructural	  analysis	  of	  C.trachomatis	  LGV2	  shows	  cytosolic	  bacteria	  
prior	  to	  host	  cell	  lysis.	  Transmission	  electron	  micrographs	  of	  HeLa	  cells	  infected	  with	  
C.trachomatis	   LGV2	   (MOI=1)	   were	   gluteraldehyde	   fixed	   at	   32hpi	   with	   malachite	  
green	  and	  negative	  stained	  using	  uranyl	  acetate	  prior	  to	  embedding	  and	  sectioning.	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a	  K+	  efflux	  in	  bacterial	  exit	  from	  host	  cells,	  the	  effect	  of	  inducing	  a	  K+	  efflux	  late	  in	  the	  
infection	  cycle	  on	  inclusions	  within	  a	  population	  of	  cells	  was	  observed.	  
	  
4.7	  An	  induced	  K+	  efflux	  induces	  chlamydial	  extrusion	  in	  favour	  of	  lysis	  
Inclusion	   membrane	   permeabilisation	   and	   subsequent	   lysis	   appears	   to	   occur	  
coincidentally	  with	  the	  loss	  of	  K+	  from	  bacteria.	  Previous	  experiments	  have	  shown	  that	  
inducing	   an	   efflux	   of	   K+	   after	   RB-­‐EB	   differentiation	   does	   not	   significantly	   influence	  
bacterial	   infectivity	   (Section	   4.2).	   However,	   any	   effect	   of	   nigericin	   treatment	   on	  
inclusion	  morphology	  and	   integrity	  at	   this	   timepoint	  was	  not	  assayed.	  To	  ascertain	   if	  
an	  induced	  K+	  efflux	  affects	  bacterial	  exit	  from	  the	  host	  cell,	  the	  number	  of	  inclusions	  
following	  nigericin	  treatment	  later	  in	  the	  infection	  cycle	  was	  quantified.	  
HeLa	   cells	   infected	   with	   C.trachomatis	   LGV2	   were	   treated	   with	   nigericin	   at	   30hpi.	  
Samples	  were	  fixed	  at	  32hpi	  and	  co-­‐labelled	  using	  an	  anti-­‐Chlamydia	  spp.	  antibody	  and	  
DAPI	  DNA	  stain.	  Bacteria	  could	  be	  observed	  within	  inclusions,	  which	  appear	  similar	  in	  
morphology	  to	  those	  seen	  under	  control	  conditions.	  However,	   there	  were	  noticeably	  
fewer	  inclusions	  in	  nigericin	  treated	  cells	  than	  under	  control	  conditions	  (Figure	  4.16A).	  
The	  average	  number	  of	  mature	  inclusions	  and	  cells,	  counted	  in	  10	  random	  FOVs	  at	  63x	  
magnification,	   after	   either	   30m	   or	   2h	   of	   nigericin	   treatment	   at	   30hpi	   were	   then	  
compared	  to	  equivalent	  control	  coverslips	  (Figure	  4.16B).	  After	  30m	  nigericin	  treated	  
coverslips	  had	  more	  cells	  remaining,	  but	  half	  the	  number	  of	  inclusions	  when	  compared	  
to	   control	   conditions.	   It	   would	   appear	   that,	   no	   matter	   the	   duration	   of	   nigericin	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Figure	   4.16.	   Ionophore-­‐induced	   K+	   efflux	   30hpi	   reduces	   the	   number	   of	  
C.trachomatis	  LGV2	   inclusions	  but	  not	   the	  number	  of	  HeLa	  cells.	   (A)	  Fluorescence	  
micrographs	   of	   C.trachomatis	   LGV2	   infected	   HeLa	   cells	   (MOI=1),	   either	   untreated	  
(control)	  or	  treated	  at	  30hpi	  with	  1µM	  nigericin	  (nigericin).	  Cells	  were	  fixed	  after	  30	  
minutes	  of	  treatment	  and	  labelled	  using	  DAPI	  DNA	  stain	  (blue)	  and	  FITC-­‐conjugated	  
Chlamydia	   spp.	   MOMP/LPS	   specific	   antibody	   (green).	   Scale	   bars,	   7.5µm.	   (B)	   The	  
average	   number	   of	   cells	   and	   inclusions	   for	   10	   random	   FOVs	   were	   counted	   at	   63x	  
magnification	  for	  each	  condition	  after	  either	  30	  minutes	  or	  2	  hours	  of	  treatment.	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treatment,	   there	   are	   considerably	   fewer	   inclusions	   when	   compared	   to	   control	  
conditions.	   Interestingly,	   nigericin	   treated	   coverslips	   have	   consistently	   more	   cells	  
remaining	  on	  the	  coverslip	  than	  the	  equivalent	  control	  conditions.	  This	  would	  suggest	  
that	   a	   greater	   number	   of	   bacteria	   have	   been	   egressed	   via	   host	   cell	   lysis	   in	   control	  
conditions,	   and	   demonstrates	   that	   cells	   that	   have	   undergone	   a	   nigericin-­‐induced	   K+	  
efflux	   30hpi	   are	   more	   likely	   to	   survive	   a	   C.trachomatis	   LGV2	   infection.	   This	   would	  
suggest	  that	  a	  greater	  number	  of	  bacteria	  were	  egressed	  from	  nigericin	  treated	  cells,	  
as	  opposed	  to	  equal	  numbers	  egressed	  and	   lysed	  as	  observed	   in	  C.trachomatis	  LGV2	  
infection	   of	   HeLa	   cells	   by	   Hybiske	   and	   Stevens	   (2007).	   This	   would	   indicate	   that	   the	  
speed	  of	  K+	  loss	  has	  an	  impact	  on	  the	  method	  of	  bacterial	  egress	  from	  host	  cells,	  i.e.	  a	  
rapid	   decrease,	   such	   as	   the	   efflux	   induced	   by	   nigericin	   treatment,	   will	   result	   in	  
bacterial	  extrusion	  whereas	  a	  gradual	  loss,	  as	  observed	  by	  live	  imaging	  (Figures	  4.7	  and	  
4.14),	  will	  result	  in	  host	  cell	  lysis.	  
To	   observe	   host	   cell	   exit	   by	   C.trachomatis	   after	   treatment	   at	   30hpi	   with	   nigericin,	  
Hoechst	   labelled	  HeLa	  cells	  were	   imaged	  every	  10	  minutes	  for	  4	  hours.	  Fifty	  minutes	  
after	  nigericin	  treatment	  a	  number	  of	  bacteria	  were	  seen	  exiting	  the	  host	  cell	  (Figure	  
4.17	  panel	  50*	  and	  4.18	  panel	  50)	  however	   the	  host	  cell	  appeared	   to	   remain	   intact.	  
Surprisingly,	  a	  considerable	  number	  of	  bacteria	  could	  still	  be	  seen	  constrained	  within	  
the	  host	  cell	  cytosol.	  The	  host	  cell	  nucleus	  then	  began	  to	  expand	  indicating	  a	  reduction	  
in	  the	  pressure	  exerted	  on	  the	  nucleus	  following	  the	  release	  of	  some	  of	  the	  bacteria	  
(Figure	   4.17	   panel	   80-­‐120).	   Two	   hundred	   minutes	   after	   nigericin	   addition	   another	  
burst	   of	   bacteria	  was	   released	   from	   the	   host	   cell	   (Figure	   4.17	   panel	   200*	   and	  4.18	  
panel	  200),	  but	  a	  large	  number	  of	  bacteria	  remained	  within	  the	  host	  cell	  (Figure	  4.17	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Figure	   4.17.	   Treatment	   of	   C.trachomatis	   LGV2	   infected	   HeLa	   cells	   with	   nigericin	  
30hpi	   causes	   bacterial	   egress	   in	   distinct	   bursts.	   Live	   confocal	   xyz-­‐projections	   of	  
C.trachomatis	   LGV2	   infected	   HeLa	   cells	   (MOI=1)	   labelled	   with	   Hoechst	   DNA	   stain	  
treated	   at	   30hpi	   with	   1µM	  nigericin.	   Asterisk	   (*)	   Indicates	   frames	  where	   bursts	   of	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Figure	   4.18.	   Bacteria	   egress	   nigericin	   treated	   cells	   in	   bursts,	   leaving	   the	   host	   cell	  
membrane	   intact.	   Live	   confocal	   xyz-­‐projections	   of	   HeLa	   cells	   infected	   with	  
C.trachomatis	   LGV2	   (MOI=1)	   and	   treated	   with	   1µM	   nigericin	   at	   30hpi.	   Cells	   were	  
labelled	   with	   Hoechst	   DNA	   stain	   and	   imaged	   from	   30h	   40m-­‐36hpi.	   First	   burst	   of	  
bacteria	   (50,	   indicated	   by	   white	   arrow)	   leaving	   the	   cell	   50	   minutes	   after	   nigericin	  
treatment.	  Second	  burst	  of	  bacteria	   (200,	  indicated	  by	  white	  arrow)	  leaving	  the	  cell	  
200	  minutes	  after	  nigericin	  treatment.	  Scale	  bars,	  10µm.	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panels	   210-­‐240).	   The	   bursts	   of	   bacteria	   being	   released	   from	   the	   host	   cell	   are	   best	  
illustrated	  in	  the	  supplementary	  movie	  S2.	  	  
These	  observations	  are	  distinct	  from	  previously	  described	  extrusion	  mechanisms	  (Todd	  
and	   Caldwell,	   1985;	   Hybiske	   and	   Stephens,	   2007;	   Lutter	   et	   al.,	   2013),	   whereby	  
packages	  of	  bacteria,	   either	   the	  entire	   contents	  of	   the	   inclusion	  or	  part	   thereof,	   are	  
extruded	   from	   the	   host	   cell.	   Classical	   extrusion	   is	   inhibited	   by	   blebbistatin,	   a	   cell	  
permeable	   myosin	   II	   specific	   inhibitor.	   Blebbistatin	   reduces	   interactions	   between	  
myosin	  motors	   and	   actin,	  which	   is	   necessary	   for	   chlamydial	   extrusion	   (Kovács	  et	   al.,	  
2004;	   Hybiske	   and	   Stephens	   2007).	   Using	   blebbistatin	   to	   suppress	   extrusion	   activity	  
during	  nigericin	  treatment	  will	  determine	  whether	  nigericin-­‐induced	  bacterial	  release	  
is	  myosin	  dependent,	  and	  therefore	  implicate	  K+	  efflux	  in	  chlamydial	  extrusion.	  
HeLa	  cells	   infected	  with	  C.trachomatis	  LGV2	  were	  treated	  30hpi	  with	  either	  nigericin,	  
blebbistatin,	  a	  combination	  of	  both	  nigericin	  and	  blebbistatin,	  or	  left	  untreated.	  After	  
6h	  of	   treatment	   the	  average	  number	  of	  cells	  and	  mature	   inclusions	   from	  10	  random	  
FOVs,	   at	   63x	   magnification,	   were	   scored	   for	   each	   condition.	   As	   shown	   previously,	  
nigericin	   treatment	   reduced	   the	   average	   number	   of	   inclusions	   dramatically,	   when	  
compared	   to	   control	   conditions,	   however	   there	   was	   no	   significant	   change	   in	   the	  
number	  of	   cells	   on	   the	   coverslip	   (Figure	   4.19).	   Blebbistatin	   treated	   conditions	  had	  a	  
greater	   number	   of	   mature	   inclusions	   per	   FOV	   than	   control	   conditions,	   and	   a	  
comparable	   number	   of	   cells	   to	   both	   control	   and	   nigericin	   conditions.	   These	   data	  
suggest	  that,	  by	  36hpi,	  a	  large	  number	  of	  inclusions	  would	  have	  been	  extruded	  under	  
normal	   circumstances,	   but	   nigericin	   treatment	   induces	   extrusion	   in	   a	   greater	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Figure	   4.19.	   Treatment	   with	   blebbistatin	   decreases	   K+	   efflux-­‐induced	   extrusion	  
from	   C.trachomatis	   LGV2	   infected	   HeLa	   cells.	   HeLa	   cells	   were	   infected	   with	  
C.trachomatis	   LGV2	   (MOI-­‐1)	   and	   either	   left	   untreated,	   treated	   30hpi	   with	   1µM	  
nigericin,	  treated	  30hpi	  with	  50µM	  blebbistatin,	  or	  30hpi	  with	  a	  combination	  of	  both	  
1µM	  nigericin	   and	   50µM	  blebbistatin.	   Cells	  were	   fixed	   at	   36hpi	   and	   labelled	   using	  
DAPI	   DNA	   stain	   and	   FITC-­‐conjugated	  Chlamydia	   spp.	  MOMP/LPS	   specific	   antibody.	  
The	  number	  of	  cells	  and	  inclusions	  from	  10	  random	  FOVs	  at	  63x	  magnification	  were	  
then	  counted.	  Error	  bars	  indicate	  standard	  deviation.	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proportion	   of	   cells.	   Treatment	   with	   both	   blebbistatin,	   to	   inhibit	   extrusion,	   and	  
nigericin,	  which	  seems	  to	  induce	  extrusion,	  caused	  a	  decrease	  in	  both	  the	  number	  of	  
cells	  and	  the	  number	  of	  inclusions.	  Fewer	  inclusion	  were	  lost	  in	  conditions	  treated	  with	  
both	  nigericin	  and	  blebbistatin	  than	  in	  conditions	  treated	  with	  nigericin	  alone	  (Figure	  
4.19).	  	  
Taken	  together	  these	  data	  indicate	  that	  a	  K+	  efflux	  induces	  bacterial	  release	  from	  cells.	  
In	   addition,	   inducing	   a	   rapid	   K+	   efflux	   from	   infected	   cells	   appears	   to	   increase	   the	  




The	   data	   presented	   in	   this	   chapter	   illustrate	   a	   novel	   K+	   cycle	   during	   chlamydial	  
development.	  Replicating	  Chlamydiae	   require	  K+,	  and	  starvation	  during	   the	  RB	  phase	  
of	  the	  infection	  cycle	  induces	  persistence	  (Chapter	  3).	  To	  further	  understand	  the	  role	  
that	  K+	  fulfils	  during	  the	  chlamydial	  infection	  cycle,	  time	  course	  experiments	  restricting	  
K+	   availability	   to	   bacteria	   at	   different	   phases	   of	   the	   infection	   cycle	  was	   undertaken.	  
Surprisingly,	   restricting	  K+	  at	   timepoints	  after	  RB-­‐EB	  differentiation	  had	  progressively	  
less	  of	   an	   impact	  on	  bacterial	   infectivity	   the	   later	   in	   the	   infection	   cycle	   the	  K+	  efflux	  
occurred	  (Figure	  4.1).	  Equivalent	  timecourse	  experiments	  inducing	  a	  K+	  efflux	  at	  similar	  
phases	   of	   the	   infection	   cycle	   (Table	   4.1)	   using	   other	   Chlamydiae-­‐host	   combinations	  
revealed	   that,	   irrespective	   of	   bacterial	   strain	   or	   host	   cell,	   a	   K+	   efflux	   once	   EBs	   are	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present	  in	  the	  inclusion	  has	  less	  of	  an	  impact	  on	  the	  infectivity	  of	  Chlamydiae	  (Figure	  
4.3).	  For	  all	  combinations	  assayed,	  the	  greater	  the	  number	  of	  EBs	  present	  at	  the	  time	  
of	  the	  induced	  K+	  efflux,	  the	  more	  infectivity	  was	  recovered	  at	  the	  end	  of	  the	  infection	  
cycle.	  This	  indicates	  that	  RBs	  and	  EBs	  have	  differing	  requirements	  for	  K+.	  	  
To	  observe	  K+	  during	  the	  C.trachomatis	  infection	  cycle,	  APG-­‐2	  a	  K+	  sensitive	  fluorescent	  
probe	   was	   used	   in	   live	   cells.	   HeLa	   cells	   contain	   diffuse	   cytosolic	   K+	   with	   a	   higher	  
concentration	  in	  the	  mitochondria	  (Figures	  4.4A	  and	  4.5A).	  At	  12hpi,	  RBs	  contained	  a	  
high	   concentration	   of	   APG-­‐2,	   which	   corresponds	   to	   a	   high	   K+	   concentration	   (Figure	  
4.5).	   Interestingly,	   as	   bacterial	   replication	  progresses,	   cytosolic	   and	  mitochondrial	   K+	  
concentrations	   decrease,	  which	   suggests	   that	   the	   bacteria	   are	   acquiring	   K+	  from	   the	  
host	   cell	   (Figure	   4.5).	   This	   was	   supported	   by	   FRAP	   analysis	   of	   the	   bacteria,	   which	  
showed	  that	  K+	  was	  continually	  acquired	  by	  RBs	  (Figure	  4.6).	  	  
Late	   in	   the	   infection	   cycle,	   once	   bacteria	   had	   differentiated	   into	   EBs	   (as	   shown	   in	  
section	  3.2,	  Figure	  3.2),	  bacteria	  exhibited	  significantly	  less	  APG-­‐2	  concentration,	  and	  
therefore	   potentially	   contained	   less	   K+	   (Figure	   4.5).	   This	   would	   suggest	   that	   the	   K+	  
accumulated	   during	   bacterial	   replication	   is	   lost	   at	   some	   point	   during	   the	   transition	  
from	   RB-­‐EB.	   This	   is	   consistent	   with	   the	   observations	   made	   by	   Chang	   and	   Moulder	  
(1978),	  which	  showed	  that	  there	  was	  a	  substantial	  decrease	  in	  total	  K+	  concentration	  
from	  HeLa	  cells	  with	  physiological	  titres	  of	  C.psittaci	  at	  48hpi.	  	  
These	   observations	   prompted	   live	   confocal	   microscopy	   of	   HeLa	   cells	   infected	   with	  
C.trachomatis	   LGV2	   during	   the	   period	   associated	   with	   RB-­‐EB	   differentiation	   (as	   per	  
Figure	  3.2),	  from	  30-­‐36hpi.	  These	  experiments	  showed	  a	  peak	  in	  K+	  concentration	  30h	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30m	  after	  infection	  (Figures	  4.7/4.14)	  followed	  by	  a	  striking	  loss	  of	  K+	  over	  a	  period	  of	  
60-­‐80	   minutes.	   When	   the	   K+	   concentration	   reached	   its	   lowest	   concentration,	  
approximately	  32hpi,	  inclusion	  size	  increased	  dramatically	  (Figure	  4.9,	  Supplementary	  
movie	   S1).	   This	   increase	   in	   the	   size	   of	   the	   inclusion	   coincides	   with	   the	   inclusion	  
membrane	   becoming	   permeable	   to	   mCherry,	   which	   is	   excluded	   from	   the	   inclusion	  
prior	  to	  this	  point	  (Figures	  4.11	  and	  4.14).	  Electron	  microscopy	  of	  C.trachomatis	  LGV2	  
infected	   HeLa	   cells	   32hpi	   revealed	   cells	   containing	   cytosolic	   bacteria	   (Figure	   4.15),	  
demonstrating	  that	  the	  inclusion	  membrane	  ruptures	  before	  the	  host	  cell	  membrane,	  
as	  briefly	  described	  by	  Hybiske	  and	  Stephens	  (2007).	  	  
Nigericin-­‐induced	  efflux	  of	  K+	  later	  in	  the	  infection	  cycle,	  at	  30hpi,	  was	  shown	  to	  induce	  
extrusion	   of	   inclusions	   in	   a	   large	   proportion	   of	   cells	   (Figure	   4.16).	   Interestingly,	  
nigericin	   induced	  K+	  efflux	   induces	  egress	  of	  Toxoplasma	  gondii	   from	  human	  foreskin	  
fibroblasts	  in	  a	  calcium	  dependent	  manner	  (Fruth	  and	  Arrizabalaga,	  2007).	  Unlike	  the	  
chlamydial	   extrusion	   mechanism	   described	   by	   Hybiske	   and	   Stephens	   (2007),	   the	  
inclusion	   did	   not	   appear	   to	   be	   extruded	   in	   its	   entirety,	   instead	   the	   bacteria	   were	  
released	   in	   bursts	   (Figure	   4.17,	   Supplementary	   movie	   S2).	   Inhibition	   of	   classical	  
myosin	   II-­‐dependent	   chlamydial	   extrusion	   mechanisms	   reduced	   bacterial	   extrusion	  
following	  K+	  ionophore	  treatment	  (Figure	  4.17).	  These	  observations	  suggest	  that	  rapid	  
K+	  efflux,	  such	  as	  the	  K+	  decrease	  following	   ionophore	  treatment,	   induces	  a	  myosin	   II	  
dependent	  extrusion	  mechanism.	  	  
Taken	   together,	   these	   data	   suggest	   that	   a	   chlamydial	   K+	   efflux	   at	   the	   end	   of	   the	  
infection	   cycle	   plays	   a	   role	   in	   bacterial	   exit	   from	   the	   host	   cell,	   with	   a	   rapid	   efflux	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inducing	  an	  egress	  type	  mechanism	  and	  a	  slower	  K+	   loss	  resulting	   in	   lysis	  of	  the	  host	  
cell.	   This	   efflux	   would	   appear	   to	   be	   the	   result	   of	   K+	   loss	   from	   bacteria	   during	   the	  
transition	   from	   RB	   back	   to	   EB,	   and	   could	   potentially	   provide	   the	  motivation	   for	   RB	  
scavenging	  of	  host	  K+	  during	  replication.	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The	   results	   described	   in	   this	   thesis	   present	   compelling	   evidence	   for	   a	   potassium	   ion	  
(K+)	   cycle	   throughout	   intracellular	   Chlamydiae	   development.	   During	   replication	   the	  
bacteria	  actively	  accumulate	  K+	  from	  the	  host,	  and	  in	  the	  majority	  of	  cells,	  this	  requires	  
the	   activation	  of	   glibenclamide-­‐sensitive	   inwardly	   rectifying	  potassium	   (Kir)	   channels.	  
At	   timepoints	   that	   correlate	  with	   RB-­‐EB	   differentiation	   K+	   is	   gradually	   lost	   from	   the	  
bacteria	   until	   a	   basal	   level	   is	   reached	   (Figure	   5.1A).	   This	   K+	   loss	   corresponds	   with	  
inclusion	   membrane	   permeabilisation	   and	   lysis,	   resulting	   in	   the	   release	   of	   bacteria	  
from	   the	   inclusion	   into	   the	   host	   cell	   cytosol,	   an	   event	   observed	  by	   live	   imaging	   and	  
electron	  microscopy	  of	  fixed	  cells.	  Rapidly	  depleting	  K+,	  using	  a	  specific	  K+	  ionophore	  at	  
late	  stages	  of	  the	  infection	  cycle	  induces	  myosin	  II-­‐dependent	  extrusion,	  implicating	  a	  
functional	  role	  for	  K+	  in	  release	  of	  pathogens	  from	  the	  infected	  cell	  (Figure	  5.1B).	  	  
These	  data	  raise	  a	  number	  of	   interesting	  questions	  about	  the	  methods	  involved	  in	  K+	  
acquisition,	   accumulation	   and	   storage,	   and	   the	   mechanisms	   by	   which	   the	   bacteria	  
utilise	  these	  ions	  to	  trigger	  their	  exit	  from	  the	  host	  cell.	  	  
K+	  uptake	  and	  loss	  by	  bacteria	  demonstrates	  a	  need	  for	  ion	  transport	  systems	  in	  both	  
the	   inclusion	  and	  bacterial	  membranes.	  Previous	   studies	  have	   identified	   three	  major	  
potassium	   specific	   transport	   systems	   in	   Gram-­‐negative	   bacteria;	   Trk,	   a	   rapid	   low	  
affinity	  transport	  system	  active	  at	  alkaline	  or	  neutral	  pH	  (Epstein,	  2003;	  Su	  et	  al.,	  2009;	  
Liu,	   2013);	   Kup,	  which	   has	   a	   similar	   K+	  affinity	   to	   the	   Trk	   system	  but	   is	   active	   under	  
acidic	  conditions	  (Trchounian	  and	  Kobayashi,	  1999;	  Epstein,	  2003;	  Liu,	  2013);	  and	  Kdp,	  
a	   highly	   specific	   system	   induced	   by	   low	   K+	  conditions	   (5mM	   or	   less)	   (Frymier	   et	   al.,	  
1997;	  Epstein,	  2003;	  Xue	  et	  al.,	  2011).	  Although	  no	  homologous	  systems	  have	  so	   far	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been	   identified	   among	   the	   hypotheticalChlamydiaceae,	   CT440	   has	   been	   shown	   to	  
localize	  to	  the	  C.trachomatis	  inclusion	  membrane	  from	  12hpi	  (Li	  et	  al.	  2008;	  2011)	  and	  
has	   predicted	   structure-­‐based	   homology	   to	   a	   neurotransmitter-­‐gated	   ion-­‐channel	  
transmembrane	  pore	  (Oliver,	  Nobeli,	  and	  Hayward;	  personal	  communication).	  	  
Following	   on	   from	   the	   observation	   that	   inhibiting	   the	   SUR	   domains	   of	   Kir	   channels	  
using	  glibenclamide	  induced	  AB	  development	  in	  host	  cells	  infected	  with	  C.trachomatis	  
at	   12hpi	   (Figure	   3.9),	   we	   sought	   to	   determine	   the	   location	   from	   which	   the	  
glibenclamide	   acts	   in	   infected	   cells.	   Experiments	   using	   fluorescently	   labelled	  bodipy-­‐
Texas	  red-­‐glibenclamide,	  revealed	  that	  the	  drug	  localises	  to	  the	  plasma	  membrane	  and	  
endoplasmic	  reticulum	  (ER)	  in	  infected	  HeLa	  cells,	  and	  was	  also	  dispersed	  throughout	  
the	   C.trachomatis	   LGV2	   inclusion	   24hpi	   (Figure	   5.2).	   This	   suggests	   that	   either	  
glibenclamide	  is	  retained	  within	  the	  inclusion,	  or	  glibenclamide-­‐sensitive	  channels	  exist	  
within	  the	  inclusion.	  This	  could	  have	  interesting	  implications	  when	  considered	  with	  the	  
observation	   by	   Dumoux	   et	   al	   (2012)	   that	   the	   rER	   is	   transiently	   recruited	   to	   the	  
chlamydial	   inclusion.	   ER	   is	   recruited	   during	   bacterial	   invasion,	   following	   which	  
Chlamydia-­‐ER	   interactions	   decrease	   until	   the	   bacteria	   have	   established	   an	   inclusion.	  
When	  HeLa	   cells	  were	   infected	  with	  C.trachomatis	  LGV2,	  proteins	   from	   the	  ER	  were	  
recruited	  to,	  and	  translocated	   into,	   the	  chlamydial	   inclusion	  at	  24hpi	   (Dumoux	  et	  al.,	  
2012),	  which	  coincides	  with	  the	  period	  of	  K+	  accumulation	  we	  have	  described	  (Figures	  
4.1	  and	  4.6).	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Figure	  5.1.	  Chlamydiae	  acquire	  K+	  from	  the	  host	  cell	  and	  via	  inwardly	  rectifying	  K+	  
channels	  (Kir)	  during	  replication,	  and	  nature	  of	  K+	  efflux	  at	  the	  end	  of	  the	  infection	  
cycle	  influences	  exit	  mechanism.	  Schematic	  representation	  of	  the	  proposed	  K+	  cycle	  
during	   intracellular	   Chlamydiae	   development.	   (A)	   Prior	   to	   infection	   epithelial	   cells	  
have	   high	   mitochondrial	   and	   cytosolic	   K+	   (green).	   Following	   EB-­‐RB	   differentiation	  
replicating	  bacteria	  acquire	  K+,	  scavenged	  from	  the	  host	  and	  requiring	  Kir	  activity.	  As	  
bacteria	  differentiate	  K+	  is	  lost	  from	  the	  inclusion.	  (B)	  The	  speed	  of	  K+	  exit	  influences	  
the	  method	   of	   bacterial	   exit	   from	   the	   host	   cell.	   Rapid	   K+	   efflux	   results	   in	  modular	  
egress	  of	  bacteria	  leaving	  the	  host	  cell	   intact.	  Gradual	  loss	  of	  K+	  results	  in	   inclusion	  
membrane	  permeabilisation	  followed	  by	  bacterial	  release	  via	  lysis.	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Identifying	  the	  function	  of	  K+	  during	  RB	  replication	  could	  further	  our	  understanding	  of	  
Chlamydiae-­‐host	   interactions.	   For	   example,	   previous	   studies	   have	   shown	   that	  
pathogens	  such	  as	  Pseudomonas	  aeruginosa	  and	  Salmonella	  typhimurium	   induce	  a	  K+	  
efflux	  from	  host	  cells	  to	  activate	  NLRC4	  (Lindestam-­‐Arlehamn	  et	  al.,	  2010)	  and	  NLRP3	  
(Franchi	   et	   al.,	   2007;	   Lindestam-­‐Arlehamn	   et	   al.,	   2010)	   inflammasome	   assemblies	  
respectively,	  and	  consequently	  induce	  caspase-­‐1	  production	  followed	  by	  IL-­‐1β	  and	  IL-­‐
18	  processing.	  Caspase-­‐1	  activation	  is	  increased	  during	  C.trachomatis	  infection	  (Abdul-­‐
Sater	   et	   al.,	   2009;	   2010a;	   2010b)	   specifically	   from	   36-­‐48hpi	   (Lu	   et	   al.,	   2000),	   which	  
coincides	  with	  our	  observations	   that	  K+	   is	  accumulated	  prior	   to	  RB-­‐EB	  differentiation	  
but	   lost	   from	  32hpi	   onwards	   (Figures	   4.6	   and	  4.7).	   This	   could	   indicate	   that	   bacteria	  
scavenge	  K+	  from	  the	  host	  in	  order	  to	  control	  inflammasome	  activation,	  or	  even	  evade	  
detection	  by	  the	  host.	  We	  have	  observed	  that	  caspase-­‐1	  is	  enriched	  within	  inclusions	  
containing	   ionophore-­‐induced	   ABs	   (Figure	   5.3),	   suggesting	   that	   inducing	   a	   K+	   efflux	  
during	   RB	   replication	   impacts	   the	   inflammatory	   response	   to	   bacteria.	   We	   have	  
demonstrated	   that	  K+	   is	   lost	   from	  bacteria	   towards	   the	  end	  of	   the	   infection	   cycle	   in	  
HeLa	   cells	   (Figure	   4.7),	   and	   that	   an	   ionophore-­‐induced	   K+	   efflux	   at	   30hpi	   causes	  
extrusion	  of	  bacteria	  (Figures	  4.16	  and	  4.17),	  which	  could	  potentially	  implicate	  a	  role	  
for	   either	   caspase-­‐1	   or	   downstream	  processes	   in	   the	   final	   stages	   of	   the	   intracellular	  
chlamydial	   infection	   cycle.	   These	   observations	  warrant	   further	   investigation	   into	   the	  
direct	  effects	  of	  K+	  efflux	  on	   inflammasome	  activity	  and	   the	   importance	  of	   cytokines	  
during	  the	  final	  stages	  of	  the	  chlamydial	  infection	  cycle.	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Figure	   5.2.	   Fluorescently	   labelled	   glibenclamide	   can	   be	   seen	   within	   chlamydial	  
inclusions.	  Live	  confocal	  xy-­‐sections	  of	  HeLa	  cells	  (control)	  or	  HeLa	  cells	  infected	  with	  
C.trachomatis	   LGV2	   (MOI=1)	   (C.trachomatis)	   were	   labelled	   at	   24hpi	   with	   BODIPY	  
TexasRed	  Glibenclamide.	  N	   indicates	  nucleus,	   I	   indicates	   inclusion,	  and	  white	  arrow	  
indicated	  labelling	  within	  the	  chlamydial	  inclusion.	  Scale	  bars,	  10µm.	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RBs	  may	  have	  a	  nutritional	  need	  for	  K+	  during	  replication.	  One	  interesting	  observation	  
during	  this	  project	  was	  that	  even	  slight	  fluctuations	  in	  K+	  concentration,	  such	  as	  those	  
caused	  by	  monensin	  treatment	  (Figures	  3.4-­‐3.6)	  were	  sufficient	  to	  induce	  persistence.	  
This	  suggests	  that	  K+	  concentrations	  must	  be	  very	  carefully	  controlled	  by	  the	  bacteria	  
to	  allow	  the	  infection	  cycle	  to	  occur.	  These	  observations	  further	  reinforce	  the	  essential	  
role	  of	  K+	  during	  chlamydial	  development.	  
The	  involvement	  of	  K+	  efflux	  in	  bacterial	  release	  from	  the	  host	  cell	  (Figure	  4.13)	  could	  
indicate	   that	   the	  bacteria	  accumulate	  K+	  during	   replication	   to	   facilitate	  exit	   from	  the	  
inclusion,	   either	   via	   lysis	   or	   extrusion.	   The	   efflux	   appears	   to	   occur	   as	   bacteria	  
differentiate	   from	   RBs	   to	   EBs	   (Figure	   4.4),	   however	   we	   currently	   have	   no	   direct	  
evidence	   that	   this	   is	   the	   case.	   It	   would	   be	   useful	   to	   ascertain	   where	   in	   the	   RB-­‐EB	  
transition,	   and	   indeed	  how,	   K+	   is	   lost	   from	   the	  bacteria.	   For	   example,	   K+	   loss	   during	  
bacterial	   reorganisation	   could	   simply	   be	   the	   result	   of	   reduced	   bacterial	   membrane	  
integrity,	   equally,	   accumulated	   K+	   could	   be	   released	   by	   the	   bacteria	   as	   a	   signal	   or	  
trigger	  to	   induce	  the	  RB-­‐EB	  transition.	  Determining	  the	  specific	  role	  of	  K+,	  as	  a	  signal	  
for,	  or	  a	  co-­‐factor	  in,	  bacterial	  reorganisation	  would	  enhance	  our	  understanding	  of	  the	  
mechanisms	  involved	  in	  RB-­‐EB	  redifferentiation.	  	  
Interestingly,	  in	  each	  experiment	  where	  K+	  concentrations	  were	  monitored	  in	  live	  cells	  
we	  observed	  an	  increase	  in	  K+	  concentrations	  after	  the	  inclusion	  membrane	  ruptured	  
(Figures	   4.7	   and	   4.14).	   This	   could	   suggest	   that	   the	   bacteria	   utilise	   a	   similar	   K+-­‐
dependent	   mechanism	   to	   lyse	   the	   host	   cell	   membrane	   as	   was	   used	   to	   lyse	   the	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inclusion	  membrane.	  Further	  investigation	  of	  these	  events	  could	  help	  determine	  how	  
bacteria	  are	  released	  at	  the	  end	  of	  the	  infection	  cycle.	  
Blebbistatin	   inhibition	   of	   nigericin-­‐induced	   chlamydial	   extrusion	   (Figure	   4.17)	   would	  
indicate	  a	  myosin	  II	  dependent	  mechanism.	  Extrusion	  has	  previously	  been	  observed	  to	  
require	   actin	   rearrangement	   in	   cells	   infected	   with	   C.trachomatis	   (Hybiske	   and	  
Stephens,	  2007;	  Lutter,	  2013),	   therefore	  observing	  changes	  to	  the	  actin	  cytoskeleton	  
following	   nigericin-­‐induced	   K+	   efflux	   could	   further	   our	   understanding	   of	   the	  
mechanisms	  of	  bacterial	  extrusion.	  	  
We	  have	  also	  shown	  that	  an	  induced	  K+	  efflux	  at	  the	  beginning	  of	  the	  infection	  cycle,	  
1hpi,	  disrupts	  inclusion	  biogenesis	  (Figure	  4.2).	  Bacteria	  remain	  intracellular	  following	  
nigericin-­‐induced	  K+	  efflux,	  however	  it	  is	  unclear	  whether	  the	  bacteria	  are	  contained	  in	  
entry	   vesicles	   or	   have	  become	   cytosolic	   (Figure	   4.2B).	   There	   also	   appears	   to	  be	   less	  
replication	  following	  a	  K+	  efflux	  early	  in	  the	  infection	  cycle.	  This	  could	  indicate	  that	  K+	  
gradients	   are	   important	   during	   the	   initial	   stages	   of	  C.trachomatis	   infection,	   or	   even	  
during	  EB-­‐RB	  differentiation.	  Indeed,	  it	  has	  been	  hypothesised	  that	  one	  of	  the	  primary	  
functions	   of	   the	   chlamydial	   biphasic	   development	   cycle	   is	   to	   enable	   the	   bacteria	   to	  
adapt	   to	  differing	  environmental	  conditions	   from	  the	  extracellular	  milieu	   to	   the	  host	  
cell	  cytosol	  (Liu	  et	  al.,	  2010).	  Further	  investigation	  into	  the	  role	  of	  K+	  at	  the	  beginning	  
of	   the	   infection	   cycle	   could	   provide	   insight	   into	   inclusion	   biogenesis	   and	   bacterial	  
adaptation	  to	  the	  intracellular	  environment.	  
	  	   238	   	  










Figure	   5.3.	   Caspase-­‐1	   is	   enriched	   within	   nigericin-­‐induced	   persistent	   inclusions.	  
Confocal	  xy-­‐sections	  of	  HeLa	  cells	  infected	  with	  C.trachomatis	  LGV2	  (MOI=1),	  either	  
untreated	  (control)	  or	  treated	  at	  12hpi	  with	  1µm	  nigericin,	  and	  fixed	  at	  24hpi.	  Cells	  
were	   then	   labelled	   using	   DRAQ-­‐5	   DNA	   stain	   (magenta)	   and	   anti-­‐caspase-­‐1	   primary	  
antibody	   followed	  by	  AlexaFluor®488	  conjugated	   secondary	  antibody	   (green).	   Scale	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The	   data	   presented	   in	   this	   thesis	   show	   that	   Chlamydiae	   require	   K+	   for	   successful	  
replication,	  and	  demonstrate	  a	  novel	   role	   for	  K+	  during	  bacterial	  exit	   from	  host	  cells,	  
suggesting	   that	   the	   rate	   of	   K+	   loss	   from	   bacteria	   influences	   the	   mode	   of	   bacterial	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Appendix	  1	  –	  Primer	  sequences	  
	  
	  
Sequence	   Amplicon	  size	  
Mycoplasma	   Forward	   5'-­‐ACTCCTACGGGAGGCAGCAGTA	  
712bp	  
Mycoplasma	   Reverse	   5'-­‐TGCACCATCTGTCACTCTGTTAACCTC	  
Eukaryotic	  18S	   Forward	   5'-­‐ATGGCCGTTCTTAGTTGGTG	  
217bp	  
Eukaryotic	  18S	   Reverse	   5'-­‐CGCTGAGCCAGTCAGTGTAG	  
C.trachomatis	  
16S	   Forward	   5'-­‐CGCCTGAGGAGTACACTCGC	   207bp	  C.trachomatis	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Appendix	  2	  –	  Ionophore	  structures	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Appendix	  3	  –	  Plasmids	  
	  
	  Plasmid	   Product	   Size	   Bacterial	  Resistance	  
pEGFP-­‐C2	   GFP-­‐X	   4735bp	   kanamycin	  
pCherry-­‐C3	   Cherry-­‐X	   711bp	   kanamycin	  
	  
Appendix	  4	  –	  ImageJ	  fluorescent	  image	  series	  mean	  pixel	  intensity	  macro	  
	  
ListeImages=newArray(nImages);	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Appendix	  5	  –	  FRAP	  wizard	  settings	  
	  
	  	   number	  of	  frames	  
interval	  
(seconds)	  
pre-­‐bleach	   3	   7.8*	  
bleach	   2	   7.8*	  
post-­‐bleach	  1	   10	   7.8*	  
post-­‐bleach	  2	   20	   20	  
*	  indicates	  minimised	  interval	  between	  frames	  
	  




5	   6	   7	   8	   9	   10	  
5	   2	   3	   5	   6	   7	   9	  
6	   3	   5	   6	   8	   10	   11	  
7	   6	   6	   8	   10	   12	   14	  
8	   6	   8	   10	   13	   15	   17	  
9	   7	   10	   12	   15	   17	   20	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